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II. Abstract 
African horse sickness virus (AHSV, genus Orbivirus, family Reoviridae) 
possesses a genome of 10 double-stranded RNA segments, causes the often fatal equine 
disease African horse sickness (AHS) and is transmitted by haematophagous Culicoides 
midges. AHSV segment 10 codes for the nonstructural membrane proteins NS3 and 
NS3a. NS3 has been implicated in the process of virus release from infected cells. Its 
isolates show sequence variation of up to 36% and cluster into three distinct groups, 
while the homologous NS3 of the Orbivirus type species bluetongue virus varies by 
only 7%. Reassortant viruses, differing only in genome segment 10, were used in this 
work to show that variation in this segment can affect virus dissemination within the 
midgut and from the midgut into the haemocoel of C. sonorensis. This demonstrates an 
effect of variation in AHSV NS3 on model vector competence. The significance of this 
result is underlined by the effect of variation in AHSV segment 10 on oral infection 
rates in the field vector C. imicola. Wild-caught C. imicola and C. bolitinos were also 
shown to become infected with heavily attenuated AHSV strains. This indicates that the 
use of live attenuated AHSV vaccines may contribute to virus spread, reassortment and 
reversion to virulence. The results of vector competence studies with two C. sonorensis 
colonies, which had previously been selected for or against vector competence for 
AHSV, show that the midgut infection barrier of the insect is defined by both the insect 
and the virus. Conversely, virus ability to overcome the midgut escape barrier was 
mainly virus-defined and did not depend on insect genotype. A technique was 
developed for identifying infected insect midguts by immunofluorescent microscopy. 
This was applied to show that C. sonorensis (of low oral susceptibility) replicate AHSV 
in their midgut when infected from the abluminal side, while midgut cells of the non- 
vector C. nubeculosus appeared to be unable to replicate the virus. Variation in genome 
segment 10 affected virus dissemination within the midgut of the vector-competent 
colony of C. sonorensis only. It is concluded that vector competence may depend on 
insect interaction with NS3/3a. This could be exploited to identify the genetically 
determined difference between vector-competent and non-competent colonies and 
appropriate experiments are suggested. Sequencing of genome segment 10 of the two 
reassortant viruses identified differences in predicted NS3 membrane configurations and 
variation in their potential membrane anchoring motifs. These differences could affect 
insect vector competence and suitable future experiments are suggested. 
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1 Introduction 
1.1 African horse sickness - the disease 
African horse sickness (AHS) is an infectious, non-contagious disease of equids. 
It is caused by African horse sickness virus (AHSV), a ten-segmented, double-stranded 
RNA virus of the genus Orbivirus, family Reoviridae. Nine serotypes of AHSV have 
been defined to date. Equids are the principal vertebrate host of the virus, which is 
transmitted solely by the bite of its blood-feeding arthropod vectors (Wetzel et al., 1970; 
Meiswinkel, 1998). The lack of horizontal and vertical transmission in the mammalian 
hosts restricts the disease to areas where suitable vector species are present and to 
seasons which allow vector activity (Mellor, 1993). AHS was first described after the 
introduction of domestic horses into sub-Saharan Africa, probably as early as 1569 in 
East Africa (Barnard, 1998). It causes seasonal epidemics of high morbidity and 
mortality in susceptible horses. 
1.1.1 Geographical distribution and at-risk areas 
Endemic areas and recent epidemics of African horse sickness 
AHSV is endemic in sub-Saharan Africa and the Sahara desert is thought to be 
an effective barrier, preventing it establishing itself outside this region (Mellor, 1994). 
All nine AHSV serotypes are present in the southern part of the continent, where 
AHSV-9 is considered to be less virulent than the other eight serotypes (Coetzer & 
Erasmus, 1994; Lord et al., 1998). However, only AHSV-9 has repeatedly been isolated 
in western Africa and has caused severe outbreaks in this region (Parker et al., 1977). 
Until the late 1980s it was also the only serotype to be repeatedly identified outside its 
traditional territory (Mellor et al., 1990b), causing outbreaks on the Arabian Peninsula 
(1959/60,1989), the Middle East and India (1959/60) and North Africa (1965/66) 
(Rafyi, 1961; Diaz Montilla & Panos Marti, 1968; Coetzer & Erasmus, 1994). In 1966, 
the North African outbreak spread into Spain but it was eradicated in the same year 
(Diaz Montilla & Panos Marti, 1968). In 1987, another outbreak occurred in Spain, 
apparently following the importation of infected zebra from Namibia (Lubroth, 1988). 
The disease, caused by AHSV-4, quickly spread into Morocco and Portugal and 
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recurred every autumn until it was finally eradicated from this region in 1991 (Mellor et 
al., 1990a; Rodriguez et al., 1992). 
Figure 1-1: Distribution of C. sonorensis and related Culicoides species in North 
America. 
(Wirth & Morris, 1984) 
Areas at risk of AHSV 
Culicoides imicola, an Afro-Asian crepuscular and nocturnal, haematophagous 
biting midge, is the main field vector of AHSV and is present in all countries where 
outbreaks have occurred. Its vector competence for orbiviruses in general is underlined 
by its presence and the transmission of the closely related bluetongue virus (BTV) in an 
area reaching from Cape Verde in the west to Laos in the east (Mellor & Boorman, 
1995). BTV is endemic in most parts of the world between latitudes 35°S and 40°N, 
although in many areas, other vector species are involved (Mellor & Boorman, 1995). 
All these areas, including parts of the Americas, Southeast Asia and North Australia, 
must therefore be considered at risk of AHSV becoming endemic should the virus be 
introduced (Mellor & Boorman, 1995). On the North American continent, for example, 
the transmission of BTV by C. sonorensis (see Arthropod Vectors, below) indicates that 
large parts of the continent could also be at risk of AHS should AHSV be introduced. 
13 
This species has been shown to be a highly efficient laboratory vector of AHSV 
(Boorman et al., 1975; Wellby et al., 1996). Figure 1-1 (page 13) shows the distribution 
of C. sonorensis and related Culicoides species in North America. 
In the northern hemisphere, the distribution of C. imicola stretches further north 
than the regions where BTV is endemic. The presence of the vector means that these 
regions should also be considered at risk of AHSV. Figure 1-2 shows where the insect 
has been found in Europe. 
Figure 1-2: Distribution of C. imicola in Europe 
Provided by Dr. E. Wittmann (2001) 
In many areas, outbreaks of AHS are curtailed by the onset of winter. However, 
AHSV can establish itself for longer periods in zones with a climate that is warm 
enough to allow overwintering of adult insects. It could also persist in a colder climate 
if the cold periods are shorter than the maximum viraemic periods of the local vertebrate 
hosts, i. e. 40 days in the case of zebra, 18 days in the case of horses (Mellor & 
Boorman, 1995). In contrast, the recent AHS outbreak in the Iberian peninsula showed 
"silent" periods of 8-12 months, in which time a very low level of vector activity was 
recorded (Mellor, 1994). Similarly, the disease-free intervals of recent bluetongue (BT) 
outbreaks in Turkey (1977-1981) and Corsica/Sardinia (2000-2001) lasted for 8-9 
months (Yonguc et al., 1982, C. Hamblin, personal communication). These silent 
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periods considerably exceed the maximum reported viraemic periods of 50 days in 
sheep and 100 days in cattle (Sellers & Taylor, 1980; MacLachlan et al., 1991; 
Koumbati et al., 1998) and it is unclear how the virus survived the disease-free periods. 
However, an alternative overwintering mechanism has been proposed (H. Takamatsu et 
al., manuscript in preparation): Ovine y8 T -cells have been shown to become 
persistently infected by BTV. These cells are actively involved in the inflammatory 
response and therefore migrate to insect biting sites in the skin. It has been shown that 
contact with skin fibroblasts can transform the persistent infection of 78 T -cells to a lytic 
infection. Such an infection could result in further replication and release of BTV in the 
skin areas that are exposed to insect bites and could lead to the infection of Culicoides 
vectors long after detectable viraemia itself has ceased. 
The risk of AHSV establishing itself in Europe was dramatically emphasised by 
the annual recurrence of the disease in Spain for four years (1987-1990) before it was 
finally eradicated through a vigorous and costly campaign of vaccination and slaughter 
(Rodriguez et al., 1992). The recurring and (for some regions) unprecedented BT 
outbreaks in southern Europe 1998 onwards (Greece, Bulgaria, Sicily, Sardinia, 
mainland Italy, Corsica and Balearic Isles) have similar implications. C. imicola has 
been found in all BT affected regions of Europe except Bulgaria, where C. obsoletus is 
the dominant species (Dr. P. Mellor, personal communication). It has been suggested 
that due to climate change, the range of C. imicola in Europe has been extending 
northward (Rawlings & Mellor, 1994; Rawlings et al., 1998), taking the risk of AHSV 
and BTV infection with it. Northward spread of C. imicola carries the added danger of 
exposing other Culicoides species, such as the palaearctic C. obsoletus (see section 
1.1.2 below) to the virus, which, if vector-competent, could spread the disease over 
much of central and northern Europe. Furthermore, a much warmer European climate, 
as has been predicted by some models, could create novel vector species through the 
mechanism detailed in section 1.3.4 (page 37). 
1.1.2 Hosts and vectors 
Mammalian hosts 
In southern and eastern Africa, the main if not the only mammalian reservoir 
hosts of AHSV are zebra species: Equus burchelli and E. zebra in the southern parts, E. 
15 
grevyi and E. burchelli in the eastern parts of the continent (Barnard, 1998). This is 
considered to be so because in these areas AHSV only seems to be continually present 
where there are large populations of zebra. Zebras, donkeys, mules and horses can be 
viraemic and therefore are likely to be infective to blood-feeding arthropods for variable 
periods after infection, up to 40 days in zebras (Barnard et al., 1994; Mellor & 
Boorman, 1995; Hamblin et al., 1998). Furthermore, vaccinated horses may be resistant 
to disease but not necessarily to infection and might therefore become silent carriers of 
the virus rather like zebra and other non-horse equids (Rodriguez et al., 1992). The 
epidemiology of the disease appears to be different in western Africa since zebra are 
absent from this region. However, the virus is still endemic in many parts and the 
question of the mammalian reservoir is unresolved. It is also interesting to note that of 
the nine serotypes of AHSV only serotype 9 seems to be able to survive (in west Africa) 
in the absence of zebra populations. Likely alternative reservoir hosts include the 
African donkey, the European donkey and mules (Hamblin et al., 1998). 
Dogs have been shown to become infected and die after the ingestion of AHSV- 
infected horseflesh (van Rensburg et al., 1981). However, they are considered to be a 
dead-end host and of little epidemiological significance since Culicoides do not readily 
feed on them and most authorities consider the induced viraemia to be low level and 
transient (Braverman & Chizov-Ginzburg, 1996). 
Camels, elephants and several ruminant species (cattle, goats, sheep and buffalo) 
have been reported to produce antibodies against AHSV, but it is not clear whether this 
seroconversion is due to virus replication or to continuous exposure to antigen because 
of repeated blood-feeding of AHSV infected arthropods (Awad et al., 1981a; Barnard et 
al., 1995). Likewise, it is unclear whether seroconversion in a range of African 
carnivores (lions, cheetahs, jackals, hyenas and the African wild dog: Lycaon pictus) is 
associated with virus replication (Alexander et al., 1995). There is little evidence that 
any of these species are of epidemiological significance, although it has been suggested 
that the camel could successfully replicate the virus (Awad et al., 1981b). The virus has 
also been isolated from the camel tick (see Arthropod vectors, below), which suggests 
that a separate camel-tick cycle might exist and could have caused the repeated spread 
of AHSV-9 across the Sahara desert (see section 1.1.1, page 12). It also begs the 
question whether serotype 9 is better adapted to camels and/or ticks than the other 
serotypes. 
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Arthropod vectors 
Six species of Culicoides, three mosquito species and two tick species have been 
associated with AHSV (Mellor & Boorman, 1995; Wittmann, 2000): 
" C. imicola and its sibling species C. bolitinos have been implicated in outbreaks of 
AHSV (Mellor, 1990; Baylis et al., 1997; Meiswinkel, 1998; Meiswinkel & 
Paweska, 1999). Both can be orally infected in the laboratory (Venter et al., 2000), 
see also chapter 5 (page 107). There is overwhelming evidence that C. imicola is the 
main field vector of AHSV (Mellor & Boorman, 1995). For a more detailed 
discussion of the role of these insect species in AHSV transmission see section 1.3 
(page 35). Figure 1-2 shows the distribution of C. imicola in Europe (page 14). 
" AHSV was isolated from mixed pools of non-engorged C. obsoletus and C. 
pulicaris during the recent outbreak in Spain (Mellor et al., 1990a). C. obsoletus 
has also been associated with BTV (Mellor & Pitzolis, 1979). 
" C. sonorensis (= C. variipennis sonorensis) is the North American field vector of 
BTV (Foster et al., 1968; Jones et al., 1981) and has been shown to replicate and 
transmit AHSV following oral infection in the laboratory (Boorman et al., 1975; 
Wellby et al., 1996). 
9 C. nubeculosus is traditionally considered to be a non-vector species for AHSV and 
BTV but an increase in larval rearing temperatures has been found to enhance its 
vector competence for these viruses dramatically (Wellby et al., 1996; Wittmann, 
2000; see section 1.3.4, page 37). 
" The mosquito species Anopheles stephensi, Culex pipiens and Aedes aegypti have 
all been shown to transmit AHSV in the laboratory but have never been linked to an 
outbreak of the disease (Ozawa & Nakata, 1965; Ozawa et al., 1966). 
" The camel tick Hyalomma dromedarii and the brown dog tick Rhipicephalus 
sanguineus sanguineus have both been shown to transmit AHSV to susceptible 
horses (Awad et al., 1981b; Dardiri & Salama, 1988). Transstadial transmission 
from larvae to nymphs and from nymphs to adults was shown for both species, but 
no transovarial transmission was recorded. The epidemiological significance of ticks 
remains unclear. 
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1.1.3 Pathogenesis and clinical signs 
Virus is released into the bloodstream of the mammalian host during blood- 
feeding by an infected arthropod vector. Susceptible horses fall ill after a typical 
incubation period of two to nine days (Coetzer & Erasmus, 1994). One of the main 
target tissues of the virus is the endothelium of the host's blood vessels, which may be 
severely damaged resulting in excessive loss of vascular fluid into perivascular spaces 
(Coetzer & Erasmus, 1994). Other tissues can be affected to various degrees, and four 
clinical patterns have been recognised (Coetzer & Erasmus, 1994). All of them usually 
are accompanied by a high fever of 40-41°C: 
1. Pulmonary AHS (peracute and acute form), featuring rapid development of 
pulmonary oedema, accompanied by exudation of large amounts of frothy 
discharge from the nostrils. Death can occur just hours after onset of 
clinical signs. This form of AHS is common in fully susceptible horses and 
in dogs. The mortality rate can exceed 90%. 
2. Cardiac AHS (subacute form), characterised by severe endocarditis leading 
to oedema starting at the temporal fossae, eyelids and lips, and later 
involving the whole head and neck region. The mortality rate can approach 
50%. 
3. An intermediate, usually acute form, with signs of both pulmonary and 
cardiac AHS and a mortality rate up to 80%. 
4. Horse sickness fever, often clinically inapparent, affecting partially immune 
horses, but also mules, donkeys and zebra. It also occurs as a reaction to 
vaccination of horses. There is no mortality. 
1.1.4 Control 
In endemic areas, control of AHS is achieved by vaccination. In areas where all 
nine serotypes circulate (e. g. South Africa), live polyvalent attenuated vaccines are 
used. The most widely used vaccines are two quadrivalent vaccines, containing 
attenuated serotypes 1,3,4,5 and 2,6,7,8, respectively. Type 9 vaccine is not used 
since type 6 is cross-protective. Since active immunisation does not afford 100% 
protection against infection or disease, stabling from before dusk until after dawn is also 
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practised, often in combination with insect-proofing of stables and use of insect 
repellents. 
In areas where AHSV is not endemic, the emphasis is on maintaining or 
regaining the disease-free status. In the event of an outbreak, the measures that were 
taken in the Spanish 1987-1990 outbreak (Rodriguez et al., 1992) are likely to be 
followed and would therefore start with an immediate ban on the movement of all 
equids. Stabling and insect control measures can be combined with the use of ring- 
vaccination and the slaughter or isolation of diseased animals. Ideally, the serotype 
responsible should be identified as quickly as possible and an appropriate monovalent 
vaccine produced and used. Traditionally, live poly- and monovalent vaccines have been 
in use. However, due to the possibility of these viruses replicating and being spread by 
insect vectors (see also chapter 5, page 107) and the added danger of vaccine viruses 
reverting to virulence and/or reassorting in the case of polyvalent vaccines, there has 
been a recent drive towards the use of non-replicative vaccines. Part of this work is to 
assess the risk of attenuated AHSV strains being transmitted by field vectors. 
1.2 African horse sickness virus 
1.2.1 Classification 
The family Reoviridae 
African horse sickness virus is one of 20 virus species within the genus 
Orbivirus, family Reoviridae (Table 1-1). The nine confirmed genera in this family 
comprise at least 73 non-enveloped species, including five that have not been assigned 
yet (Mertens et al., 2000; Dr. P. Mertens, personal communication). The unifying 
features of the family are a similar structure of the genome, consisting of 10-12 dsRNA 
segments, and a common replication strategy (Joklik, 1983; Calisher & Mertens, 1998). 
All family members possess an icosahedral capsid of 70-85 nm diameter that is 
composed of up to three protein layers. The primary determinant of virus species within 
the family is an ability to exchange genetic material, i. e. genome segments, during co- 
infection of the cell. This process, known as reassortment, has been found to correlate 
well with the more traditional, serology-based methods of species determination and 
genomic analysis (Mertens et al., 2000). As more information becomes available on less 
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extensively studied family members, proof of reassortment may supplement other 
methods of species definition. 
Table 1-1: Genera in the family Reoviridae 
(Calisher & Mertens, 1998; updated with data from Dr. P. Mertens, personal communication) 
Genus 
Orthoreovirus 
Orbivirus 
Cypovirus 
Aquareovirus 
Rotavirus 
Coltivirus * 
Seadornovirus (proposed)* 
Fijivirus 
Phytoreovirus 
Oryzavirus 
Entomoreovirus (proposed) 
Unassigned viruses 
Total 73 28 
* Based on sequence comparisons, it has been proposed that the genus Coltivirus should be split into 
two genera, Coltivirus and Seadornavirus (a new genus). 
The virus core contains one copy of each of the genome segments. RNA 
segments have a type one cap structure at the 5' terminus of the positive RNA strand 
and are phosphorylated at the 5' terminus of the negative strand, but they are not 
polyadenylated at the 3' end (Chow & Shatkin, 1975; Shatkin & Kozak, 1983). The 
virus core also contains the virus-encoded RNA polymerase, a helicase and capping and 
methylation enzymes (Joklik, 1983). 
The genus Orbivirus 
The genus Orbivirus was originally proposed to accommodate a group of 
arboviruses which shared several characteristics (Borden et al., 1971; Murphy et al., 
No. of genome No. of species Unassigned viruses segments (serotypes) 
10 
10 
10 
11 
11 
12 
12 
10 
12 
10 
10 
11 or 12 
4 (7) 
20 (154) 
14 (14) 
6 (22) 
5 (5) 
2 (5) 
2 (5) 
5 (8) 
3 (6) 
2 (2) 
5 (8) 
5 
3 
11 
2 and > 160 
uncharacterised 
5 
4 
4 
1 
20 
1971). One of these characteristics, high resistance to detergents, suggested the absence 
of a lipoprotein envelope, setting this group apart from other arboviruses (Borden et al., 
1971). Although orbiviruses do share a number of features with orthoreoviruses, such as 
resistance to organic solvents and a ten-segmented dsRNA genome (Verwoerd, 1969; 
Verwoerd, 1970), they were also found to differ in their ecology (obligate arthropod 
transmission) and their acid lability (Owen, 1964; Stanley, 1967). The creation of a new 
genus for the orbiviruses was further justified by the discovery that they possess an 
icosahedral core particle with a T=13 (1) surface arrangement (Hewat et al., 1992). 
Rotaviruses possess a very similar inner capsid layer but they are not arthropod-borne 
viruses. 
Table 1-2: Virus species in the genus Orbivirus 
(using data from Mertens et al., 2000) 
Virus Serogroup (Species) I Serotypes Host Species Principal vector 
1-African horse sickness virus 
species (AHSV) 
2-bluetongue virus species 
(BTV) 
3-Changuinola virus species 
(CGLV) 
4-Chenuda virus species 
1 
(CNUV) 
5-Chobar Gorge virus species 
2 
(CGV) 
6-Corriparta virus species 
(CORV) 
7-Epizootic haemorrhagic 
disease virus species (EHDV) 
8-Equine encephalosis virus 
species (EEV) 
9-Eubenangee virus species 
(EUBV) 
I0-Ieri virus species 
3 (IERN) 
11-Great Island virus species 
1' 4 
(GIV) 
AHSV-1 to 9 Equids, dogs, elephants, camels, 
cattle, sheep, goats, predatory 
carnivores and in special 
circumstances humans 
BTV-1 to 24 Cattle, sheep, goats, camels. 
Elephants, (domestic and wild 
ruminants), predatory carnivores. 
Twelve "named" Humans, rodents, sloths. 
serotypes 
Seven "named" serotypes Seabirds 
Two "named" serotypes Bats 
Three "named" serotypes Humans, rodents. 
EHDV-1 to 8 
EEV 1 to 7* 
Cattle, sheep, deer, camels, llamas, 
wild ruminants, marsupials. 
Equids 
Four "named" serotypes 
Three "named" serotypes 
Thirty six "named" 
serotypes 
Unknown 
(isolated from insect vectors) 
Birds 
Seabirds, rodents, humans 
Culicoides 
Culicoides 
Phlebotomine flies, 
mosquitoes 
Ticks: Ornithodoros; 
Argas 
Ticks: Ornithodoros 
Culicine mosquitoes 
Culicoides 
Culicoides 
Culicoides and 
Anopheline, Culicine 
mosquitoes. 
Culex mosquitoes 
Ticks: Argas, 
Ornithodoros, Ixodes. 
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Virus Serogroup (Species) Serotypes Host Species Principal vector 
12-Lebombo virus species Single serotype (LEBV- Humans, rodents. Culicine mosquitoes. 
(LEBV) 1) 
13-Orungo virus species ORUV-1 to 4 Humans, camels, cattle, goats, Culicine mosquitoes. 
(ORUV) sheep, monkeys 
14-Palyam virus species (PALV) Eleven "named" Cattle, sheep Culicoides and Culicine 
serotypes mosquitoes 
15-St Croix River Virus (SCRV) SCRV-1 unknown hosts ticks 
16-Umatilla virus species Four "named" serotypes Birds Culicine mosquitoes 
(UMAV) 
17-Wad Medani virus species 
1 Two "named" serotypes Domestic animals Ticks: Boophilus, 
(WMV) Rhipicephalus, 
Hyalomma, Argas. 
18-Wallal virus species (WALV) Two "named" serotypes Marsupials Culicoides. 
19-Warrego virus species Two "named" serotypes Marsupials Culicoides and 
(WARV) Anopheline, Culicine 
mosquitoes 
20-Wongorr virus species 
1 Eight "named" or Cattle, macropods Culicoides and 
(WGRV) "numbered" serotypes mosquitoes 
Tentative species and unassigned viruses within the genus 
Andasibe virus (ANDV) unknown hosts mosquitoes 
Ife virus (IFEV) rodents, birds, ruminants mosquitoes 
Itupiranga virus (ITUV) unknown hosts mosquitoes 
Japanaut virus (JAPV) unknown hosts mosquitoes 
Kammavanpettai virus (KMPV) birds unknown 
Lake Clarendon virus (LCV) birds ticks 
Matucare virus (MATV) unknown hosts ticks 
Tembe virus (TMEV) unknown hosts mosquitoes 
Codajas virus rodents mosquitoes 
Tracambe Virus unknown hosts mosquitoes 
Peruvian horse virus Culicoides horses 
Peruvian Rodent virus (PC21) unknown hosts rodents 
Total 162 
1- The 36 virus isolates, currently grouped within the Great Island virus species, as well as the 8 virus isolates in the Wongorr 
virus species have not been extensively compared in serum neutralisation assays. However, preliminary serological studies of 
the GIV species indicate that they may represent different serotypes. 
2- Chobar Gorge and Fomede are related but distinct as analysed by complement fixation tests. These viruses form the Chobar 
Gorge virus serogroup (species). 
3- leri, Arkonam and Gomoka are closely related viruses and form the Ieri virus serogroup (species). 
4- The newly recognised Great Island virus species contains virus isolates previously classified in the Kemerovo virus and Great 
Island virus complexes of the Kemerovo serogroup. 
*- The precise assignment of the serotype numbers to the previously "named" serotypes was proposed by Howell et al. (2002). 
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1.2.2 Virus structure 
All orbiviruses contain 10 segments of dsRNA, surrounded by two capsid shells. 
The inner capsid, made up from the inward-facing virus protein VP3(T2) and the 
outward-facing VP7(T13), encloses the 10 segments of RNA and the minor proteins 
VP1(Pol), VP4(Cap) and VP6(Hel), which are the core associated enzymes. The virus 
structure of the prototype Orbivirus species BTV is illustrated in Figure 1-3 (page 24) 
and the genome assignment and orbivirus protein functions are summarised in Table 1-3 
(page 25) and described in section 1.2.4 (page 30). VP7 is the main species (i. e. 
serogroup) specific antigen, common to all AHSV serotypes. Similarly, VP3 is highly 
conserved across the serogroup, but neither of these proteins is serologically cross- 
reactive with the corresponding proteins of other Orbivirus species. The outer capsid 
layer consists of VP2 and VP5. VP2 is involved in cell entry and in combination the two 
proteins determine the serotype (defined by serum neutralisation test-SNT) of a given 
virus (Roy et al., 1994). By analogy to BTV, VP2 is thought to interact directly with 
neutralising antibodies while VP5 exerts an indirect effect on neutralisation by 
modulating VP2 conformation (Cowley & Gorman, 1989; Mertens et al., 1989). More 
recently, AHSV and BTV VP5 have both been shown to directly interact with 
neutralising antibodies, although on a lesser scale than VP2 (Martinez-Torrecuadrada et 
al., 1999; DeMaula et al., 2000). VP5 must therefore be considered a co-determinant of 
serotype. 
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Figure 1-3: Schematic diagram of bluetongue virus structure 
Provided by Dr. P. Mertens 
The virus RNA genome segments are numbered one to ten according to their 
migration order in agarose gel electrophoresis (Table 1-3, page 25). Apart from the 
seven structural proteins VP1-VP7 there are three virus-encoded proteins that cannot be 
routinely isolated from mature virus particles and are therefore termed "nonstructural 
proteins" (NS I to NS3). Segments five, nine and ten each code for more than one 
protein. These proteins are symbolised by VP5/5a, VP6/6a/6b/6c and NS3/3a, 
respectively (Roy et al., 1994). 
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1.2.3 Nonstructural protein NS3/3a 
Structure and function 
The two nonstructural proteins NS3 and NS3a are encoded from two in-phase 
overlapping reading frames of segment 10 and vary only in 10 additional amino acids at 
the amino terminus of NS3 (van Staden & Huismans, 1991). In BTV, both proteins seem 
to be synthesised in equimolar amounts and nothing is known about possible functional 
differences between them. They are therefore collectively referred to as NS3/3a in this 
thesis. NS3/3a is a transmembrane protein with two highly conserved hydrophobic 
regions. Experiments with AHSV have shown that mutations inserted into these regions, 
turning them hydrophilic and thus unable to "bridge" the cell membrane, reduce their 
cytotoxic effect on insect cells (van Staden et al., 1995; van Staden et al., 1998). In 
BTV, the protein contains two potential glycosylation sites, one of them between the 
two transmembrane regions (Roy, 1992; Roy et al., 1994). 
Studies using recombinant baculovirus expression systems show that BTV-like 
particles can be synthesised but are not released from the cells in the absence of NS3/3a. 
Addition of a baculovirus expressing NS3/3a results in the successful release of virus 
like particles from these cells (Hyatt et al., 1993). This experiment strongly suggests 
that the presence of NS3/3a is vital for the escape of virions from the insect cell. It may 
perform a similar function in mammalian cells. A role of NS3/3a in virus release is also 
indicated by the discovery of two potential ubiquitin-ligase recruiting motifs in BTV 
NS3/3a (Strack et al., 2000). The two motifs, PPRY at NS3 amino acid (aa) 36-39 and 
PSAP at as 41-44, are identical with retroviral "L (=late assembly) domains". The late 
assembly domains PPxY (oncoretroviruses, e. g. Rous sarcoma virus) and P(T/S)AP 
(lentiviruses, e. g. Simian immunodeficiency virus) are located on the Gag polyprotein 
and have been shown to recruit ubiquitin ligase activity, resulting in Gag-ubiquitination 
(Strack et al., 2000). The insertion of point mutations into the motifs abolished 
ubiquitination and prevented budding of retrovirus-like-particles from the cell. 
Proteasome-inhibition with lactacystin also inhibited budding, presumably via 
ubiquitin-depletion of the cell (Strack et al., 2000). It is concluded by the authors that L 
domains are essential for virus exit in retroviruses and fulfil their role by way of 
protein-ubiquitination, possibly involving cell membrane proteins that are normally 
involved in endocytosis by mono-ubiquitination. While retroviruses were shown to 
26 
possess either one of the two motifs, BTV, Broadhaven virus and Palyam virus NS3/3a 
were shown to contain both motifs in very close proximity, overlapping in the case of 
Broadhaven virus (Table 1-4). A very similar motif in Ebola virus was shown to be 
particularly effective when the sequence was inserted into chimaeric retrovirus like 
particles (VLPs). 
Table 1-4: Candidate L domains in some orbivirus NS3 
(Strack et al., 2000) 
Virus Sequence Position, amino acids 
Broadhaven virus' SPTA 'AYA 10-18 
Bluetongue virus TISQNNR'i M 32-45 
Palyam virus VPYQI'I I \l" V 21-33 
domain; PPxY domain 
It has been suggested that variation in NS3/3a may affect the timing and titre of 
AHSV release from insect cell culture (Martin et al., 1998). Exchange of this protein 
has been shown to modify virulence in a mouse model system. For the latter studies, 
reassortant viruses were used (OHara et al., 1998). 
Involvement of NS3/3a in virus release from cultured insect cells suggests that it 
might be involved in the mesenteronal escape barrier (see section 1.3.5, page 39). It has 
been shown for BTV that many individuals from competent insect vector colonies do 
not develop a disseminated virus infection but harbour an infection localised to the 
midgut cells, the primary target tissue for orally ingested virus. The mechanism of this 
"trapping" of virus is not well understood but may relate to the exit mechanism. In that 
case, there is a real possibility that variation in NS3/3a could affect the existence or non- 
existence of a mesenteronal escape barrier in a given virus-insect combination, i. e. co- 
defines vector competence of the insect for a particular virus strain. 
NS3/3a sequence variation 
One of the most striking features of AHSV is the high level of variability in 
segment 10 compared to the homologous segment 10 genes in BTV, Palyam virus and 
epizootic haemorrhagic disease virus (EHDV) (Sailleau et al., 1997; Martin et al., 1998; 
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van Niekerk et al., 2001b). The degree of variability is illustrated by a rootless 
phylogenetic tree of the predicted AHSV NS3 protein sequences (Figure 1-4, page 29). 
On the basis of their sequences, isolates of segment 10 and NS3 can be assigned to one 
of three distinct groups (Sailleau et at., 1997). Early work suggested a firm relationship 
between serotype and NS3/3a, with serotypes 4,5,6 and 9 clustering into the a group, 
serotypes 3 and 7 grouping into the ß group and serotypes 1,2 and 8 falling into the y 
group (Sailleau et at., 1997). However, orbiviruses can reassort, i. e. exchange segments 
of RNA during co-infection of cell cultures. Prolonged viraemia in zebra and lifelong 
infection of susceptible insects enhance the chance of reassortment taking place. Almost 
100% of zebra in the Kruger National Park (South Africa) have been shown to 
seroconvert for at least five serotypes of AHSV in their first year of life (Lord et al., 
1998). This makes co-infection with two or more serotypes very likely in at least some 
animals. Culicoides vectors become persistently infected and may take several blood 
meals in their lifetime. These are ideal conditions for reassortment to take place. 
Therefore, the relationship between the type of segment 10 ((X, ß, y) and serotype, as 
determined by genome segments 2 and 6, may be a relatively unstable one. Indeed, 
recent work shows that isolates of AHSV-8 cluster into various groups of NS3/3a, 
providing strong evidence that reassortment does take place in the field (van Niekerk et 
al., 2001b). Analysis of NS3 sequences available on protein databases shows that 
isolates of serotype 1 also cluster into more than one group (Figure 1-4, page 29). If 
reassortment does take place to an appreciable extent it must be considered a powerful 
factor in AHSV evolution. Variants in segment 10 can only be expected to survive in 
two scenarios. One is that variation represents an adaptation to selective pressures in the 
past, but these factors have subsequently disappeared and variants now have no 
selective advantage over each other. They are therefore passed on with constant 
frequencies. The other scenario is that variation does represent adaptation to present 
environmental pressures and variants survive because each of them has found an 
ecological niche. In view of the likely involvement of NS3/3a in cell exit by budding 
and the absence of lysis or cytopathic effect (CPE) in the Culicoides cell culture, it is 
thought likely that NS3/3a is essential for virus dissemination and possibly the vector 
status of the insect. Variations in NS3/3a could therefore reflect adaptation to distinct 
vector insect species or populations. 
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Figure 1-4: Variation in AHSV NS3 
Unrooted neighbour joining tree of AHSV NS3 protein sequences. Sequences were obtained from 
SwissProt and TrEMBL databases. For each isolate, the serotype (ST) is given, followed by the 
accession number. Bar (bottom left) represents 1% variation. The tree was designed using the 
"distances" program in GCG 10. Three distinct groups are labelled as alpha, beta, and gamma. 
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Figure 1-5: Orbivirus replication cycle based on bluetongue virus 
(reproduced with permission from Dr. P. Mertens) 
1.2.4 Replication cycle 
The replication cycle of AHSV is thought to resemble that of BTV and indeed 
all other members of the family Reoviridae. Properties shared by all these viruses 
include the possession of dsRNA, the composition of their genome of RNA segments, 
the lack of complete uncoating and the possession of their own enzymes transcribing 
dsRNA into mRNA (Zarbl & Millward, 1983). Orbi-and coltiviruses differ from other 
family members in the formation of characteristic cytoplasmic tubules during 
replication. These tubules are formed by NS 1 (Eaton et al., 1990). The following outline 
of virus replication is mainly based on the BTV replication cycle and primarily relies on 
observations made in mammalian cells (Figure 1-5). 
Adsorption 
Virus binding to an unknown receptor is mediated by VP2 (Huismans et al., 
1983). It was also shown that BTV particles lacking VP2, but containing VP5, could not 
bind to BHK cells in suspension (Huismans et al., 1983). The importance of VP2 for 
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successful infection is underlined by the finding in AHSV-4 that immunisation with this 
protein protects horses against experimental infection (Stone-Marschat et al., 1996). 
Cleavage of VP2 by trypsin, chymotrypsin or species-specific mammalian serum 
proteases results in production of infectious subviral particles (ISVPs) with enhanced 
infectivity for Culicoides midges (Marchi et al., 1995; Mertens et al., 1996). Core 
particles, which lack VP2 and VP5, have been shown to have only low levels of 
infectivity for mammalian cells but to have an infectivity similar to whole virus 
particles for insect cells (Mertens et al., 1996). This suggests that removal of VP2 and 
VP5, and the exposure of the core surface layer allows VP7 to mediate an alternative 
attachment process in Culicoides insects. This view is supported by cell attachment 
experiments (Xu et al., 1997) and observations of BTV core particle neutralisation by 
anti-VP7 antibodies (Hutchinson, 1999). It has been hypothesised that a mutual 
adaptation may exist between regional Culicoides populations and VP7 sequences of 
local BTV strains in endemic areas but no supporting evidence for this has been found 
(Wilson et al., 2000). However, the high variability of VP2 and VP5 allows for 
speculation on the potential adaptation of these proteins to Culicoides receptor 
variation. 
Cell entry and uncoating 
Up to three independent pathways for the initiation of infection by BTV may 
exist. Intact virus particles have been observed entering the cell via receptor-mediated 
endocytosis (Eaton et al., 1990). ISVPs have been associated with shorter eclipse 
periods, suggesting a non-endosomal route of entry, possibly by direct plasma 
membrane penetration (Eaton et al., 1990). However, in more recent experiments, both 
BTV virus particles and ISVPs have been found to require a "low pH step" in order to 
productively infect mammalian and insect cells, strongly suggesting that they both use 
the endosomal pathway of infection (Hutchinson, 1999). In contrast, BTV core infection 
does not require a low endosomal pH, possibly because cores have already lost the acid 
labile outer capsid proteins (Hutchinson, 1999). Core particles can infect host cells via a 
VP7-mediated pathway that appears to utilise an alternative cell receptor. Cores have 
been shown to bind to cell surface glycosaminoglycans (Hutchinson, 1999). 
Partial uncoating, i. e. removal of VP2 and probably VP5 from BTV virions, 
takes place in endosomes (Huismans et al., 1983; Eaton et al., 1990). Core particles are 
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released from the endosome by an unknown mechanism before endosome fusion with 
lysosomes takes place. Cores appear in the cell cytoplasm within an hour of infection 
with virus particles. Removal of both outer capsid proteins is required for the virus 
transcriptase to be activated (van Dijk & Huismans, 1980). 
Transcription of the parental genome 
Virus dsRNA cannot act as mRNA and host cell polymerases are unable to 
transcribe from dsRNA. Therefore, orbivirus particles need to supply their own 
transcription enzymes. They also provide enzymes necessary for capping and 
methylation of the 5'RNA termini (Table 1-3, page 25). 
The virus polymerase becomes active once partial uncoating, i. e. the removing 
of outer capsid proteins has taken place. As in most members of the Reoviridae, 
complete uncoating of virions does not occur in orbiviruses and the genome remains 
within the core. BTV dsRNA transcription is fully conservative, i. e. parental strains are 
not found amongst transcription products. Transcription is asymmetric, i. e. only one 
parental strain is transcribed and results in full-length ssRNA copies. Each virus particle 
contains approximately ten copies of polymerase, so it is thought likely that each 
parental RNA segment is transcribed by only one molecule of the polymerase (Stuart et 
al., 1998). ssRNAs transcribed from parental cores are capped at the 5' end but not 
adenylated at the 3' terminus (Zarbl & Millward, 1983; Eaton et al., 1990). They serve 
two purposes, to act as mRNA for virus protein synthesis and as a template for the 
synthesis of negative-strand RNA within nascent progeny virus particles. 
Formation of progeny double-stranded RNA 
Capped, positive-strand ssRNA molecules, transcribed from parental cores, are 
used as a template for one round of negative-strand synthesis. The negative strand 
remains with its template to re-form the dsRNA genome segments. This process takes 
place inside nascent core particles, which are precursors of progeny virus particles. 
ssRNA-3dsRNA polymerase activity, like dsRNA->ssRNA activity, is provided by 
VP'. 
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Transcription from the progeny double-stranded RNA 
Messenger RNA that is transcribed from parental cores is also referred to as 
"early" mRNA, while the mRNA from progeny cores is "late" mRNA. These two types 
of mRNA differ in the timing of their synthesis and possibly in their structure. In BTV, 
early mRNA is mainly found at about two to six hours after infection, while late mRNA 
is synthesised from approximately four hours post infection and reaches a maximum at 
around 12 hours post infection (Eaton et al., 1990). In Orthoreovirus progeny cores, 
guanylyl transferase, transmethylases and capping enzymes are inactive. This 
corresponds with a switch in cell metabolism from cap dependent to non-cap dependent. 
Uncapped transcripts do not serve as templates for minus-strand synthesis (Zarbl & 
Millward, 1983). In rotavirus replication, host cell shut-off occurs as a result of the 
poly(A) binding protein (PABP) eviction from the eIF4F complex, mediated by the 
binding of the non-structural protein NSP3 to eIF4GI (Piron et al., 1998). Although it is 
unknown whether the same mechanisms exist in Orbivirus species, observations of 
inhibited cap dependent translation late in BTV infection of mammalian cells suggest a 
mechanism for host cell shut-off (Stirling, 1996). This is observed from approximately 
12 h post infection. The absence of a reduction in host protein synthesis in C. sonorensis 
(KC) cells correlates with a persistent infection, the absence of CPE in these cells and 
the tolerance of Orbivirus infections by Culicoides midges (Fu, 1996; Stirling, 1996). 
Translation of virus messenger RNA 
During replication of Orthoreovirus, early mRNA is capped and can therefore 
compete with host cell mRNA for translation at the ribosome (Zarbl & Millward, 1983). 
Late virus mRNA is uncapped and this coincides with a virus-induced switch in the 
translational apparatus from cap dependent to non-cap dependent. As a result host cell 
mRNA, as well as early virus mRNA, cannot be translated. The consequence is 
shutdown of host cell protein synthesis and high efficiency of virus mRNA translation, 
due to absence of competition (Zarbl & Millward, 1983). It is possible that an 
equivalent mechanism exists in orbiviruses such as BTV and AHSV but the viral 
proteins involved have not yet been identified. 
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Morphogenesis 
The process of orbivirus assembly is not well understood but starts with the 
formation of sub-core particles containing ssRNA, which is sensitive to ribonuclease 
activity (Eaton et al., 1990). The process that selects exactly one copy of each ssRNA 
segment for packaging into each nascent sub-core particle is not currently understood, 
but it is at this stage that genome segment reassortment must take place. Replication of 
genome segments and addition of viral polypeptides to the nascent particles result in the 
formation of core particles that contain ribonuclease-resistant dsRNA. It is significant 
for the process of core formation that virus proteins VP1, VP3, VP4, VP6 and VP7 are 
self-assembling (French & Roy, 1990; Loudon & Roy, 1991). Experiments using 
baculovirus expression systems show that VP3 and VP7 can form core-like particles in 
the absence of other virus proteins or viral RNA (French & Roy, 1990; Maree et al., 
1998). VP2 is probably added to progeny cores at the periphery of virus inclusion 
bodies (VIBs, see Virus inclusion bodies and superinfection, below). VP5 is added at 
the same point or possibly even later (Eaton et al., 1990). If co-expressed with VP3 and 
VP7, VP2 and VP5 also self-assemble to form virus-like particles (French et al., 1990). 
Virus exit from the cell 
There are probably three mechanisms for the release of orbiviruses from cells. 
Budding is associated with the acquisition of a temporary virus envelope and is 
common in insect cells but virions can also exit through the cell membrane without 
becoming enveloped (Eaton et al., 1990). Large quantities of virus are also released 
following cell lysis in mammalian cells. The presence of NS3/3a is necessary for virus 
exit from insect cells to occur (Hyatt et al., 1993). It has also been shown to modify 
virulence in a mammalian model, suggesting that it might perform similar functions in 
equine hosts (O'Hara et al., 1998). The role of NS3/3a is discussed in section 1.2.3 
(page 26). 
Virus inclusion bodies and superinfection 
After leaving the endosome, parental core particles bind to intermediate 
filaments, start transcription and become associated with a matrix called a "virus 
inclusion body" (VIB) precursor. The matrix is thought to be formed by condensation of 
virus proteins translated on ribosomes outside the matrix, with viral ssRNA transcribed 
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by core particles. Continued aggregation of virus proteins and RNA leads to complete 
surrounding of the parental core particle by the matrix and a VIB is formed. Within this 
VIB, progeny core particles assemble. The nonstructural protein NS2, a nonspecific 
ssRNA-binding, multimer-forming protein, is common in the VIB and thought to be 
important in the genome replication and assembly of progeny cores (Huismans et al., 
1987; Theron & Nel, 1997). The addition of VP2 and VP5 to progeny cores means that 
the resulting progeny virus particles cannot transcribe, thus slowing down the virus 
replication in the host cell. In cell culture, BTV has been shown to circumvent this 
obstacle via superinfection of the cell by progeny virus particles following their release 
(Hyatt et al., 1989). Consequently, the reinfecting progeny virus particles are stripped of 
their outer capsid proteins and become transcriptionally active core particles. Since 
persistently infected insect cells only contain a single large VIB (Dr. P. Mertens, 
personal communication) it is likely that these particles, or the VIB they produce, fuse 
with the existing VIB. Such close association may aid the occurrence of genome 
reassortment. 
Peculiarities of virus replication in insect cells 
No CPE is observed in insect cell culture derived from the BTV vector C. 
sonorensis (KC cells). These cells will survive for at least three weeks following 
infection with BTV or AHSV. There is also no evidence to suggest that the vector 
insects themselves are adversely affected by infection with BTV or AHSV. Therefore, 
host protein synthesis is not shut down in insect cells and cell lysis is not used as a way 
of virus exit from the cell. A transformation of RNA translation to a non-cap dependent 
mode appears very unlikely to occur in insect cells. 
1.3 Culicoides biting midges and AHSV transmission 
1.3.1 Culicoides biting midges 
Culicoides (Diptera: Ceratopogonidae) are a genus of small (1-3 mm), mainly 
haematophagous insects (Meiswinkel et al., 1994). They inhabit all major landmasses 
except for the polar regions and a few geographically isolated island groups, such as 
New Zealand and the Hawaiian archipelago (Boorman, 1993; Meiswinkel et al., 1994). 
Approximately 1200 species have been identified but many more are thought to exist. 
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Life cycle 
The complete life cycle of Culicoides includes egg, four larval stages, pupa and 
adult (imago). Depending on species and climate, the cycle takes between seven days 
and seven months to complete and in temperate regions, the longer periods often 
include a diapause of the fourth stage instar larva (Kettle, 1984). Culicoides are also 
thought to overwinter as inactive adults in frost-free areas of temperate countries 
(Rawlings & Mellor, 1994). Immature stages depend on the presence of moisture and 
organic matter (swamps, damp soil, animal dung etc. ) for their development and the 
absence of suitable breeding grounds can be a limiting factor for a species' distribution 
and abundance (Meiswinkel et al., 1994). Females of the haematophagous species 
require a blood meal from a warm-blooded animal for each batch of eggs to mature 
while the males never blood-feed. Blood-feeding will usually take place once every few 
days in a lifespan that can last from a few days to over four weeks, dependent on 
ambient temperature, humidity, wind speeds etc (Baylis et al., 1998). 
Economic and public health importance 
As a biting nuisance, Culicoides can seriously interfere with human outdoor 
activity (e. g. in parts of Scotland). They also cause sweet itch, a severe allergic 
dermatitis that can make horse-keeping virtually impossible in affected areas. 
Culicoides-transmitted animal parasites include the economically significant nematode 
Onchocerca cervicalis of horses and a range of nematodes and protozoa of various 
mammalian and avian species (Linley, 1985). 
Although Culicoides species also transmit Oropouche virus, which causes a flu- 
like disease of humans in Latin America (Anderson et al., 1961), their greatest 
significance is as vectors of animal viruses. Over 50 viruses have been isolated from 
Culicoides insects (Meiswinkel et al., 1994), among them AHSV, BTV, EHDV and 
equine encephalosis virus (EEV). AHSV and BTV are such a threat to livestock that the 
diseases these viruses cause have received OIE list A status. 
1.3.2 Association of Culicoides with AHSV 
Culicoides imicola was first implicated in the transmission of AHSV by Du Toit 
in 1944 (Wetzel et al., 1970). The virus has been repeatedly isolated from blood-free C. 
imicola catches in areas where AHS was reported (Mellor et al., 1990a; Baylis et al., 
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1997; Meiswinkel, 1998) and this species has been shown to become persistently 
infected in the laboratory (Venter et al., 2000). Furthermore, the time of C. imicola 
abundance has been linked with the timing of AHS epidemics (Ortega et al., 1998). This 
leaves little doubt that C. imicola is the most important vector species of AHSV (Mellor 
et al., 2000) 
More recently, Culicoides bolitinos, a sibling species of C. imicola, has also 
been implicated in AHS outbreaks (Meiswinkel & Paweska, 1999). C. bolitinos is 
abundant in areas of southern Africa considered too dry and cool to sustain large 
populations of C. imicola, and may therefore extend the at-risk area for AHS (Venter & 
Meiswinkel, 1994; Venter et al., 2000). 
1.3.3 Vector capacity and vector competence 
Vector capacity describes the ability of an insect vector population to transmit a 
pathogen to the vertebrate hosts. The main determinants of vector capacity are the size 
of the vector population, the number of blood meals taken by a vector per host per day, 
the daily survival rate of the vectors, the length of the extrinsic incubation period and 
vector competence (Mullens, 1991). The extrinsic incubation period (EIP) is the time 
span from a vector's consumption of an infectious blood meal to the onset of the 
vector's transmissiveness during a subsequent blood meal. 
Vector competence describes the proportion of individuals in a vector population 
that are capable of becoming transmissive, if infected, with a given pathogen. Applied 
to an individual insect, it denotes the ability or otherwise of this insect to become 
infected with a pathogen and transmit it to a suitable vertebrate host after the EIP. Vector 
competence depends on vector genotype, environmental factors and the nature of the 
infecting pathogen. This work investigates how variation in Culicoides vector genotype 
and variation in AHSV genome can affect Culicoides vector competence, measured as 
the proportion of insects that become infected (infection rate) or develop a fully 
disseminated infection (termed "disseminated-infection rate" in this thesis). 
1.3.4 Replication of orbiviruses in Culicoides insects 
More research has been carried out on BTV than on any other orbivirus, but 
events in the vector-competent insect are thought to be very similar for all these viruses 
(Mellor & Boorman, 1995). After oral ingestion of the virus during a blood meal from a 
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viraemic vertebrate host and deposition of the blood meal in the midgut, virus particles 
infect the midgut cells from the luminal side (Figure 1-6, page 40). Cleavage of VP2 by 
mammalian serum proteases or insect gut proteases may result in production of ISVPs 
with increased infectivity for Culicoides midges (Marchi et al., 1995; Mertens et al., 
1996). The virus replicates within the midgut cells and progeny virus particles are 
released through the basement membrane on the abluminal cell surface, into the 
haemocoel. From the haemocoel, the virus infects secondary target organs, such as 
neuronal ganglia and salivary glands, resulting in a fully disseminated infection 
(Jennings & Mellor, 1987). Once an insect has acquired a disseminated infection it 
remains infectious for the rest of its live, but is unable to pass on the virus transovarially 
(Jones & Foster, 1971; Fu, 1996). The ovary appears to be protected from infection by 
the existence of an ovarial sheath (Fu, 1996). 
Instead of infecting the midgut cells and emerging from their abluminal side, 
virus particles may also reach the haemocoel directly through gaps in the monolayer 
midgut cell sheet. This phenomenon is referred to as a "leaky gut" syndrome and may 
be of particular significance in non-vector Culicoides species, since it allows virus 
particles to bypass refractory midgut cells. Once virus has reached the haemocoel, it 
will usually be replicated in secondary target organs such as neuronal ganglia and 
salivary glands. It may then be secreted with the saliva in subsequent blood-meals. The 
potential significance of the "leaky gut" syndrome is highlighted by the fact that an 
increase in the larval rearing temperatures of C. nubeculosus, a northern European 
species not considered to be a competent vector of BTV or AHSV, leads to a significant 
number of insects developing a fully disseminated infection (Mellor et al., 1998) 
(Wittmann, 2000). This suggests that a change in climatic conditions, with a significant 
rise in temperatures, could "create" new vector species. Bypassing of the midgut cells is 
also aided by the simultaneous infection of insects with virus and microfilariae (Mellor 
& Boorman, 1980). 
In vector-competent Culicoides species, higher environmental temperatures 
accelerate virogenesis, resulting in higher infection rates and faster dissemination of 
infection (Wellby et al., 1996; Wittmann, 2000). This reduction of the time between 
ingestion of an infectious blood meal and the presence of virus in the saliva (EIP) 
potentially enhances vector capacity. However, high temperatures also tend to decrease 
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adult lifespan which has a diminishing effect on vector capacity (Wellby et al., 1996; 
Wittmann, 2000). 
1.3.5 Barriers to orbivirus infection, dissemination and transmission in the insect 
Even in vector-competent Culicoides species, such as the North American C. 
sonorensis for BTV or the African C. imicola for AHSV and BTV, only a proportion of 
insects are likely to be competent vectors for a particular virus. Failure of a virus to turn 
an insect into a transmissive vector can be due to a number of barriers, which are 
outlined in Figure 1-7 (page 40). 
1. Failure to infect the midgut cells (mesenteronal infection barrier, MIB). 
2. Failure to spread from the infected midgut cells into the haemocoel, 
(mesenteronal escape barrier, MEB). 
3. Failure to disseminate through the haemocoel following release from the 
midgut cells through the basal lamina (dissemination barrier, DB). 
4. Failure to infect the salivary gland from the haemocoel (salivary gland 
infection barrier, SGIB). 
5. Failure to be released from the salivary gland into the saliva during blood- 
feeding (salivary gland escape barrier, SGEB). 
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1.3.6 The model vector system C. sonorensis (= C. variipennis sonorensis)- 
AHSV/BTV 
Terminology and laboratory colonies 
To facilitate vector competence studies of BTV in its North American field 
vector, then known as C. variipennis and comprising a total of five subspecies 
(Holbrook et al., 2000), a laboratory colony of the subspecies C. v. sonorensis was 
established in the USA in 1957 (Jones, 1957). Eggs obtained from the American 000 
colony spawned a new colony at Pirbright which has been successfully maintained 
without further introductions since 1967 (Boorman, 1974). In 1995, insects from this 
colony were selected for or against susceptibility to oral infection with AHSV-9 (Wellby 
et al., 1996). Selection took place over three generations of females and the vector- 
competent colony was designated PIRB-s-3 (Wellby et al., 1996). Both colonies have 
been maintained without further selection or additions since then and have been named 
the VC (vector-competent) = PIRB-s-3 and the NVC (non vector-competent) for the 
purpose of this work. The uncertain taxonomic status of C. v. sonorensis, the subspecies 
most closely associated with orbivirus transmission in North America, has been 
reflected in the literature by the synonymous use of the term "C. variipennis" in various 
vector competence studies (Jones & Foster, 1974; Boorman et al., 1975). The term "C. 
variipennis complex" has also been used. 
Based on isozyme electrophoresis and morphological differences, there is now 
strong evidence for the existence of at least three genetically distinct groups within this 
complex (Tabachnick, 1990; Holbrook et al., 2000). The absence of intermediate forms 
in an environment of high sympatry (habitat-sharing) seems to justify the proposition of 
three species within the old C. variipennis complex, which are now called C. sonorensis 
(elevated from subspecies status), C. variipennis and C. occidentalis (Holbrook et al., 
2000). The Pirbright colonies originated from populations that are now designated as C. 
sonorensis and this term is used throughout this thesis. 
Genetic control of vector competence 
The ability to select and maintain laboratory colonies with varying susceptibility 
rates for AHSV and BTV from a parent colony of C. sonorensis shows that the 
expression of the barriers to virus infection and dissemination is controlled by the insect 
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genotype (Jones & Foster, 1974; Wellby et al., 1996). It has been suggested that a single 
gene locus confers resistance to arbovirus infection when occupied by the dominant 
allele, while the presence of the recessive allele or alleles imparts susceptibility, the 
degree of which is under polygenic control (Jones & Foster, 1974). Evidence for the 
existence of a single gene locus with a strong influence on resistance and susceptibility 
has also been found by Tabachnick, although the presence of further gene loci 
controlling resistance and susceptibility could not be ruled out. In relation to the single 
gene locus, the maternal genotype appears to define the F1 phenotype while the paternal 
genotype is passed on to the F2 generation in a dominant fashion (Tabachnick, 1991). 
The existence of a MIB and a MEB has been demonstrated in the C. sonorensis- 
BTV system (Jennings & Mellor, 1987; Fu et al., 1999). The existence of a mechanism 
hindering virus spread through the haemocoel has also been shown for this system and 
implicates the fat body as a defence organ (Fu et al., 1999). While there is evidence that 
no SGIB or SGEB exists in Culicoides species (Jennings & Mellor, 1987; Fu et al., 
1999), these barriers have been shown to exist in various mosquito-arbovirus systems 
(Hardy et al., 1983; Hardy, 1986). The combination of these data suggests that the 
hereditary factors described above affect the midgut escape or infection barriers, the 
dissemination barrier, or a combination of them. 
Effects of virus titre and virus strain 
The titre of the infectious blood meal has been shown to have an effect on the 
proportion of insects which develop a persistent infection (infection rate) and it has been 
postulated that an "appropriate" titre of the blood meal will result in infection rates 
approaching the insect-defined "susceptibility rate" while significantly lower blood 
meal titres will result in much lower infection rates (Jones & Foster, 1974). The same 
work also suggests that infection rates close to the insect's genetically defined 
susceptibility rate can only be achieved by the "appropriate" virus. As a protein 
involved in virus exit from infected cells (see 1.2.3, page 26), it can be speculated that 
NS3/3a has a direct effect on the MEB. 
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1.4 Project objectives 
The infection of an insect vector by an arbovirus and the dissemination of that 
virus through the vector's body are complex processes. The factors that determine 
whether infection is successful and results in transmission of the virus are multiple. 
They can be classed into insect-defined, virus-defined and environmental factors. 
However, these factors often exert their effect in an indirect fashion and modify each 
other. This and the difficulty involved in working with vector insects explain why at 
present, the mechanisms controlling the various barriers to virus dissemination in the 
insect are poorly understood. Yet, global climate-change and the ever-increasing 
international movement of humans, livestock and goods potentially aid the spread of 
many human, animal and crop pathogens and their arthropod vectors. The recent and 
current outbreaks of bluetongue in the Mediterranean basin, which have affected several 
countries that have never before recorded the disease, are typical examples of this. 
Consequently, control measures aimed at arboviral infections, in particular, will become 
more important. Clearly, the design and implementation of effective control strategies 
will benefit from a good understanding of the mechanisms that control the vector status 
of an insect. 
The first aim of this project was to assess the effect of variation in AHSV 
segment 10 on oral infection rates and vector competence in the model vector C. 
sonorensis. It was hypothesised that, because of its involvement in virus release from 
the cell, NS3/3a (encoded by segment 10) may be necessary for virus dissemination 
from the cell and variation in this protein may thus modulate the mesenteronal escape 
barrier of the insect. Two reassortant viruses that differ only in virus genome segment 
10 were available to help test this hypothesis. These two reassortant viruses, AHSV-A79 
and AHSV-A790, were previously produced in the Orbivirus group by Dr. R. O'Hara 
and allowed her to identify a modifying role for NS3/3a in virus virulence in mice. Two 
laboratory colonies of C. sonorensis, previously selected for and against vector 
competence for AHSV-9, were used to study the role of NS3/3a in virus dissemination 
within adult insects. To aid in the interpretation of the data obtained, it was necessary to 
determine the AHSV titre that indicates a fully disseminated infection in the insect 
vector. This is an important benchmark for the present work and for future studies on 
the C. sonorensis-AHSV model system. 
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The second aim of this project was to assess the vector competence of two field 
vectors, C. imicola and C. bolitinos, for various AHSV strains including the reassortant 
viruses. The effect of variation in virus genome segment 10 on wild insects was tested 
and its relevance to the epidemiology of AHS considered. The susceptibility of the two 
field vectors to three highly attenuated AHSV strains was also examined. The 
attenuation process used to produce these strains was identical to the attenuation 
procedure used for the production of a previous generation of commercial, live 
attenuated virus vaccines. The safety of such live attenuated virus vaccines with regard 
to virus spread by insect vectors, potential genome reassortment and reversion to 
virulence is discussed. 
The third aim of this project was to develop techniques for the characterisation 
of mesenteronal infection and escape barriers. These techniques were then used to 
investigate the susceptibility of Culicoides midgut cells to AHSV infection from the 
luminal and the abluminal sides. Results, when using a susceptible and a non- 
susceptible population of the vector species C. sonorensis and the orally refractory 
species C. nubeculosus, are compared. 
The fourth aim of this project was to collect preliminary data leading towards an 
understanding of the cellular mechanism at the basis of the effect that NS3/3a has on 
virus dissemination. These experiments included cell-release assays carried out in a C. 
sonorensis (KC) cell line. 
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2 Materials and methods 
2.1 Standard solutions 
Tris-Acetate/EDTA electrophoresis buffer (IOx TAE) 
For one litre: 
" 48.8 g Tris base 
" 11.42 g Glacial acetic acid 
" 20.0 ml 0.5 M EDTA pH 8.0 
Electrophoresis sample buffer (5x ESB) 
9 0.32 M Tris-HCI (pH 6.8) 
" 10% (w/v) SDS 
9 10% ß-Mercaptoethanol 
" 0.02% (w/v) Bromophenol Blue 
0 15% (v/v) Glycerol 
Tris-glycine buffer 
" 200 mM Glycine 
0 25 mM Tris-HC] (pH 8.8) 
" 0.1%(w/v)SDS 
K-MES 
0.5 M MES equilibrated to pH 6.3 with KOH and sterilised by filtration (200 nm 
syringe filter). Stored at -20°C. 
Luria-Bertani (LB) medium 
For 1 litre: 
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" 10 g Bacto tryptone 
"5g Bacto yeast 
9 10 g NaCl 
in distilled water, adjusted to pH 7.0 with NaOH and autoclaved. 
2M Magnesium ions (Mg2+) 
1M MgC12 +1M MgSO4 
SOB medium 
For one litre: 
" 20 g Bacto tryptone 
"5g Bacto yeast 
" 0.584 g NaCl (10 mM) 
" 0.186 g KCl (2.5 mM) 
in distilled water, adjusted to pH 7.0 with NaOH and autoclaved. 
Tris-EDTA buffer (10x TE buffer) 
For one litre: 
" 100m11MTrispH8.0 
" 20 ml 0.5 M EDTA pH 8.0 
Transformation buffer (TFB) 
For one litre: 
0 7.4 g KC1 (100 mM) 
0 8.9 g MnC1.4H20 (45 mM) 
0 1.5 g CaC12.2H20 (10 MM) 
0 0.8 g HA00013 (10 mM) 
filtered and stored at 4°C 
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Solutions for DNA minipreparation 
Solution I 
25 mM Tris-HC1(pH 8.0) 
10 mM EDTA 
50 mM glucose 
5 mg/ml lysozyme 
Solution II 
0.2 M NaCl + 1% SDS 
THE buffer 
" 50 mM Tris pH 8.0 
9 0.2 M NaCl 
"5 mM EDTA pH 8.0 
Sodium/Sodium citrate buffer (20x SSC solution) 
" 175.3 g NaCl 
" 88.2 g sodium citrate 
" adjust to pH 7.0 with 10 N solution of NaOH 
" adjust volume to 11 with H2O 
Denhardt's solution (100x) 
For 100 ml 100x solution: 
92g Ficoll 
"2g Polyvinylpyrrolidone (PVP) 
"2g Bovine serum albumin (BSA) 
Prehybridisation buffer 
For 20 ml buffer: 
" 10 ml formamide 
"5 ml 20x SSC solution 
Solution III 
3M KOAc (pH 4.8) 
for 100 ml: 
60 ml 5M KOAc 
11.5 ml glacial acetic acid 
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"2 ml 100x Denhardt's solution 
" 0.2m110%SDS 
" 0.2 ml salmon sperm DNA at 10 mg/ml (Sigma, boiled and iced immediately 
before use) 
" 2.6 ml H2O 
Hybridisation buffer 
For 40 ml: 
9 20 ml formamide 
9 10 ml 20x SSC solution 
" 0.8 ml 100x Denhardt's solution 
9 0.4m110%SDS 
" 0.4 ml salmon sperm DNA at 10 mg/ml (Sigma) 
" 1% (w/v) glycine 
" H20 to 40 ml 
ELISA coating buffer (pH 9.6) 
0 0.1 M carbonate/bicarbonate buffer 
ELISA blocking buffer 
" 0.05% Tween 20 in PBS 
" 5% (w/v) skimmed milk powder (Marvel) 
Western blot transfer buffer 
0 14.4 g Tris base 
" 3.0 g glycine 
" 200 ml methanol 
0 H2O to 1000 ml 
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Western blot blocking buffer 
" 0.1 % Tween 
" 5% Marvel milk powder 
" TBS (below) to 1000ml 
Tris buffered saline (TBS) IOx stock solution 
" 48.8 g Tris base 
" 160 g NaCl 
" H2O to 2 1, adjusted to pH 7.6 with HC1 
2.2 Cells and viruses 
2.2.1 Cell culture 
Mammalian cells 
BHK-21 cells were provided by the Arbovirology group at IAH Pirbright and 
were identical with those used for diagnostic purposes. They were therefore regularly 
tested for their sensitivity against AHSV and BTV. Cells were grown as monolayers in 
175 cm2 flasks until 90% confluent, using Dulbecco's modified Eagles medium 
(DMEM) with 5% foetal calf serum (FCS). 
Insect cells 
The Culicoides sonorensis (KC) cell line was developed from two-day-old 
embryos of C. sonorensis (Wechsler et al., 1989). These cells were obtained from Dr W. 
Wilson in February 2001. They were grown in Schneider's insect medium containing 
15% FCS at 28°C. C. sonorensis cells have repeatedly been shown to grow orbiviruses 
without showing CPE (Wechsler et al., 1989; Fu et al., 1999; Hutchinson, 1999). 
2.2.2 Stock viruses 
All stock viruses were provided by courtesy of Dr R. O'Hara (IAH Pirbright), 
Dr. S. Zientara, AFSSA, Maisons Alfort, or the OIE Regional Reference Laboratory 
for AHS and BT at Pirbright. All viruses except AHSV-4 (Morocco), AHSV-A79 and 
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AHSV-A790 were originally isolated from South African horses and were originally 
obtained from the OIE World Reference Laboratory at Onderstepoort, South Africa. 
South African AHSV strains 
Virus designation, date of isolation and passage history of the virus strains that 
were originally obtained from South Africa are shown in Table 2-1. 
Table 2-1: Designation and passage history of AHSV strains 
Virus name' Designation Date of freeze-drying Passage No. 3 
3wt 13/63 4/12/87 MB3; BHK9 
6wt 39/63 23/7/75 MB3; BHK8 
8wt 10/62 25/11/63 MB3; BHK9 
3att L 29/6/60 +BHK6 
6att 114 29/6/60 +BHK6 
Batt 18/60 27/4/76 +BHK7 
1- The number indicates serotype; wt stands for minimal virus attenuation ("wild type") and all denotes 
heavily attenuated strains that underwent ? 100 passages in neonatal mouse brain. 
2- Number of specimen received by the laboratory/year of isolation. This information was not available 
for the virus isolates 3att and Gatt. 
3- BHK(n) represents the number of passages in BHK-21 cells and MB(n) symbolises the number of 
passages in neonatal mouse brain carried out at IAH Pirbright (excluding the passages during attenuation 
of att strains). 
The reassortant viruses AHSV-A79 and AHSV-A 790 
Reassortant viruses were produced by Dr R. O'Hara in the Pirbright Orbivirus 
group (O'Hara, 1994; O'Hara et al., 1998). They were produced by co-infection of 
BHK-21 cells with AHSV-3att and AHSV-8wt and underwent at least three plaque 
purifications. The parental origins of their genome segments were subsequently 
determined by SDS-PAGE and, in the case of segment 9, by sequencing (O'Hara et al., 
1998). Reassortant virus strains A790 and A79 were found to differ in segment 10 only 
(Table 2-2, page 51). All differences in biological properties between them must 
therefore be due to this change. These viruses underwent up to 10 passages in BHK-21 
cells. 
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Table 2-2: Derivation of genome segments in the two reassortant viruses AHSV- 
A790 and AHSV-A79 
Virus Strain' Derivation of genome segments2 Virulence in Mice 
123456789 10 
3att (v) vvvvvvvvvv virulent 
8wt (a) aaaaaaaaaa avirulent 
A790 aaaaaavavv intermediate 
A79 aaaaaavava avirulent 
1- The A in the reassortant virus names indicates that the majority of their genome segments is 
derived from the avirulent (in mice) parent AHSV-8wt; the numbers behind it specify which genome 
segments are derived from the other parent strain AHSV-3att (O'Hara et al., 1998). 
2- Genome segments derived from the AHSV-3att are designated a and segments derived from 
AHSV-8wt are designated v. 
a, v- Highlighting the variation between A790 and A79 in genome segment 10. 
AHSV-4 (Morocco) 
This virus strain was originally isolated during the 1989-1991 AHS outbreak in 
Morocco and supplied by courtesy of Dr. S. Zientara, Maisons Alfort, France. It was 
exclusively used for immunofluorescence studies and underwent 4 passages in BHK-21 
cells at IAH Pirbright. 
2.2.3 Virus propagation 
175 cm2 flasks containing a 90% confluent monolayer of BHK-21 cells had their 
growth medium removed and were inoculated with 100 µl of virus solution, containing 
AHSV at circa 4 1og10TCID50. After approximately 30 min incubation at room 
temperature the virus was removed and maintenance medium was added. Cells were 
then incubated at 37°C until full CPE was observed, usually after 48 to 72 h. At this 
point, the tissue culture fluid was removed and centrifuged for 5 min at 700 g to 
separate it from suspended cells. The supernatant was then removed and stored at 4°C. 
It's titre was determined using the virus infectivity assay (below) before it was used for 
experiments. 
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2.2.4 Virus infectivity assay 
Ten fold dilution series of samples were prepared in DMEM. At least four 100 
µl samples of the each dilution were added to individual wells of a 96-well tissue 
culture plate (Nunc), containing a 90% confluent monolayer of BHK-21 cells in 100 µl 
DMEM (1% FCS, 1% of 100 iu/ml penicillin and 100 µl/ml streptomycin). 100 µl 
DMEM was added instead of virus to one row per plate to act as a negative control. 
Plates were incubated at 37°C for at least seven days. From day three, plates were 
examined daily for the presence of CPE. Examination was carried out using optical 
microscopy. Inconclusive readings were verified by an indirect sandwich, antigen 
detection ELISA (below). Virus infectivity was calculated using the method of 
Spearman and Kärber and expressed as log1OTCID50/ml (Kärber, 1931): 
TCIDso /volume =X o- 
d+ dIxi 
2n 
Xo - highest dilution at which all wells were positive (showed CPE) 
d- loglo of the dilution step (loglol0 = 1) 
n- number of wells (replicates) per dilution tested 
I X; - sum of all positive wells above and including X0. 
Example: Loglo virus dilution Number of positive wells/number of replicates per dilution 
0 4/4 
1 4/4 
2 1/4 
3 0/4 
TCID50 /100, u1=1- 
1+1 
x5=1.75 = TCID50 /Ml= 2.75 
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2.2.5 Antigen detection ELISA 
The indirect sandwich ELISA for the detection of AHSV antigen was carried out 
according to a method developed by the regional AHSV reference centre at IAH 
Pirbright (Hamblin et al., 1991). Antisera were raised against purified ISVP (AHSV 
serotype 9) and titrated prior to being used in tests to determine the optimum dilution 
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for each of them. Antisera and all other reagents were provided by courtesy of C. 
Hamblin at IAH Pirbright. 
50 µl of rabbit hyperimmune antiserum, diluted 1/1000 with coating buffer, were 
added to each well of a Dynatech ELISA plate and adsorbed in a humidity chamber for 
16 h at room temperature. The plate was washed three times with PBS and 50 µ1 
aliquots of the sample were added to the wells. The plate was then incubated on an 
orbital shaker at 37°C for 1h and washed with PBS as before. 50 µl of guinea-pig 
antiserum was added to each well at a 1/400 dilution in blocking buffer and the plates 
were incubated on an orbital shaker and washed with PBS as before. 50 µl rabbit anti- 
guinea-pig serum conjugated to horse radish peroxidase (Sigma) was added to each well 
at a dilution of 1/4000 in blocking buffer and the plates were incubated and washed as 
before. 50 µl chromagen/substrate solution (ortho-phenylene diamine at 0.4 mg/ml 
containing 0.05% H202 (30%) were added to each well. The reaction was stopped after 
15 min with 50 µl 1.25 M sulphuric acid per well. Plates were read spectro- 
photometrically at 492 nm using a "Titretek Multiscan Plus" ELISA reader. 
2.2.6 Serum neutralisation test 
AHSV strains were serotyped against reference sera obtained from the OIE 
Regional Reference Laboratory at IAH Pirbright, following an established protocol used 
by this centre. The test is based on the formation of antibody-antigen complexes when a 
virus strain is incubated with its homologous antiserum. This reaction is serotype- 
specific and dependent on the antigen-antibody ratio. When the antibody concentration 
is sufficiently high then all virus particles will be bound in complexes and will therefore 
not infect monolayers of susceptible BHK-21 cells. This apparent reduction in virus titre 
is visualised by the absence of CPE, which in contrast will be present at the same virus 
concentration if incubated with non-homologous serum. For an AHSV test strain to be 
identified as one of the nine serotypes, its apparent titre (calculated as for the virus 
infectivity assay above) has to be reduced by >_ 2 logio (100 fold) by the appropriate 
serum. Cross-reactions are known to occur between the following serotypes: 1-2,3-7,5- 
8 and 6-9 (Lord et al., 1998). 
10% horse serum was heat-inactivated by 30 min incubation at 56°C and added 
to microtitration plates at 100 µl/well. Test virus solution was diluted ten fold in tissue 
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culture fluid and added to these wells at concentrations of 10-1 to 10-7 of the original 
tissue culture supernatant. Plates were then incubated at 37°C and 5% CO2 for one hour, 
4°C overnight and again at 37°C and 5% CO2 for one hour. This was followed by the 
addition of 50 µl BHK-21 cells in tissue culture supernatant with 3% FCS at 105 
cells/ml. Plates were then incubated at 37°C and 5% CO2 for seven days and examined 
for the presence of CPE daily from day three. Every sample and dilution was tested in 
quadruplicates using sera against all nine serotypes of the virus. Controls were included 
for each virus strain tested and included one control of BHK-21 cells in tissue 
culture/FCS only, with no serum and no virus added. This was to ensure that the cells 
used in the test were viable. A second control contained cells and titrated virus but no 
serum. This was in effect a virus infectivity assay as described in section 2.2.4 and 
served to established the virus titre present in the sample and the reduction in AHSV 
infectivity caused by each reference serum. A third control contained cells and titrated 
virus but AHSV-seronegative (normal) horse serum. This controlled the quality of the 
reference sera and measured their non-specific binding of AHSV. 
2.3 Insects 
2.3.1 Origin and identity 
The identity of the insects used for this work is summarised in Table 2-3 (page 
55). C. sonorensis and C. nubeculosus were obtained from the Pirbright laboratory 
colonies of these insect species. C. imicola and C. bolitinos were collected nightly 
between February and March 2000 near livestock in South Africa, using down-draught 
suction light traps equipped with 8W UV light tubes (Venter et al., 1998). Catching 
sites for C. imicola and C. bolitinos are shown in Figure 2-1 (page 55). Mosquito 
netting was placed around the traps to prevent the capture of larger insects. Midges were 
collected into plastic beakers with crumpled paper providing shelter from the down- 
draught of the trap. Insects were collected each morning before sunrise and transferred 
into unwaxed cardboard cups with mesh tops. They were then maintained at 23.5±1°C 
with a 10% sucrose solution medicated with penicillin, gentamycin and streptomycin. 
They were starved for 24 h before blood-feeding to increase their feeding rate. 
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Figure 2-1: Catching sites for Culicoides insects in South Africa 
(A) Onderstepoort, (B) Clarens 
Table 2-3: Culicoides insects used in this work 
Z, 
-- ýr 
Insect species (subgenus); 
Vector status 
Natural Origin of insects in 
designation distribution experiments 
C. sonorensis (Monoculicoides), 
BTV field vector, AHSV 
formerly C. variipennis sonorensis; 
model vector with high 
vector-competent colony (VC), 
oral susceptibility 
previously named PIRB-s-3 
BTV field vector, AHSV 
C. sonorensis non-competent 
model vector with low 
colony (NVC) 
oral susceptibility 
Major AHSV field 
C. i, nicola (Avaritia) 
vector 
AHSV field vector, 
C. bolitinos (Avaritia) probably of regional 
significance 
For the USA Taken from the wild in 1957 and 
and Canada, see colonised in Denver, USA; since 1967 
Figure 1-1, page maintained at Pirbright, UK, selection of 
13; also in females for/against oral susceptibility to 
Mexico AHSV-9 over 3 generations 
Africa, S and Live wild catches at Onderstepoort near 
SE Asia, some Pretoria (25°29'S, 28°11'E; 1219 m 
parts of S a. s. l. ) and Clarens (eastern Free State at 
Europe (Figure 28°32'S, 28°25'E; 1631 m a. s. l. ), S. 
1-2, page 14) Africa 
Live wild catches at Clarens, S. Africa 
Southern Africa 
(see above) 
Usually refractory to oral 
Palaearctic 
Taken from the wild in Hertfordshire in 
C. nubeculosus (Monoculicoides) infection with AHSV or 1969 and maintained at Pirbright since Eurasia 
BTV 1971 
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2.3.2 Oral infection and maintenance of C. sonorensis and C. nubeculosus insects 
C. sonorensis and C. nubeculosus were orally infected at the Pirbright laboratory 
following a method described previously (Mellor et al., 1974), with the chick skin 
membrane being replaced by a parafilm membrane (Figure 2-2, page 57). Three-day-old 
adult insects were used in all experiments unless stated otherwise. They were allowed to 
feed on a 1: 1 mixture of AHSV solution (infected BHK-21 tissue culture supernatant) 
and fresh heparinised horse blood for approximately 30 min. After feeding, fully 
engorged females were selected under a CO2 induced anaesthesia and placed in a 
meshtop, waxed card pillbox (max. 150 individuals/box). They were maintained at 25°C 
and provided daily with a 10% sucrose solution, supplemented with 100 iu/ml 
penicillin, 100 µl/ml streptomycin and 2.5 µl/ml fungizone. At the end of the nine-day 
extrinsic incubation period, survivors were selected under CO2 anaesthesia and stored 
individually in Eppendorf tubes at -70°C until assayed unless stated otherwise. 
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Figure 2-2: Oral feeding apparatus for C. sonorensis and C. nubeculosus 
(reproduced with permission from Wittmann, 2000) 
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Figure 2-3: Oral feeding apparatus for C. imicola and C. bolitinos 
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2.3.3 Oral infection and maintenance of C. imicola and C. bolitinos insects 
Insects were collected and maintained until blood-feeding as described in section 
2.3.1. They were blood-fed through a one-day-old chick skin membrane using a 
previously described method (Venter et al., 1991; Figure 2-3). Defibrinated, AHSV- 
negative and AHSV-seronegative horse blood was used to produce a suspension of 10% 
AHSV solution (in tissue culture supernatant) and 90% horse blood. A sample of the 
blood meal was taken before and after blood-feeding, stored at -70°C and later assayed 
to ensure that there was no significant drop in virus titre during the course of the blood 
meal. Feeding lasted 30 min and was carried out at 23.5°C, 50-70% relative humidity 
and approximately 1% daylight. The blood meal had a temperature of 37°C. Engorged 
females were immobilised at -10°C and then transferred to a chill table. Fully engorged 
Culicoides were selected and placed in an unwaxed cardboard cup with a fine mesh top. 
They were maintained at 23.5°C with a cotton wool pad soaked in a 10% medicated 
sucrose solution as before the blood meal. After 10 days, surviving Culicoides were 
identified to species level on the chill table and individually stored in Eppendorf tubes 
at -70°C until assayed. 
2.3.4 Intrathoracic (IT) inoculation of C. sonorensis and C. nubeculosus insects 
Insects were inoculated into the thorax with AHSV using a procedure described 
by Boorman (Boorman, 1975). Briefly, a semiautomatic device was used (Figure 2-4, 
page 59). It is based on the controlled release of air pressure to force the inoculum into 
the body of the insect and allows constant volumes to be inoculated. The applied air 
pressure and the time for which pressure is applied can both be controlled individually 
and compensate for variation in aperture size between needles. 
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Figure 2-4: Schematic of a semi-automatic insect inoculation device 
(reproduced from Boorman, 1975) 
2.3.5 Grinding of insect samples 
Insect samples to be assayed for the presence of virus were defrosted, 
individually ground with motor-driven plastic pestles (Anachem) in 1.5 ml Eppendorf 
tubes and suspended in 1 ml of tissue culture fluid. Antibiotics and an antifungal agent 
were added at 100 iu/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml fungizone. 
Samples were then assayed as described in section 2.2.4, page 52. 
2.4 Electrophoresis 
2.4.1 Agarose gel electrophoresis 
Agarose gels consisted of 0.8% agarose or low melting point agarose in TAE 
buffer. Agarose was melted in a microwave and ethidium bromide (10 mg/ml) was 
diluted 1: 10,000 into the solution before gels were poured. Electrophoresis was carried 
out in TAE buffer at 80-120 V for 30-40 min. Samples were visualised under UV light. 
2.4.2 SDS-PAGE 
Samples were mixed 1 in 5 in 5x ESB. Protein samples were denatured with a 
freeze-boil cycle. Analysis by 11% SDS polyacrylamide gel electrophoresis (PAGE) 
was carried out using a method adapted from Laemmli (1970). Resolving gels (1.5 mm 
compressed 
air 
filter 
needle 
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thick, 15 cm wide, 16 cm long) were run with Tris-glycine buffer at up to 200 V/60 mA 
until the dye front reached the bottom of the resolving gel. Gels were then used for 
RNA cross-hybridisation experiments (see sections 2.5.13 and 2.5.14, page 64) or dried 
onto Whatman 3 MM filter paper on a vacuum dryer (Hoefer) at 60°C for 4h and 
exposed to X-ray film. 
2.5 Biochemical and molecular techniques 
2.5.1 RNA extraction 
Virus RNA was extracted following a modified protocol published in 1981 
(Clarke & McCrae, 1981). Alternatively, RNA was extracted using Trizol (Life 
Technologies) according to the manufacturer's instructions. 
2.5.2 Reverse transcription of virus genome segment 10 
Reverse transcription (RT) from dsRNA to cDNA was carried out using 
modified standard protocols (Sambrook et al., 1989). 3 pg of genomic virus dsRNA was 
mixed with 1 . tl of each primer (at 25 pmol/µl) in H2O (total volume 10 µl), denatured 
at 95°C for 5 min and immediately transferred to chilled methanol (stored at -70°C) to 
facilitate primer-binding before renaturing of dsRNA strands would set in. The RNA- 
primer mix was then incubated with 2 tl methyl-mercapto-hydroxide at room 
temperature for 10 min. This reducing reaction was stopped with 1 tl 0.7 M ß- 
mercapto-ethylamine. After a further 5 min the whole reaction mix was added to a 
premix of 1 µl RNAsin, 5 µl lOx RT reaction buffer, 2.5 µl DTT, 2 µl 20 mM dNTP mix 
and 24.5 µl H2O (total volume 48 µl). Heating of this mix to 37°C was followed by the 
addition of 2 tl reverse transcriptase and incubation at 37°C for 40 to 60 min. Reverse 
transcriptase RT reaction buffer were supplied by Life Technologies. Primers used were 
those published by Martin et al. (1998): (5' GTTTA AATTA TCCCT TGTC... 3') 
upstream and (5' GTAAG TCGTT ATCCC GGCT... 3') downstream and were supplied 
by Cruachem or MWG 
2.5.3 PCR amplification of genome segment 10 
cDNA was amplified by using standard protocols (Sambrook et al., 1989). 5 
of the RT reaction product (above) was used in the following reaction mix: 
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- 10 µl lOx reaction buffer 
-1 µl DTT 
- 2µldNTPmix 
-2 µl MgC12 (50 mM) 
-2 µl primer 1 (25 pmoUµl) 
-2 µl primer 2 (25 pmol/µl) 
-5 µl RT reaction product 
- 75 µl H2O 
-1 µl taq polymerase 
The mix was vortexed, spun down to the bottom of the tube and overlayed with 
mineral oil. The PCR reaction included an initial 5 min denaturation at 95°C, followed 
by 30 cycles of 1 min denaturing at 95°C, 1 min annealing at 55°C and 1 min extending 
at 72°C. The last cycle was followed by an extra 7 min extension time at 72°C. The 
reaction was carried out with taq polymerase and reaction buffer supplied by Roche 
Pharmaceuticals. Primers used were the same as those used in the RT reaction. 
2.5.4 Alternative RT-PCR protocol 
RT-PCR reactions were also carried out using a kit supplied by Amersham 
Pharmacia. The kit consists of ready-to-use beads that include all the reagents required 
for the reverse transcription and the amplification steps of the reaction. 
The primer-template mix was heated to 95°C for 3 min, placed on ice for 2 min 
and then added to the beads which had been reconstituted with milli-Q water. Primers 
were the same as in section 2.5.2 above. Reaction conditions were those described in 
2.5.2 and 2.5.3, with the PCR reaction immediately succeeding the RT reaction. The 
main advantages of this protocol are better standardisation of the reaction, a reduction in 
pipetting (= potential for error or contamination) and a combination of the RT and PCR 
steps in one tube, combined in one program on the thermocycler. 
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2.5.5 Purification of cDNA 
PCR products were excised from a LMP (low melting point) agarose gel and 
extracted using phenol/phenol-chloroform/chloroform (Sambrook et al., 1989). 
2.5.6 Ligation of cDNA 
DNA fragments were ligated into plasmids with the pGEM-T Easy Vector 
System I (Promega), using T4 DNA Ligase and 2x Rapid Ligation Buffer. 
2.5.7 Transformation of E. coli 
25 ml of SOB medium was mixed with 0.5 ml of 1M Glucose and 250 µl of 2 
M Mgt+. The resulting growth medium was inoculated with three to five colonies of XL 
I Blue cells and the culture shaken overnight at 37°C. 25 ml of SOB medium, 0.5 ml of 
1M Glucose and 250 µl of 2M Mg2+ was inoculated with 100 µl of that overnight 
culture and shaken at 37°C until it reached an OD600 of 0.4-0.6. The culture was then 
placed on ice for 10 min, transferred to a universal and spun for 10 min at 100 g and 
4°C. 
The pellet was gently resuspended in 12.5 ml of ice-cold transformation buffer 
(TFB), placed on ice for 10 min, spun for 10 min at 100 g, resuspended in 2 ml TFB and 
placed on ice for 5 min. Dimethyl formamide (DMF) was added to 3.5% (70 µl) and the 
solution swirled and placed on ice for 5 min. 70 µl ß-mercapto-ethanol in 10 mM K- 
IVES (5.2 µl ß-mercapto-ethanol + 100 µl K-MES) was added and the tubes placed on 
ice for a further 10 min. Another 70 µl DMF was added, the solution swirled and 
aliquoted into 200 µl quantities. 
10 µl ligation mix was added to the fresh competent cells, mixed by inverting 
and placed on ice for 30 min. The cells were then heat shocked at 42°C for 45 seconds, 
added to 800 µl SOB medium and shaken for 1h at 37°C. 
The transformed cells were spread on LB ampicillin IPTG (Isopropylthio-ß-D- 
galactoside) & X-gal (5-bromo-4-chloro-3-indolyl-ß-D-galactosidase) agar plates and 
incubated overnight at 37°C. Positive (white) colonies were picked with cocktail sticks, 
cultured in 10 ml LB media containing ampicillin and used for DNA minipreparation. 
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2.5.8 Minipreparation of DNA 
An overnight culture of bacteria transformed with plasmid DNA was centrifuged 
at 100 g for 10 min. The supernatant was stored at 4°C for maxipreparations, the pellet 
resuspended in 0.1 ml solution I and placed at room temperature for 5 min. 0.2 ml 
solution II was added, the mixture inverted several times and left on ice for 10 min. 0.15 
ml solution III was added, the tubes were vortexed and placed on ice for a further 5 min. 
Cell debris was removed by 5 min centrifugation at 1200 g and 4°C, followed by the 
addition of 300 µl isopropanol to the supernatant. After vortexing and 2 min 
centrifugation at 1200 g, the pellet was resuspended in 100 µl TE and the DNA 
precipitated with the addition of 10 µl 3M sodium acetate in 330 µl ethanol and 
incubation on ice for 2 min. The DNA was pelleted at 1200 g for 5 min, resuspended in 
50 gl TE and stored at -20°C. 
2.5.9 Restriction endonuclease analysis 
DNA minipreparations were used to check plasmids for the presence of correct- 
size inserts. These pGEM-T Easy plasmid digests were carried out using 1 µl EcoRI 
enzyme, 1 µl RNAse A, 2 µl 10x buffer H or Multi-Core (all provided by Promega) and 
1 µg DNA in a reaction volume of 20 µl. Incubation for 1h at 37°C was followed by 
agarose gel electrophoresis. 
2.5.10 Maxipreparation of DNA 
Midi- and Maxipreparations of DNA were carried out using QUIAGEN Midi 
and Maxi kits, following protocols provided by the manufacturer. 
2.5.11 Sequencing of plasmid DNA 
Plasmid DNA was sequenced using a cycle sequencing kit (ALFexpress 
AutoCycle Sequencing Kit, supplied by Pharmacia). Electrophoresis was carried out 
and results were processed on an ALFexpress automatic sequencing machine 
(Pharmacia). DNA sequences were exported into the sequence analysis programs GCG 
10 and GeneDoc and analysed as described in section 2.6 (page 67). 
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2.5.12 RNA probe production 
A RNA probe for cross-hybridisation was produced following a modified 
published protocol (Mertens et al., 1987). Approximately 1 µg of dsRNA was 
fragmented in 100 µl 0.1 M NaOH at 0°C. The reaction was stopped after 10 min with 
15 µl 1M acetic acid and 10 µl 1M Tris-HC1(pH 8.0). The RNA was then precipitated, 
washed and dried as described in the RNA extraction protocol. [32P]-labelling was 
carried out by adding 2 µl [Y32 PIdATP, 2 µl polynucleotide kinase, 86 µl H2O and 10 µl 
lOx kinase reaction buffer, followed by 40 min incubation at 37°C (Sambrook et al., 
1989). Labelled dsRNA was then separated from unincorporated label using a Sephadex 
G100 column and stored in THE buffer at -20°C. 
2.5.13 dsRNA blotting 
Transfer of denatured dsRNA from the polyacrylamide gel to a Hybond-N 
transfer membrane was carried out using a 2117 MULTIPHOR II electrophoresis unit. 
Twelve pieces of Whatman 3 MM filter paper and the transfer membrane were all cut to 
gel size and thoroughly soaked in blotting buffer (2.93 g glycine, 5.81 g Tris, 0.375 g 
SDS in 11 dH2O) prior to assembly of the blotting unit. The gel was then placed 
between nine layers of filter paper on the anodic side and three layers of filter paper on 
the catodic side. Electrophoresis was carried out at 250 V, 25 W for 3.5 h. 
2.5.14 Cross-hybridisation of AHSV dsRNA 
Samples of AHSV genomic dsRNA were subjected to SDS-PAGE. Each lane A 
was loaded with approximately 3000 cpm of the AHSV genomic RNA, which had been 
[32P]pCp-labelled with RNA ligase. This radio-labelled RNA served as a size marker for 
the unlabelled genomic dsRNA of the same AHSV strain that was loaded in each lane B 
at about 1 µg per lane. 
The dsRNA was denatured by soaking the gel in 0.1 M NaOH for 30 min 
immediately after electrophoresis (24 h at 150 V). The gel was then washed in blotting 
buffer (section 2.5.13), blotting of dsRNA onto a Hybond-N transfer membrane 
(Amersham) was carried out as described in above and the dsRNA was crosslinked to 
the transfer membrane with a Spectrolinker XL-1000 (Spectrometers Corporation). The 
membrane was incubated in prehybridisation buffer for 4h at 50°C and then incubated 
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for a further 16 h in the hybridisation solution/RNA probe mixture. The probe was 
boiled for 3 min immediately before addition to the preheated hybridisation buffer. 
Hybridisation was followed by four washes with 2x SSC containing 0.1% SDS at room 
temperature and two washes with 0.1x SSC containing 0.1% SDS at 58°C. Each wash 
lasted 15 min. The membrane was then dried and autoradiographed at -70°C. 
Alternatively, a phosphor imaging screen was used. 
2.5.15 Conjugation of peptide to keyhole limpet haemocyanin (KLH) via SMCC 
SMCC [Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carbonate, Pierce] 
contains an activated carboxyl group at one end which can react with amino groups, but 
also a maleimido group at the opposite end that reacts with the sulfhydryl group of 
cysteine residues. SMCC can therefore be used as a crosslinker between the peptide and 
carrier proteins such as KLH (Pierce). SMCC was reacted with the amino groups on the 
carrier protein: 150 µl KLH (10 mg/ml in dH2O) plus 100 µl SMCC (4 mg/ml in dH2O) 
at room temperature for Ih, followed by removal of unreacted crosslinker using a 
desalting column. 10 mg peptide was dissolved in 0.5 ml DMSO and 1.5 ml dH2O. 10 
mg of the SMCC-activated KLH was added and the reaction mix incubated for 4h at 
room temperature. The solution was then dialysed overnight against PBS, using a Slide- 
a-Lyzer dialysis cassette (Pierce). The peptide-KLH conjugate was used to immunise 
guinea pigs and rabbits. 
2.5.16 Sample fixation for immunofluorescent microscopy 
KC cell monolayers on microscopy coverslips or freshly dissected Culicoides 
guts were incubated with 4% paraformaldehyde for 30 min (guts 45 min), washed with 
PBS three times and permeabilised in PBS plus 0.5% Triton X-100 for 10 (15) min. 
Samples were rinsed with PBS three times and stored at 4°C or processed for 
immunofluorescence microscopy immediately. 
2.5.17 Staining protocol for immunofluorescent microscopy 
Fixed samples were blocked with 1% BSA in PBS for 1 h. Primary antibodies 
were added to the blocking buffer and incubated with the samples for a further hour. 
This was followed by five washes with PBS and incubation with the appropriate 
secondary antibodies (Table 2-4) for 1 h. Three PBS washes were then followed by 
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sample mounting on microscopy slides in Vectashield mounting medium (Vector 
Laboratories, Burlingame, USA). Alternatively, samples were successively incubated 
for 30 min with one of Texas Red-Wheat Germ Agglutinin, Oregon Green-Phalloidin 
and TO-PRO-3 (Table 2-4). Samples were washed in PBS three times after each 
incubation and then mounted on microscopy slides. All incubations were carried out at 
room temperature. 
Table 2-4: Fluorophore-conjugated secondary antibodies and stains used in 
immunofluorescence microscopy 
Antibody/Stain' Target Colour 
Goat anti-Guinea Pig antibody 488 nm 
Goat anti-Guinea Pig antibody 594 nm 
Goat anti-Rabbit antibody 594 nm 
Goat anti-Mouse antibody 594 nm 
Texas Red-Wheat Germ Agglutinin 
Oregon Green-Phalloidin 
Guinea Pig IgG Green 
Guinea Pig IgG Red 
Rabbit IgG Red 
Mouse IgG Red 
Lectins in cell membranes Red 
Actin filaments Green 
TO-PRO-3 DNA, RNA Blue 
1 
supplied by Molecular Probes, Eugene, USA 
2.5.18 Western blots 
Infected or uninfected cells were lysed with lysis buffer (Promega) 24 h (post 
infection (pi) and stored at -20°C if necessary. Lysates were then denatured at 100°C for 
5 min and the proteins resolved by SDS-PAGE on mini-gels (Bio-Rad) in conjunction 
with a pre-stained broad range protein marker (New England Bio-labs) at 200 V and 
400 mA until the dye front ran off the bottom of the gel. Proteins were transferred onto 
an Immobilon P membrane (Millipore) in transfer buffer (see section 2.1, page 45) at 
100 V and 400 mA for 1 h. The membrane was placed into 10 ml blocking buffer 
(section 2.1) in a 50 ml Falcon tube and incubated overnight with constant rotation. 
For development, the primary antibody was added to the tube and incubated for 
1h under constant rotation. The membrane was washed twice for 30 sec and then twice 
for 10 min in TB S/ I% Tween. It was then incubated with the secondary antibody (15 t1 
anti-rabbit peroxidase-linked antibody, Amersham) in 10 ml blocking buffer for 1h 
with constant rotation and washed as before. Blots were developed by incubating with 
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Luminol enhancer and Stable Peroxide (2.5 ml of each, SuperSignal, Pierce) for 1 min. 
Blots were immediately wrapped in Saran wrap and exposed to film. 
2.6 Nucleotide and protein sequence analysis 
Nucleotide sequences obtained with the ALF automatic sequencing machine 
were imported into GCG 10, aligned and exported into GeneDoc (version 2.6) as a 
multisequence file (MSF). Further alignment, translation into predicted protein 
sequences and comparison to other predicted protein sequences (imported from 
databases such as TrEMBL and SwissProt) were carried out in GeneDoc. The output 
was used to grow unrooted neighbour joining trees in GCG 10, using the "distances" 
command. The resulting trees were edited in TreeView (version 1.6.6). GeneDoc files of 
protein sequences were searched for potential motifs using a PROSITE database of such 
motifs. Transmembrane arrangements of individual NS3 sequences were predicted 
using GCG 10 and the web-based programs TMBN M, TMAP and HMMTOP (listed at 
http: //ca. expasy. org/tools/#pattern). 
2.7 Statistical data analysis 
Datasets were tested for statistical significance between them using a Chi- 
Square (, j) test. This test compares the number of positives and the number of 
negatives in a series of datasets to the numbers that would be expected to occur if the 
datasets belonged to the same entity. Differences between expected and real values 
receive a score and on the basis of these scores a Z' value is calculated. At p=0.05, 
Z2>3.84 indicates a statistically significant difference at one degree of freedom (df. =1) 
and f>7.81 indicates statistical significance at d. f. =3. A p-value of 0.05 denotes a 5% 
chance that the conclusion of statistical significance reached by the test is incorrect. 
Lower p-values indicate a lower risk of an erroneous result, e. g. p=0.01 means 1% 
likelihood that the stated test result is incorrect. The degree of freedom is calculated as 
n-1 where n is the number of datasets compared. For instance, for a comparison of 
infection rates between two populations of an insect species: d. f. =2-1=1. If more than 
two datasets are compared (e. g. four batches of an insect colony infected with four 
different viruses, d. f. =3) and the test indicates statistically significant differences 
between them, then significant differences may be found in one, more than one or all six 
pairwise comparisons of these four batches. 
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3 Characterisation of AHSV strains 
3.1 Introduction 
Virus characteristics, including sample origin, passage history, serotype and 
attenuation level are important for the correct interpretation of experimental results. 
This chapter focusses on the two reassortant viruses AHSV-A79 and AHSV-A790 
because they are a very important tool for establishing the role of NS3/3a in AHSV 
infection of the insect vector. 
AHSV-A790 and AHSV-A79 were produced in the Orbivirus group at IAH 
Pirbright by Dr. R. O'Hara (O'Hara, 1994; O'Hara et al., 1998). They were derived from 
the parent strains AHSV-3att and AHSV-8wt through co-infection of BHK-21 cells, 
followed by three plaque purifications. The origin of their 10 genome segments was 
determined by SDS-PAGE, taking advantage of the variation in migration speed of the 
dsRNA genome segments between the two parent strains. Since segment 9 of AHSV- 
3att co-migrates with that of AHSV-8wt, this segment was sequenced in each of the 
reassortant viruses (O'Hara et al., 1998). Origins and passage histories for the 
reassortant virus strains and all other viruses used in this work are shown in section 
2.2.2 (page 49). 
The first aim of this chapter was to confirm the identity of the two reassortant 
viruses. These two viruses and their parent virus strains AHSV-8wt and AHSV-3att 
were characterised using a serum neutralisation test (SNT), polyacrylamide gel 
electrophoresis (SDS-PAGE) and cDNA sequencing (section 2, page 45). 
The second aim of this chapter was to identify motifs of potential biological 
significance in the NS3 and NS3a sequences and any differences in these regions 
between the two reassortant viruses. Such motifs include, for instance, ubiquitinase- 
binding motifs (see section 1.2.3, page 26), myristylation motifs (membrane anchors) 
and glycosylation sites. The presence of such motifs does not demonstrate that they are 
biologically active. However, differences in the presence or distribution of these and 
other motifs could account for different biological virus properties conferred by the two 
variants of the protein. 
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To identify potentially significant motifs, genome segment 10 cDNA sequences 
were translated into protein sequences and analysed as described in section 2.6 (page 
67). Full NS3 sequences were analysed wherever possible. Therefore, this chapter does 
not collectively refer to the two proteins as NS3/3a, as do other sections of this thesis. 
NS3 proteins differ from the corresponding NS3a sequences by the presence of 10 to 11 
additional, in-frame, N-terminal amino acid (aa) residues. 
3.2 Results 
3.2.1 Serum neutralisation test 
The results of the SNT are shown in Table 3-1. The titre of AHSV-3att was 
reduced from 6.01og10TCID50/ml (titre with normal horse serum) to 3.01og10TCID50/ml 
with anti-serotype 3 serum, a reduction by 3.0 1og10TCID50/ml. Other sera reduced the 
AHSV-3att titre by much smaller and insignificant margins, ranging from 0 
log10TCID50/ml (serotype 4) to 1.25 1og10TCID50/ml (serotype 7). 
The titres of AHSV A790, AHSV-A79 and 8wt were most heavily reduced by 
anti-serotype 8 serum. This serum caused a reduction in virus titre (compared to normal 
horse serum) of 3.25,3.5 and 3.5 1og10TCID50/ml, respectively. Antisera to other 
serotypes reduced the virus titres by 0.25-1.0 1og1OTCID50/ml (AHSV-A790), 0.25-1.5 
1og1OTCID50/ml (AHSV-A79) and 0.25-1.25 1og10TCID50/ml (AHSV-8wt), with 
antiserum to serotype 5 causing the largest reduction in all three viruses. 
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Table 3-1: Serum neutralisation test with four AHSV strains 
Serum serotype 
Normal 
horse 123456789 
serum 
AHSV-3att 6.0 5.5 5.5 3.0 6.0 5.25 5.25 4.75 5.5 5.5 
AHSV-A790 6.0 5.25 5.25 5.75 5.5 5.0 5.5 5.75 2.75 5.25 
AHSV-A79 7.0 6.0 6.25 6.5 6.75 5.5 6.0 6.25 3.5 6.0 
AHSV-8wt 6.5 5.75 5.5 6.0 6.25 5.25 5.5 5.75 3.0 5.75 
Ten-fold dilution series of AHSV strains were incubated with normal horse serum (negative control), or 
horse serum raised against one of the nine AHSV serotypes, in 96-well microtitration plates. BHK-21 
cells were added and formed a monolayer at the bottom of the wells. Neutralisation of AHSV by 
homologous antibodies abolished viral CPE in the BHK-21 cells. CPE was looked for between days 3 and 
7. Virus titres were calculated in loglo TCID50/ml (Kärber, 1931). A virus titre reduction of at least 2 loglo 
TCID50/ml against one serum compared to all others, indicated that the tested virus was homologous to 
this serum. Cross-reactions commonly occur between the following serotypes: 1-2,3-7,5-8 and 6-9 (Lord 
et al., 1998). Titres in red signify a titre reduction that indicates that the virus belongs to the serotype 
tested. 
'-Negative control serum. 
3.2.2 Polyacrylamide gel electrophoresis 
SDS-PAGE was carried out, as described in section 2.4.2 (page 59), to confirm 
the origin of the genome segments in the reassortant viruses. Figure 3-1 A) (page 71) 
shows that segment 10 of AHSV-A790 migrated at the same speed as segment 10 of 
AHSV 3att, while AHSV-A79 segment 10 migrated at the same speed as AHSV-8wt 
segment 10. Figure 3-1 B) shows that AHSV-A790 and AHSV-A79 segments 1-6 and 8 
migrated at the same rate as those of AHSV-8wt and that AHSV-A790 and AHSV-A79 
segments 7 migrated at the same rate as that of AHSV-3att. Segment 9 migrated at the 
same speed in all four virus strains. 
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Figure 3-1: SDS-PAGE images of dsRNA genomes: Reassortant 
viruses AHSV-A790 and AHSV-A79; parent virus strains AHSV-3att 
and AHSV-8wt 
A) This image shows that segments 10 of AHSV-8wt and AHSV-A79 (left) co-migrate, 
as do segments 10 of AHSV-A790 and AHSV-3att (right), (red arrows). 
B) This gel contained more evenly matched amounts of AHSV-A79 and AHSV-A790 
dsRNA and shows that these two virus strains are identical with AHSV-8wt in the 
migratory pattern of segments 1-6 and 8, but identical with AHSV-3att for segment 
7. The identity of reassortant segment 9 cannot be established from this image but 
was previously established by sequencing (O Hara et al., 1998). The identity of 
reassortant segment 10 is not obvious from B) due to insufficient separation (shorter 
running time) but is visible in A). 
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3.2.3 Sequencing of genome segment 10 
Figure 3-2 (page 74) shows the alignment of predicted amino acid sequences for 
NS3 of reassortant and parent virus strains. These were obtained through cDNA 
sequencing of genome segment 10 from AHSV A790, AHSV-A79, AHSV-8wt, or were 
retrieved from the EMBL database in the case of AHSV-3att (which had previously 
been sequenced in the Orbivirus group). Sequencing of AHSV-8wt did not result in a 
full-length segment 10 sequence and the predicted sequence of its NS3 therefore starts 
at as residue 12. This corresponds to as residue 1 for virus protein NS3a in this virus 
strain. 
The figure illustrates that the two reassortant viruses AHSV-A790 and AHSV- 
A79 differ in 57 out of 217 as residues of NS3, equivalent to 26% protein sequence 
variation. It also shows that AHSV-A790 NS3 is identical with AHSV-3att in 215 of 
217 residues (>99% homology), while homology between AHSV-A79 and AHSV-8wt 
is >99.5% (205 of 206 residues). The type of NS3 found in AHSV-A79 and AHSV-8wt 
((x group, Figure 3-3, page 75) is very highly conserved at the N-terminal (appendix I, 
page 160), the region missing from the AHSV-8wt sequence. 
Figure 3-2 shows potential myristylation, ubiquitin ligase-recruiting and 
glycosylation motifs. AHSV-3att and AHSV-A790 each possess two potential 
myristylation motifs near the NS3 N-terminal (aa 15 and as 37), which are absent in 
AHSV-8wt and AHSV-A79. The latter two viruses each possess one potential 
myristylation site near the NS3 C-terminal (aa 211), which is absent in AHSV-3att and 
AHSV-A790. A further myristylation site and an ubiquitin ligase recruiting motif are 
conserved in NS3's of all four viruses. NS3 of AHSV-A79 shows a potential N- 
glycosylation site at as 9, which is absent in AHSV-3att and AHSV-A790 (with no 
AHSV-8wt sequence available for this domain). However, appendix I shows that this 
region is identical for all but one of the a-group NS3 available. 
Figure 3-3 illustrates the differences in the NS3 amino acid sequences between 
the reassortant viruses and their parent strains, in the context of other available AHSV 
NS3 sequences. It confirms that the NS3 proteins of AHSV-A79 and AHSV-A790 
cluster into different groups ((x and ß groups, respectively), alongside their parent 
strains. The figure also illustrates previous observations that the type of NS3 does not 
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always correlate with serotype (van Niekerk et al., 2001b). Isolates of AHSV-8 cluster 
into all three groups, while isolates of AHSV 1 cluster into two groups. 
Figure 3-4 (page 76) shows the predicted configuration of NS3 in the 
cytoplasmic membrane for AHSV-A79 (a group) and AHSV-A790 (ß group) together 
with ay group, serotype 8 virus (ST8_Q64905; prediction method see section 2.6, page 
67). It illustrates that NS3 of AHSV-A79 is likely to have two transmembrane regions, 
thus conforming to the model suggested by van Staden et al. (1995). In contrast, NS3 of 
AHSV-A790 is more likely to possess only one transmembrane region (as is 
ST8_Q64905). These protein configurations are representative for all NS3 sequences 
from the three clusters, with the one exception of ST4_DQB5. This virus strain belongs 
to the a group (Figure 3-3) but, in the model used, is equally likely to have two 
transmembrane helices (like other (x group NS3's) or only one transmembrane region 
(like all ß and y group NS3's). 
73 
* 
AHSV-3att: 
AHSV-A790: 
AHSV-A79 : 
AHSV-8wt : 
AHSV-3att: 
AHSV-A790: 
AHSV-A79 : 
AHSV-8wt : 
AHSV -3att: 
AHSV -A790: 
AHSV -A79 : 
AHSV -8wt : 
) 
-I 
) 
40 
SQRT 
SQRT 
* 140 * 160 
AHSV-3att: i Iý DLSGD S 
AHSV-A790: ýT II DLSGDG S 
AHSV-A79 L' S 
IF 
EYKKN 
AHSV-8wt :LS EYKKN 
AHSV- 3att: 
AHSV- A790: 
AHSV- A79 : 
AHSV- 8wt : 
AHSV-3att: 
AHSV-A790: 
AHSV-A79 : 
AHSV-8wt : 
S 
DS 
Residues conserved 
across all virus strains. 
Residues conserved 
between 3att and A790. 
13 Residues conserved 
between 8wt and A79. 
Figure 3-2: NS3 protein sequence alignment of two reassortant viruses and their 
two parent strains 
Differences between NS3 sequences from parent and reassortant viruses are shown in RED/BLUE, potential 
ubiquitin ligase recruiting motifs are (' 1\'t \, potential myristylation motifs are PINK and a possible 
glycosylation motif is (, III ;l (AHSV-A79, as 9). 
Segment 10 nucleotide sequences of virus strains AHSV-8wt, A79 and A790 were obtained by sequencing their 
RT-PCR products directly or after cloning as described in section 2.5, page 60. Segment 10 of AHSV-3att was 
sequenced previously in the Orbivirus group (Martin et al., 1998) and its sequence was obtained from the EMBL 
database (AJ007304). All sequences were aligned and translated into protein sequences using GeneDoc. 
Sequencing of AHSV-8wt did not result in a full-length sequence (first 11 residues are missing, sequence 
represents full NS3a sequence). 
This figure shows >99% homology between the predicted protein sequences for AHSV-8wt and A79; and 
separately between AHSV-3att and A790. 
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Figure 3-3: Clustering of reassortant and parent virus NS3 sequences into a, ß 
and y groups of AHSV NS3 
Unrooted neighbour-joining tree of AHSV NS3 protein sequences. Reassortant viruses and their 
parent strains are highlighted in RED m, L,. upi or GREEN (r) Lroup). Protein sequences were 
obtained from SwissProt and TrEMBL databases, determined by DNA sequencing and translation 
(AHSV-A79, AHSV-8wt, AHSV-A790) or obtained from EMBL as a nucleotide sequence and 
translated (AHSV-3att, accession number AJ007304). For protein sequences obtained from 
databases, the serotype (ST) is given, followed by the accession number. Bar (bottom left) 
represents 1% variation. The tree was designed using the "distances" program in GCG 10. 
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Figure 3-4: Probable membrane associations of a, ß and y group NS3 
Probable transmembrane, cytoplasmic and extracellular locations of NS3 regions were calculated in the 
program TMHMM (available at http: //www. cbs. dtu. dk/services/TMHMM-2.0). 
All three NS3 strains are highly likely (>90%) to have their N-terminal located in the cytoplasm (blue 
Iine), to have a transmembrane helix at as 111/112-133/134 (red), followed by an extracellular domain 
(pink). This extracellular domain is predicted to stretch from as 135 to 153 in AHSV-A79, followed by 
another transmembrane helix (aa 154-173, predicted with 64% certainty) and a cytoplasmic C-terminal. 
AHSV-A790 and ST8_Q64905 are likely (62% certainty) to have only one transmembrane helix, 
followed by an extracellular C-terminal. 
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3.3 Discussion 
Identity of reassortant AHSV genome segments 
The results of the SNT confirm that AHSV-3att is a serotype 3 virus (Table 3-1, 
page 70). In addition, the reduction in titre of this virus when titrated against AHSV 
serotype 7 antiserum was greater than with any other serotype (other than serotype 3). 
This is evidence of the well-documented cross-reactivity between these two serotypes 
(Lord et al., 1998). The virus strains AHSV-A790, AHSV-A79 and AHSV-8wt all typed 
as serotype 8 viruses (Table 3-1). In addition, for all three viruses, titre reduction was 
greater when titrated against anti-serotype 5 serum than against any of the remaining 
sera. Again, this is evidence of the cross-reactivity between AHSV serotypes 5 and 8. 
The experiment confirms the serological status of AHSV-3att and AHSV-8wt. For the 
reassortant viruses, it can be concluded that the serotype-defining VP2 and VP5, 
encoded by genome segments 2 and 6, are derived from the parent AHSV-8wt. 
The results of the SDS-PAGE suggest that AHSV-A790 segment 10 is identical 
with AHSV-3att segment 10 and that the segment 10 of AHSV-A79 is identical with 
that of AHSV-8wt. The results also suggest that segments 1-6 and 8 of both reassortant 
viruses are derived from AHSV-8wt while their segment 7 is derived from AHSV-3att. 
Although all segment 9's run at the same speed and their origin therefore cannot be 
deduced from SDS-PAGE, segment 9 has previously been shown to be derived from 
AHSV-3att in both reassortant viruses by cDNA sequencing (O'Hara et al., 1998). The 
results are in keeping with previous SDS-PAGE results (O'Hara, 1994) and with the 
concept that the two reassortant virus strains differ in segment 10 only (as shown in 
Table 2-2, page 51). 
The results of the sequencing of reassortant and parent virus genome segment 
10's show conclusively that segment 10 of AHSV-A79 is derived from AHSV 8wt, 
while segment 10 of AHSV-A790 is derived from AHSV-3att. This also confirms 
previous results (O'Hara, 1994). The variation of the AHSV-A790 NS3 sequence from 
the AHSV-3att in two as residues could be due to point mutations that have occurred 
since the reassortant was derived from its parent strains, could be a gel reading error or 
could result from the RT-PCR reaction. Similarly, the single difference in NS3 sequence 
between AHSV-A79 and AHSV-8wt may have the same origin. Sequencing did not 
reveal the 11 N-terminal as residues of AHSV-8wt NS3, but the high degree of 
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conservation of this region in all a-group sequences (appendix I) strongly suggests that 
it is also conserved in this virus, and thus likely to be identical with AHSV-A79. 
Potential motifs and transmembrane regions in NS3 protein sequences 
Comparison of NS3 protein sequences was preferred over analysis of cDNA 
sequences because only variation in protein sequences is likely to lead to differences in 
the biological properties of the two reassortant viruses. This comparison also allowed 
motifs of potential biological significance to be identified. 
The identification of identically located ubiquitinase binding motifs (PPxY, at as 
25), in both reassortants and their two parent strains, means that the presence of this 
motif cannot explain biological differences between these viruses. However, the 
conservation of this motif in all a- and y-group NS3's and the majority of ß-group 
NS3's suggests that it is of biological significance. It may be that, in common with 
identical motifs in the retrovirus gag protein (see section 1.2.3, page 26), it may 
facilitate virion exit from the cell. An additional P(T/S)AP ubiquitinase binding motif, 
present in all available y-group sequences at as 30, might further enhance virion 
budding from the host cell. A combination of PPxY and P(T/S)AP motifs in close 
proximity on a chimaeric retrovirus gag protein was found to enhance budding of VLPs 
(Strack et al., 2000). 
The identification of a myristylation motif at as 60 in both reassortant viruses 
and all analysed sequences of other AHSV's (located at as 59 in y-group NS3) confirms 
the previous finding of van Niekerk et al. (2001b) and suggests that this binding site for 
the membrane anchor myristylic acid may be essential for protein targeting to the cell 
membrane. Membrane anchors are usually but not exclusively found at the N-terminal 
of the protein, for instance in HIV-1 (Zhou et al., 1994). Additional myristylation motifs 
are present in different locations in the two reassortants and are highly conserved within 
each NS3 cluster (see Figure 3-2, page 74 and appendix I, page 160). It is noteworthy 
that all possible myristylation motifs are located in predicted cytosolic protein domains, 
which is required for their functioning as membrane anchors. Interestingly, the NS3 of 
ST4_Q9DQB5, which is the only a-group protein without a C-terminal myristylation 
motif, is also the NS3, in this group, with the lowest likelihood (50%) of possessing a 
cytosolic C-terminal. 
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The potential N-terminal N-glycosylation site found in AHSV-A79 is present in 
all a-group NS3's but this region is strongly predicted to be cytosolic (indicating that 
glycosylation of this site is very unlikely). All other identified potential glycosylation 
sites are also very strongly predicted to be cytosolic or (in the y-group NS3's) to be part 
of the transmembrane helix. Glycosylation of any of the analysed NS3 variants is 
therefore highly unlikely. If this is so then it means that no known motifs are present in 
the N-terminal of NS3, which would be absent in NS3a. Such motifs, had they been 
present, could have indicated differences in protein function between NS3 and NS3a. 
Potential glycosaminoglycan-binding sites were identified in AHSV-A790, 
AHSV-3att and many other ß-group NS3's. Binding of glycosaminoglycans is a 
characteristic of secretory proteins and the significance of this motif in NS3 is unclear. 
A large number of theoretical phosphorylation sites is present in all NS3 variants but 
these are too numerous to discuss. 
In the absence of techniques for the successful rescue of orbivirus particles from 
the introduction of cDNA molecules into host cells, the significance of the potentially 
important motifs that have been discussed above could be explored by cloning and 
mutating AHSV NS3's, and expressing the mutants in a baculovirus expression system 
together with all other, wild-type AHSV proteins. Reduced or abolished budding of 
VLPs from the cell could then be related to the mutations of NS3. More simply, mutated 
NS3's could be expressed in a baculovirus system or, using vaccinia virus, they could be 
transfected into host cells. The cellular location of NS3 could then be visualised with 
anti-NS3 antibodies. Expression of NS3 with an attached Green Fluorescent Protein 
(GFP) would make it possible to follow the path of protein translocation after synthesis 
using live fluorescent microscopy. The effects of specific mutations could then be 
studied. 
The different transmembrane arrangement of the two reassortant viruses is 
predicted with only with approximately 2: 1 likelihood by the program TMHIlV M. Very 
similar results were obtained with the program GCG 10. Other programs, including the 
web-based TMAP or HMMTOP, produced different numbers of possible 
transmembrane helices (programs available at http: //ca. expasy. org/tools/#pattern). All 
programs did, however, predict more transmembrane regions, and therefore a different 
membrane arrangement, for AHSV-A79 compared to AHSV-A790. It is therefore 
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possible that this different arrangement, perhaps in conjunction with the different 
number and location of myristylation motifs, is responsible for different biological 
properties of the two viruses in mammalian and insect host systems. 
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4 Culicoides sonorensis vector competence for AHSV 
4.1 Introduction 
AHSV is endemic in many parts of sub-Saharan Africa and causes a disease of 
high mortality in horses. Its main vector is C. imicola, a small haematophagous biting 
midge which occurs in most parts of Africa, large parts of Asia and some parts of 
southern Europe, where it has probably been spreading northward over the last two 
decades (Rawlings et al., 1998). Outbreaks of AHS in Europe occurred in 1966 in Spain 
(Diaz Montilla & Panos Marti, 1968) and in 1987-1990 in the Iberian peninsula 
(Rodriguez et al., 1992; Mellor, 1993; Mellor, 1994). As a result of these outbreaks an 
effort was made to predict areas at risk from AHSV. 
The ability of AHSV to be transmitted and consequently to cause disease in the 
field depends on the availability of suitable insect vectors. Accurate prediction of at-risk 
areas therefore requires, among other things, a knowledge of vector capacity (i. e. the 
ability of the insect vector population to transmit the pathogen to the vertebrate host) 
and of how this is affected by variables in the insect, the virus strain and the 
environment (section 1.3.3, page 37). Vector competence (i. e. the ability of vector 
insects to become infected with the pathogen and transmit it to a suitable vertebrate host 
after the extrinsic incubation period, EIP) is one of the variables which determine vector 
capacity and is itself characterised by factors that can be classed as virus-defined, 
insect-defined and environmental. 
This chapter concentrates on the effects of insect-controlled factors (such as age 
and previously selected susceptibility to AHSV-9) and virus-controlled factors (such as 
variation in virus genome segment 10) on the dissemination of AHSV in C. sonorensis 
and consequently on C. sonorensis vector competence. C. sonorensis is the North 
American field vector of BTV (Jones et al., 1981) and is a well characterised model 
vector of AHSV (Boorman et al., 1975; Mellor et al., 1975; Wellby et al., 1996). Two 
laboratory colonies of this species are maintained at IAH Pirbright. They were selected 
for high vector competence (VC colony) and low vector competence (NVC colony) for 
AHSV-9 in 1995 (Wellby et al., 1996) and have been maintained without further 
selection since then (section 1.3.6, page 41). C. sonorensis is used as a model because it 
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has thus far proved impossible to establish laboratory colonies of the field vector C. 
imicola (Mellor et al., 2000). 
The first objective of this chapter was to establish the post-incubation virus titre 
that indicates a fully disseminated AHSV infection in C. sonorensis. A fully 
disseminated infection indicates infection of the salivary glands and that virus 
transmission is possible during subsequent blood meals on susceptible mammals. 
Knowledge of this titre is necessary to assess the effects of variation in insect-defined 
and virus-defined factors on virus dissemination within the insect and on vector 
competence. The BTV titre that indicates such a fully disseminated infection in the 
vector C. sonorensis is known to lie between 2.5 and 3.0 log1OTCID50/fly (Jennings & 
Mellor, 1987; Fu, 1996). These experiments, carried out by the Pirbright Arbovirology 
group, were based on virus transmission across a membrane during blood-feeding and 
release of virus during artificially induced salivation, respectively. The experiments 
described here were designed to obtain a measure of insect infectivity to mammalian 
hosts. Therefore, only methods based on the detection of live virus were considered as 
proof of virus presence in blood meals, saliva or body tissues. Methods for the 
identification of viral protein or RNA, such as ELISA, immunofluorescence 
microscopy, PCR or nuclear probes, although in some cases more sensitive, were 
considered unsuitable because of their ability to detect non-infectious viral proteins or 
RNA. Because of the complex nature of the experiments, three different methods were 
used to show fully disseminated infection in the insect: 
1) Transmission of virus during membrane-feeding. 
2) Artificial induction of salivation. 
3) Virus infectivity assay in insect heads. 
1) Detection of virus transmitted during membrane-feeding was selected as the 
method that most closely resembles virus transmission from the infected insect to a 
susceptible vertebrate host. Membrane-feeding through parafilm is a well established 
technique and has also been used in this chapter for infecting C. sonorensis and C. 
nubeculosus by the oral route (see 2.3.2, page 56). 
2) Salivation was artificially induced by the application of Malathion (malathion 
500 g/1; Murphy Chemical Co., Wheathamstead, Hertfordshire). Malathion contains the 
organophosphate diethyl-(dimethoxythiophosphorylthio)succinate (C10H1906PS2) and 
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inhibits cholinesterase. The subsequent accumulation of the neurotransmitter 
acetylcholin at cholinergic synapses of the peripheral and central nervous system has 
various effects across the body. One of these effects is the overstimulation of the 
salivary glands and excessive salivation. The amount of virus secreted during 
Malathion-induced salivation, therefore, may not reflect the quantities released during 
blood-feeding. The presence of virus in the saliva will, however, prove that the virus has 
disseminated throughout the insect body and has infected the salivary glands. 
3) Previous observations indicate that salivary gland infection or exit barriers do 
not exist in Culicoides species (Fu et al., 1999; Mellor et al., 2000), i. e. if the virus has 
replicated in secondary target organs such as the neuronal ganglia of the head, it will 
also have replicated in the salivary glands and will be secreted with the saliva during 
blood-feeding (section 1.3.5, page 39). Therefore, detection of live virus in the insect 
head was chosen as an indicator of full virus dissemination within the insect. Similar 
approaches have been taken before, for instance the recovery of dengue virus from 
mosquito legs as an indicator of virus dissemination in Aedes aegypti (Turell et al., 
1987). 
The experiments described in this chapter were carried out at 9 days post 
infection (dpi) unless stated otherwise. This EIP was chosen because C. sonorensis have 
been shown to develop maximum titres after an EIP of nine days (Wellby et al., 1996). 
To confirm that virus detected at 9 dpi is not a residue from the infectious blood meal, 
insects from the infection-refractory species C. nubeculosus (Table 2-3, page 55) were 
fed an infectious blood meal and assayed at 9 dpi in the same way as C. sonorensis. 
Assuming that the gut lumina of the two haematophagous species C. sonorensis and C. 
nubeculosus represent similar environments (both belong to the subgenus 
Monoculicoides), the absence of residual virus from C. nubeculosus at 9 dpi would 
indicate an inability of the virus to survive for this period in either Culicoides species, 
unless virus replication takes place. AHSV-8wt was used for the experiments in this 
chapter described so far, since it achieved the highest infection rates of all AHSV strains 
in C. sonorensis. 
The second objective of this chapter was to determine whether susceptibility to 
AHSV varies with the age of the insect at the time of ingestion of an infectious blood 
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meal. This is particularly important for the standardisation of vector-competence studies 
and the comparison of the results of different workers. This experiment is based on an 
incidental observation in the early stages of this project, which is described in the next 
paragraph. 
When experiments to establish infection rates in both C. sonorensis colonies 
with the reassortant viruses were started, insects were fed infectious blood meals at 
either two or three days of age. This terminology denotes the time span from placing 
mature pupae into pillboxes to the time of the blood-feeding. Most insects emerged 
during the first day in the pillbox. However, a small proportion usually hatched later and 
consequently were younger than the terminology would suggest. On one occasion, when 
blood-feeding two-day-old insects from the NVC colony with AHSV-A79, it was found 
that only a small proportion (less than 10%) of females had fully engorged. This 
particular batch of insects contained an unusually large number of teneral (i. e. very 
young) adults. Because of the poor feeding rate, the blood-feeding of a second batch of 
insects from the same colony and of the same age was delayed by 24 h. This allowed a 
comparison of the infection rates of two- and three-day-old insects under otherwise 
identical experimental conditions. Infection rates were determined using the methods 
described in sections 2.3.5 and 2.2.4 (pages 59 and 52). Disseminated-infection (DI) 
rates were calculated as the percentage of assayed insects that developed a fully 
disseminated infection, and would therefore be competent vectors. 
A third objective of the work described in this chapter was to re-evaluate the 
levels of vector competence of the two C. sonorensis colonies. The data obtained 
provide an estimate of the colonies' genetic stability since selection (i. e. over a period of 
several years). They also indicate whether selection for or against vector competence for 
an AHSV-9 strain lead to similar changes in the vector competence for other AHSV 
strains. To achieve this aim, insects from the VC C. sonorensis colony were infected 
orally as described in section 2.3.2 (page 56). Batches of insects were infected with one 
of the reassortants AHSV-A790 or AHSV A79, or with one of the parent virus strains 
AHSV-3att or AHSV-8wt (section 2.2.2, page 49). To evaluate the vector competence of 
the NVC colony of C. sonorensis, batches of insects from this colony were also infected 
with one of AHSV A790, AHSV-A79, AHSV-3-att or AHSV-8wt. Blood meal titres 
were identical with those used in the VC colony. Infection rates for all insect batches 
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were determined and DI rates calculated as described for the second objective of this 
chapter, above. The proportion of virus-positive insects that registered a fully 
disseminated infection was also determined for all insect batches. 
To assess the stability of the two insect colonies in terms of their susceptibility to 
infection by the four virus strain, the experiment was repeated after an interval of 
approximately two years. On this occasion, the virus assay's sensitivity was increased 
ten-fold by assaying not only the first (and subsequent) ten-fold dilutions, but also the 
original, undiluted solution of 1 ml tissue culture media, containing one ground-up 
insect. This step reduced the minimum detectable virus titre from 1.75 (experiment I) to 
0.75 (experiment II) 1og10TCID50/insect. Titres of the blood meals ranged from 5.75 to 
6.5 log10TCID50/ml. 
The fourth and arguably the most important objective of the work described in 
this chapter was to assess whether variation in AHSV genome segment 10 could affect 
virus dissemination throughout the body of the insect vector and, consequently, its 
vector status. Genome segment 10 codes for the small non-structural protein NS3/3a, 
which is involved in virus exit from the cell (Hyatt et al., 1993). Following oral 
ingestion by the insect and successful replication in the midgut cells, NS3/3a could 
affect virus release from the insect's midgut into the haemocoel. Detection of a 
significant effect of genome segment 10 might indicate that variation in this segment 
represents adaptation to different insect vector species or populations. Such a finding 
would help to explain the observed high degree of variation in this genome segment. 
The data used to address these questions originate from the experiments used to re- 
examine the vector competence of the VC and NVC colonies (described above). 
Infection rates and DI rates were compared between the two reassortant viruses AHSV- 
A790 and AHSV A79, which differ in segment 10 only. 
The fifth aim of this chapter was to verify a personal communication by Dr. E. 
Wittmann from the Pirbright Arbovirology group that AHSV-6wt does not infect C. 
sonorensis by the oral route. This observation raised the question whether this virus 
strain is capable of infecting individuals of this species by any route and, if it is not, 
what is the mechanism that prevents the virus from establishing an infection in the 
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insect host via the oral route. AHSV-6wt readily replicates in both BHK-21 and KC 
cells. The latter are an embryonic tissue culture cell line derived from C. sonorensis. To 
confirm that C. sonorensis is resistant to oral infection with AHSV-6wt, insects from the 
VC colony were fed an infectious blood meal as before, containing AHSV-6wt at 6.5 
1og10TCID50/ml. Infection rates were determined as described before. To establish 
whether AHSV-6wt can successfully replicate in the insect if the gut barriers MIB and 
MEB (section 1.3.5, page 39) are bypassed, further C. sonorensis flies were inoculated 
intrathoracically with AHSV 6wt as described in section 2.3.4 (page 58). 
4.2 Methods 
Transmission of virus during membrane feeding 
C. sonorensis from the VC colony were given an infectious blood meal 
containing AHSV-8wt at a final concentration of 6.5 log1oTCID50/ml. Approximately 
100 engorged females were selected and incubated for nine days at 25°C as described in 
section 2.3.2 (page 56). Sucrose solution was withdrawn at 7 dpi to encourage 
subsequent blood-feeding. Survivors were then placed individually in 0.5 ml Eppendorf 
tubes that had had their bottoms cut off and replaced with parafilm (Figure 4-1, page 
87). These tubes were positioned in the wells of microtitration plates containing 100 µl 
heparinised horse blood at 37°C. The bottom of the wells contained a 90% confluent 
monolayer of C. sonorensis (KC) cells (section 2.2.1, page 49). These cells have been 
found to be highly susceptible to infection with AHSV and were found to grow well in 
heparinised horse blood. The microtitration plates containing the preheated blood and 
the Eppendorf tubes with midges inside were incubated at 37°C for 1 h. Insects were 
then removed and stored at -70°C until assayed. 100 µl Schneider's insect medium was 
added to each well and the plates incubated at 29°C for seven days. Since KC cells do 
not show CPE, 100 gl supernatant was then transferred to BHK-21 cells to assay for the 
presence of AHSV as described in section 2.2.4 (page 52). 
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Figure 4-1: Membrane-feeding of individual C. sonorensis for the detection of 
AHSV transmission into a blood meal 
Artificial induction of salivation 
The experiment was conducted following a protocol that had previously been 
established for C. sonorensis (Boorman, 1987) and was subsequently used to establish 
the titre that indicates a fully disseminated infection of C. sonorensis with BTV (Fu, 
1996). C. sonorensis from the VC colony were orally infected with AHSV-8wt (6.5 
1og10TCID50/ml) and fully engorged females were incubated for nine days at 25°C. 100 
surviving midges were then individually placed on double-sided sticky tape in a Petri 
dish with their ventral side facing upward. A glass capillary tube was used to apply 
approximately 1µl of 0.01% Malathion to the ventral abdomen. Over the following 20 
min, saliva was collected from the probosces of salivating midges with very fine 
capillary tubes. The tubes were stored in tissue culture medium at -70°C until assayed 
for AHSV. 
Virus infectivity assay in insect heads 
C. sonorensis insects from the VC colony were orally infected with AHSV-8wt 
(6.75 log1OTCID50/ml) and incubated at 25°C as described in section 2.3.2 (page 56). 
After an EIP of nine days, survivors were anaesthetised with CO2 and their heads 
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separated from their bodies with dissecting needles. While the insect bodies were stored 
and assayed as described for entire insects in sections 2.3.5 (page 59) and section 2.2.4 
(page 52), the heads were processed immediately. Individual heads were ground in 20 pl 
tissue culture fluid between the frosted surfaces of two microscopy slides. The resulting 
suspension was made up to 100 µl with tissue culture medium and assayed for the 
presence of virus in a single well of a microtitration plate (section 2.2.4, page 52). 
4.3 Results 
4.3.1 AHSV titre that indicates dissemination of infection in C. sonorensis 
Transmission of virus during membrane feeding 
72 female C. sonorensis survived the nine-day EIP and were used in the 
transmission experiment. Only two of these midges then visibly blood-fed across the 
parafilm membrane, although some other individuals seemed to probe the membrane. 
No virus was detected in any of the 72 blood meal residues when tested for AHSV 
released by insects during blood-feeding. The lowest virus detection level was 0.75 
1og10TCID50/ml. To ascertain that the failure to transmit virus across the membrane was 
not due to an absence of infectivity in the insects, 21 of the 72 insects were ground up 
and assayed for AHSV, including the two visibly engorged midges. Virus was detected 
in 12 of these insects (infection rate: 57%) and the maximum titre detected was 3.5 
log1OTCID50/fly. The two blood-fed insects both proved to be virus-negative at the 
detection level of 0.75 1og10TCID50ifly). 
Artificial induction of salivation 
Salivation could only be observed in five out of 100 insects. No AHSV was 
detected in any of the saliva samples collected (detection level: 0.5 
log10TCID50/sample). Assay of the insects for AHSV showed that over 50% of insects 
were infected and titres ranged from 0.75 to 3.5 1og10TCID50/fly (data not shown). 
Three of the five insects that visibly salivated were infected with virus titres of >_3.0 
log10TCID5o/fly, the other two were virus-negative. 
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Virus infectivity assay in insect heads 
The virus assay of insect heads and bodies shows that insect bodies containing 
less than 2.5 1og1OTCID50 were never associated with the presence of virus in the insect 
head while titres of 3.0 1og10TCID50 or higher were consistently associated with virus 
presence in the head (Table 4-1). Titres of 2.5 and 2.75 log10TCID5o were in most cases 
associated with an infected insect head. 
Table 4-1: Dissemination of AHSV-8wt in C. sonorensis (VC colony) 
Virus titre in the insect body Number of insect bodies 
Number of virus-positives in 
the corresponding insect heads 
0.75 10 
100 
1.25 20 
1.5 10 
1.75 30 
210 
2.25 20 
2.5 54 
2.75 76 
366 
3.25 44 
3.5 88 
Three-day-old insects were given an infectious blood meal of AHSV-8wt (6.75 log, oTCID50/ml) and 
incubated for 9 days at 25°C. Insect heads were separated from the bodies and both were stored at -70°C. 
Bodies were individually assayed for AHSV (minimum detection level: 0.75 log10TCID50/fly) and 
grouped according to their virus titres (column 2). Insect heads were assayed for AHSV and virus- 
positives were grouped according to the titres of their corresponding bodies (column 3). 
Oral susceptibility of C. nubeculosus to AHSV-8wt -a control experiment 
The results in Table 4-2 (page 90) show that adult females of the species C. 
nubeculosus, which is orally refractory for AHSV infection, do not contain detectable 
levels of AHSV at nine days after ingestion of a blood meal containing infectious virus. 
Since this C. nubeculosus has repeatedly been shown not to replicate AHSV following 
oral ingestion, this result indicates that non-replicating AHSV does not survive in 
Culicoides for nine days pi. 
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Table 4-2: Susceptibility of adult C. nubeculosus to oral infection with AHSV-8wt 
O dpi 9 dpi 
Number positive/number assayed 5/5 0/28 
Range (log1OTCID5/fly) 3.0-3.5 - 
Three-day-old insects were given an infectious blood meal of AHSV-8wt (6.75 log1OTCID50/ml) and 
incubated at 25°C for 9 days. They were then stored at -70°C and individually assayed for AHSV 
(minimum detection level: 0.75 1og10TCID50/flY) 
4.3.2 Effect of insect age on susceptibility to oral infection with AHSV 
The infection rates of the two insect batches are shown in Table 4-3 (page 91). 
The infection rates in the two-day-old insects were higher than in the three-day-old 
midges, but this difference was not of statistical significance (, j=2.680, p=0.101, 
df. =1). Nevertheless, in the two-day-old group there were significantly more insects 
with a high virus titre indicating the presence of a disseminated infection (DI rate; 
j=12.448, p<0.001, d f. =1). A titre of >2.5 1og10TCID50/insect was used as an 
indicator of the presence of a fully disseminated infection. This value results from the 
experiments described in section 4.3.1 and is discussed in section 4.4, page 97. The 
number of insects with a disseminated infection as a proportion of all infected was also 
significantly higher (, j=8.316, p=0.004, d. f. =1) in the two-day-old group. As a 
consequence of the considerable differences in infection rates between two and three 
day old insects, all vector competence studies were carried out with three-day-old 
insects. Using two-day-old insects throughout was not feasible because feeding rates 
were very variable and often too low to allow the determination of infection rates. 
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Table 4-3: Effect of insect age on oral infection and dissemination in C. sonorensis 
infected with AHSV-A79 
Insects infected at two Insects infected at three 
days of age days of age 
Number positive/number tested 12/27 (44%) 19/70 (14%) 
(Infection rate IR in percent)' 
Number with disseminated 
infection/number tested (DI rate in 8/27 (30%) 3/70 (4%) 
percent)' 
Number with disseminated 
8/12 (67%) 3/19 (16%) 
infection/number positive (percent)' 
Insects from the NVC colony were given an infectious blood meal of AHSV-A79 (6.75 
log1OTCID50/ml) and incubated at 25°C for 9 days. They were then stored at -70°C and 
individually assayed for AHSV (minimum detection level: 0.75 log10TCID50/fly). 
1- Values rounded up or down to nearest integer 
DI rate: Disseminated-infection rate 
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4.3.3 Infection rates of reassortant viruses and their parent virus strains in C. 
sonorensis 
Experiment I 
The data presented in Table 4-4 and Figure 4-2 (page 93) show a significantly 
higher IR achieved with AHSV-A79 than with AHSV-A790 in the VC colony 
(, j=14.081, p<0.001, d. f. =1). There is no significant difference between any of the four 
virus strains in the NVC colony (, j=7.606, p=0.055, d. f.. =3). The same data also show 
that there are significant differences between the VC and the NVC colonies in regard of 
their IRs with AHSV-A79 (2=31.552, p<0.001, d. f.. =1) and AHSV-8wt (, j=17.072, 
p<0.001, d. f. =1), with the IRs being higher in the VC colony. However, AHSV-A790 
exhibits no statistically significant difference in its ability to infect the VC and the NVC 
colonies (, j=3.504, p=0.061, d. f. =1). Neither does AHSV-3att (, f=0.458, p=0.498, 
d. f. =1). 
DI rates (Table 4-4) show highly significant differences between VC and NVC 
colonies for AHSV-8wt (,, J=20.762, p<0.001, d. f.. =1) and AHSV-A79 (, J=30.181, 
p<O. 001, d. f. =1), but the difference is only just significant for AHSV-A790 (, 1=6.546, 
p=0.011, df. =1). DI rates are higher with the VC colony than with the NVC colony for 
all three viruses. VC and NVC colonies do not differ significantly in their response to 
infection with AHSV-3att (, 1=2.941, p=0.086, d f=l). Between the two reassortant 
viruses, there is a statistically significant difference in the VC colony (AHSV 
A79>AHSV A790; , 
j=11.672, p=0.001, d. f.. =1) but not in the NVC colony (, j=1.123, 
p=0.289, df. =1). 
The number of insects with a disseminated infection as a proportion of all virus- 
positive midges does not differ significantly between the reassortant virus strains in the 
VC colony (Z2=0.183, p=0.669, d. f.. =1) or the NVC colony (, j=0.114, p=0.735, 
d. f.. =1). 
92 
Table 4-4: Infection prevalences of two reassortant viruses and their parent strains 
in two colonies of C. sonorensis - Experiment 1 (1999) 
Vector-competent (VC) colony Non-competent (NVC) colony 
AHSV- AHSV- 
3att A790 A79 8wt 3att A790 A79 8wt 
Number positive/number tested 8/49 32/101 34/54 90/143 37/179 25/121 10/70 23/70 
(Infection rate in percent)' (16%) (32%) (63%) (63%) (21%) (21%) (14%) (33%) 
Number with disseminated 
1/49 24/101 27/54 69/143 17/179 9/121 3/70 14/70 
infection/number tested (DI 
(2%) (24%) (50%) (48%) (9%) (7%) (4%) (20%) 
rate in percent)' 
Number with disseminated 
1/8 24/32 27/34 69/90 17/37 9/25 3/10 14/23 
infection/number positive 
(12%) (75%) (79%) (77%) (46%) (36%) (30%) (61%) 
(percent)' 
Three-day-old insects were given an infectious blood meal (6.0-7.0 logi0TCID50/ml) spiked with the 
appropriate AHSV strain and incubated for 9 days at 25°C. They were then stored at -70°C and 
individually assayed for AHSV (minimum detection level: 1.75 log1oTCID5o/fly). 
1- Values rounded up or down to nearest integer 
DI rate: Disseminated-infection rate 
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Figure 4-2: Infection rates of two reassortant viruses and their 
parent strains in two colonies of C. sonorensis - Experiment I 
(1999) 
Three-day-old insects were given an infectious blood meal spiked with the appropriate 
AHSV strain (6.0-7.0 logtoTCID50/ml) and incubated for 9 days at 25°C. They were 
then stored at -70°C and individually assayed for AHSV (minimum detection level: 
1.75 log, OTCID50/flY). 
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Experiment II 
The results of the second experiment, carried out two years after experiment I, 
are shown in Table 4-5. Figure 4-3 (page 95) illustrates that the VC colony is highly 
susceptible to infection with AHSV-8wt and AHSV-A79 but much less so to infection 
with AHSV-3att or AHSV-A790. There is a significant difference in IRs achieved by 
AHSV-A79 and AHSV-A790 in this colony (AHSV A79>AHSV A790; f=49.726, 
p<0.001, d. f. =1). The NVC colony recorded lower IRs, which are fairly uniform for the 
four virus strains tested: There was no significant difference between the two reassortant 
viruses (, 2=1.703, p=0.192, d. f.. =1). The only statistically significant differences 
(although not highly so) in the NVC colony were for the virus pairs AHSV-8wt - 
AHSV-A790 (, j=9.590, p=0.002, d. f. =1) and AHSV-8wt - AHSV-3att (, 
j=5.620, 
p=0.018, d. f. =1). IRs were significantly higher with the VC than with the NVC colony 
for all four viruses (AHSV-3att: , Z2=10.138, p=0.001, d. f.. =1; AHSV-A790: 
j=12.394, 
p<0.001, d. f. =1; AHSV-A79: f=86.825, p<0.001, d. f. =1; AHSV-8wt: f=56.169, 
p<0.001, d. f. =1). 
Table 4-5: Infection prevalences of two reassortant viruses and their parent strains 
in two colonies of C. sonorensis - Experiment 11 (2001) 
Vector-competent (VC) colony Non-competent (NVC) colony 
AHSV- AHSV- 
3att A790 A79 8wt 3att A790 A79 8wt 
Number positivelnumber tested 
(Infection rate in percent)' 
26/73 
(36%) 
29/91 
(32%) 
76/91 
(84%) 
70/84 
(83%) 
16/106 
(15%) 
15/123 
(12%) 
21/115 
(18%) 
30/105 
(29%) 
Number with disseminated 
1/73 
infection/number tested (DI 
(1%) 
rate in percent)' 
Number with disseminated 
2/91 61/91 52/84 4/106 2/123 
(2%) (67%) (62%) (4%) (2%) 
15/115 
(13%) 
16/105 
(15%) 
1/26 2/29 61/76 52/70 4/16 2/15 15/21 16/30 
infection/number positive 
(4%) (7%) (80%) (74%) (25%) (13%) (71%) (53%) 
(percent)' 
Three-day-old insects were given an infectious blood meal spiked with the appropriate AHSV strain 
(5.75-6.5 1og10TCID50/ml) and incubated for 9 days at 25°C. They were then stored at -70°C and 
individually assayed for AHSV (minimum detection level: 0.75 1og1OTCID50/fly). 
1- Values rounded up or down to nearest integer 
DI rate: Disseminated-infection rate 
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Figure 4-3: Infection rates of two reassortant viruses and their 
parent strains in two colonies of C. sonorensis - Experiment II 
(2001) 
Three-day-old insects were given an infectious blood meal spiked with the appropriate 
AHSV strain (5.75-6.5 log, oTCID50/ml) and incubated for 9 days at 25°C. They were 
then stored at -70°C and individually assayed for AHSV (minimum detection level: 
0.75 log, 0TCID50/fly). 
0 VC colony 
  NVC colony 
Figure 4-4: Proportion of insects with a fully disseminated infection 
(DI rates) in two colonies of C. sonorensis - Experiment 11 (2001) 
Three-day-old insects were given an infectious blood meal spiked with the appropriate 
AHSV strain (5.75-6.5 log, 0TCID50/ml) and incubated for 9 days at 25°C. They were 
then stored at -70°C and individually assayed for AHSV (minimum detection level: 
0.75 log, oTCID50/fly). 
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Figure 4-4 (page 95) shows DI rates for experiment II (also see Table 4-5, page 
94). It illustrates a statistically significant difference in DI rates between the VC and 
NVC colonies for AHSV-8wt (VC>NVC;, 
j=44.121, p<0.001, d. f. =1) and AHSV-A79 
(VC>NVC; f =63.602, p<0.001, d f. =1), but not for AHSV-A790 (VC>NVC; 
, 
f=0.093, p=0.760, d. f. =1) and AHSV-3att (NVC>VC; f=0.920, p=338, d f. =1). 
There is also a statistically significant difference between AHSV-A79 and AHSV-A790 
in the VC colony (,? =84.506, p<0.001, d. f.. =1) and in the NVC colony (. =11.681, 
p=0.001, d. f. =1), with the DI rate being the higher for AHSV-A79 in both cases. 
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Figure 4-5: Number of insects with a fully disseminated infection as 
a proportion of infected insects from the two colonies of C. 
sonorensis - Experiment 11 (2001) 
Three-day-old insects were given an infectious blood meal spiked with the appropriate 
AHSV strain (5.75-6.5 log10TCID5(/ml) and incubated for 9 days at 25°C. They were 
then stored at -70°C and individually assayed for AHSV (minimum detection level: 
0.75 logi0TCID501flY)" 
Figure 4-5 illustrates the proportion of infected insects that developed a fully 
disseminated infection. There is a significant difference between AHSV-A79 and 
AHSV-A790 in the VC colony (J=47.077, p<0.001, d. f.. =1) and in the NVC colony 
(j=11.849, p=0.001, d f. =1), with higher values for AHSV-A79 in both cases. The 
differences between the VC and the NVC colonies are insignificant (AHSV-A79: 
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j=0.757, p=0.384, d. f. =1; AHSV-A790: 
f =0.496, p=0.481, d. f. =1) or on the verge of 
statistical insignificance (AHSV-8wt: j=4.237, p=0.040, d. f. =1; AHSV-3att: 
, 
j=4.226, p=0.040, d. f. =1). It is noteworthy that for AHSV-3att and AHSV-A790, the 
proportion of insects with a fully disseminated infection is higher with the NVC than 
with the VC colony and, for AHSV-3att, significantly so. 
4.3.4 Susceptibility of C. sonorensis to AHSV-6wt 
The results in Table 4-6 show that C. sonorensis insects do not develop 
detectable virus titres when AHSV-6wt is imbibed. The results also show that AHSV- 
6wt replicates in C. sonorensis to high titres (>_ 3.5 1og10TCID50/fly) following 
intrathoracic inoculation (as described in section 2.3.4, page 58). 
Table 4-6: Infection rates of AHSV-6wt in C. sonorensis (VC colony) 
Infectious blood meal Intrathoracic 
9 dpi injection 9 dpi 
Number positive/number assayed 0/17 35/35 
Infection rate (%) 0 100% 
Range (1og1OTCID50/fly) - all >_ 3.5 
Three-day-old insects were given an infectious blood meal spiked with AHSV-6wt (6.5 
1og10TCID50/ml) and incubated for 9 days at 25°C. They were then stored at -70°C and 
individually assayed for AHSV (minimum detection level: 0.75 log1OTCID50/fly). 
4.4 Discussion 
AHSV titre that indicates a fully disseminated infection in C. sonorensis 
The virus infectivity assay of insect heads shows that the titre that indicates a 
fully disseminated infection of C. sonorensis with AHSV lies within the range 2.5 to 3.0 
1og10TCID50/insect. Within this range the vast majority of insects had a fully 
disseminated infection, although a small number (two individuals) showed evidence of 
a localised infection. A control experiment shows that the orally refractory C. 
nubeculosus does not contain detectable virus titres at 9 dpi, indicating that AHSV 
cannot survive in Culicoides for this period without replication. This is further 
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supported by the absence of AHSV-9 from C. nubeculosus at 4 dpi (Wellby et al., 
1996). In addition, there was a complete and consistent absence of detectable AHSV- 
6wt from the orally infected, susceptible (VC) C. sonorensis colony at 9 dpi (Table 4-6, 
page 97). The presence of infectious AHSV in orally infected C. sonorensis at 9 dpi 
must therefore be due to virus replication in the insect. 
The experiment for the detection of AHSV-transmission across a membrane 
failed due to the very poor feeding rates. Culicoides midges are well known for being 
reluctant blood-feeders when kept in isolation. In future experiments, it might be 
possible to circumvent this problem by membrane-feeding one marked, infected female 
in the presence of circa 20 uninfected Culicoides. No logical explanation could be found 
for the regular failure of insects to salivate upon Malathion application. Increased 
concentrations of Malathion did not result in salivation but induced rapid death of the 
majority of insects. 
In combination, the data in section 4.3.1 (page 88) strongly suggest that virus 
titres below 2.5 1og10TCID50 arise from a localised, not fully disseminated infection of 
the insect. The presence of virus in all insect heads associated with bodies containing 
>_3. O log1OTCID50 demonstrates that this virus titre always indicates a fully disseminated 
infection of C. sonorensis with AHSV. The inconsistent association of 2.5 and 2.75 
1og10TCID50 titres with virus detection in the insect head may either reflect the 
limitations of the virus assay or variation between individual insects, or both. The virus 
infectivity assay used for this work is generally considered to possess an accuracy of 
±0.5 1og10TCID50, which means that all the variation in the data can easily be explained 
within the inherent variability of the test. Consequently, for the purpose of this work, a 
titre of 2.5 1og10TCID50/fly or above was chosen as an indicator of a fully disseminated 
infection in the insect. 
The results show that the virus titre that indicates a fully disseminated infection 
of C. sonorensis with AHSV is similar to that indicative of a fully disseminated BTV 
infection, i. e. 2.5 or 3.0 log10TCID5o/fly (Jennings & Mellor, 1987; Fu, 1996). This is an 
important reference point for vector competence studies in the C. sonorensis-AHSV 
model since it distinguishes between potentially transmissive and non-transmissive 
vector insects. With this knowledge the epidemiological significance of laboratory- 
based susceptibility studies can be assessed. The fact that the titres indicative of a 
disseminated AHSV and BTV infection are both within the region from 2.5 to 3.0 
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log1OTCID50/insect suggests that similar figures might apply to other orbiviruses in C. 
sonorensis. Therefore, vector competence studies with, for instance, EHDV, might also 
benefit from this information. The data confirm previous experiments showing that C. 
sonorensis is a competent laboratory vector of AHSV (Mellor et al., 1975) and strongly 
suggest that field populations of this North American species could replicate and spread 
AHSV if this virus were to be introduced into areas where the vector occurs. C. 
sonorensis is widespread and often abundant in the south and west of the USA, where it 
transmits BTV (Figure 1-1, page 13). 
Effect of insect age on the susceptibility to oral infection with AHSV 11 
This experiment provides evidence that teneral adults (less than three days old) 
are more likely to develop a fully disseminated infection with at least one AHSV strain 
than older adults. Although the experiment was carried out only once and with limited 
numbers, the difference between the two and three day old insects is statistically highly 
significant. The most obvious explanation for the higher susceptibility of teneral adults 
to virus dissemination is that an immature adult's midgut is likely to be considerably 
more "leaky" than in older insects. This view is supported by the observation of a high 
proportion of "just emerging" insects in the two day old batch used in this experiment. 
While proof of the higher incidence of a "leaky gut" in teneral adults would require 
extensive electron microscopy, the oral infection of two-day-old C. sonorensis with 
AHSV-6wt could also help to resolve this question. The identification of AHSV-6wt- 
positive insects at 9 dpi would strongly suggest that a "leaky gut" is more common at 
two days of age than in older insects since this virus failed to infect three-day-old 
insects by the oral route but replicated following IT inoculation. 
The epidemiological significance of increased oral infection rates in teneral 
insects is doubtful. Feeding rates of the two-day-old insects were very poor in the 
laboratory. In a natural environment, insects might not seek a blood meal at all at this 
age. However, the finding is very important to vector competence studies with 
laboratory colonies since it emphasises the importance to always compare insects of the 
same age. 
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Vector competence of the VC and NVC colonies of C. sonorensis 
The disseminated-infection (DI) rates, as an indicator of vector competence, 
show that the previous selection for and against vector competence for AHSV-9 have 
lead to similar changes in vector competence for some, but not all AHSV strains used in 
this work (experiments I and II): AHSV-8wt and AHSV-A79 achieve consistently and 
significantly higher DI rates in the VC colony than in the NVC colony, while AHSV- 
3att and AHSV-A790 either show no significant differences between the two insect 
colonies or (in the case of AHSV-A790 in experiment I) the difference between VC and 
NVC colony verges on being statistically insignificant. The high reproducibility of the 
results illustrates that the level of susceptibility to AHSV is a stable trait in the VC and 
NVC colonies. At a generation interval of three to four weeks, the time span of about 
two years between the initial and the repeat experiments undertaken in the present work 
equals approximately 25-35 insect generations, while the later experiments were carried 
out about six years after the original selection for vector competence was completed. 
This means that the VC and NVC colonies have retained significantly different 
susceptibility rates to AHSV for approximately 75-100 generations. 
It is notable that the difference in vector competence between colonies only 
affects those viruses which, like AHSV-9 in the original selection process, possess the 
potential for achieving high infection rates in C. sonorensis (i. e. AHSV-A79 and AHSV- 
8wt). This pattern suggests that infection rates are a function of both virus and vector 
characteristics, and that varying virus characteristics alone, such as variation in segment 
10, only have a notable effect on infection rates in highly susceptible insect vectors. The 
result is in keeping with the suggestion that C. sonorensis populations possess intrinsic 
susceptibility rates and that virus characteristics define how much the actual DI rate 
approaches the maximum DI rate = susceptibility rate. However, the presented results 
do not clarify whether the susceptibility rate is indeed a constant, insect defined 
characteristic or whether it can be indefinitely increased by increasing virus titres in 
infectious blood meals, possibly approaching 100% in the extreme. It is likely that with 
high virus titres, as with other factors (e. g. high temperature, simultaneous filarial and 
viral infection), the "leaky gut" may account for infection rates that actually exceed the 
genetically determined susceptibility rate. 
The almost complete absence of significant variation in infection rates and 
disseminated-infection rates between the two reassortants in the NVC colony (with the 
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exception of the disseminated-infection rate in experiment II), coupled with highly 
significant differences in the VC colony, suggests that the insect host susceptibility to 
infection could actually relate to some host interaction with NS3/3a. However, this 
remains speculation. 
The data for dissemination of infection in those insects that already have a 
detectable midgut infection represent the virus's ability to overcome the MEB. The VC 
and NVC colonies exhibit little or no statistical significance in this respect in 
experiment II (illustrated in Figure 4-5, page 96) but this is not the case in experiment I 
(Table 4-4, page 93). However, as experiment II was 1 1og10TCID50/fly more sensitive 
than experiment I, it was considered to provide the more accurate results. Since the 
change in test sensitivity from 1.75 to 0.75 log1OTCID50/insect affects the number of 
insects that register with a localised midgut infection, but not the number with a fully 
disseminated infection, it also changes the ratio: disseminated/disseminated+localised 
infections. 
It can be concluded that the selection process for and against vector competence 
in the VC and NVC colonies resulted primarily and perhaps entirely in modification of 
the events preceding virus dissemination from the midgut (i. e. infection of the midgut 
cells, replication in these cells and infection of further midgut cells). To try and 
elucidate whether the resistance to oral infection of some insects is due to a barrier 
preventing the virus from entering the midgut cells or to an inherent incompetence of 
these cells to replicate AHSV, attempts were made to infect insect midguts from both C. 
sonorensis colonies from the abluminal side (see chapter 6). This approach also tests the 
hypothesis that the abluminal midgut cell membranes do not differ significantly 
between the NVC and VC colony, which is implied in the assertion that the two colonies 
possess essentially the same MEB. 
Effect of variation in AHSVgenome segment 10 on virus dissemination in C. sonorensis 11 
The work presented here shows that AHSV segment 10 has a significant effect 
on infection and vector status of the model vector C. sonorensis. After previous findings 
that genome segment 10 modulates virulence in a mammalian model (O'Hara, 1994; 
O'Hara et al., 1998), this is further evidence that this segment is a key player in defining 
virus characteristics like virulence and transmission. It is nevertheless surprising to see 
that variation in virus genome segment 10 (between AHSV-790 and AHSV-79 in the 
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VC colony) affects total detectable infection rates, both in experiment I (illustrated in 
Figure 4-2, page 93) and experiment II (Figure 4-3, page 95). It is surprising because 
NS3/3a, as a non-structural protein, cannot participate in the initiation of infection. It's 
involvement in virus exit from the cell led to speculation that if this protein has an effect 
on the outcome of infection in the insect vector, it would exert its effect by affecting the 
MEB, not the MIB. The virus assay's sensitivity (1.75 1og10TCID50/fly in experiment I 
and 0.75 1og10TCID50/fly in experiment II) is well below the titre indicative of a 
disseminated infection (2.5 1og10TCID50/fly). This means that the number of virus- 
positive insects includes a varying proportion of insects with a localised midgut 
infection, making the total infection rates largely a measure of the virus' ability to 
overcome the MIB. There appears to be only one logical explanation for the resulting 
question of how a virus protein that is involved in cell exit apparently affects an 
infection barrier: 
In the first stage of the infection process, only a few midgut cells become 
infected and consequently, virus titres remain below the current detection level of 0.75 
1og10TCID50/fly. Only the spread of progeny virus particles from the initially infected 
cells to other midgut cells achieves detectable virus titres and this event must be 
controlled by NS3/3a and occur less commonly in AHSV-A790 than in AHSV-A79. 
The virus spread from midgut to midgut cells could occur directly via the cell 
membrane dividing the two cells, via the gut lumen or even via the haemocoel. Progeny 
virions could bud from infected midgut cells directly into neighbouring cells. This has 
previously been observed in cells infected with a cypovirus (Belloncik, 1996; Belloncik 
et al., 1996). BTV superinfection of insect cells has been shown to take place in tissue 
culture (Hyatt et al., 1989) and in a similar process, progeny AHSV particles could be 
released into the gut lumen to then re-enter infected cells but also to enter previously 
uninfected midgut cells. It is possible that an analogous process takes place on the 
abluminal side of the midgut cell, without necessarily and immediately leading to virus 
dissemination through the insect body. Such a low level of virus release into the 
haemocoel in the absence of dissemination has been described for BTV in C. sonorensis 
(Fu et al., 1999). Since the insect gut has enormous potential for expansion to allow 
large blood meals to be ingested, the gut cell membranes fold heavily when not 
stretched by a recent blood meal. This might allow virus particles to emerge from the 
abluminal side and immediately attach to the abluminal membrane of the same or a 
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neighbouring midgut cell, without being disseminated across the whole insect body via 
the haemocoel. At this stage, the fat body might also play a role in restricting infection 
to the midgut (Fu et al., 1999). 
Evidence for replication of AHSV below detection level has been found before 
in the VC colony of C. sonorensis (Wellby et al., 1996). It was shown that virogenesis 
can take place at undetectable levels during low environmental temperatures but 
increases to detectable levels when insects are subsequently incubated at higher 
temperatures. The gradual colonisation of the midgut by the virus as proposed here has 
previously been observed in Culex mosquitoes orally infected with the flavivirus 
Japanese encephalitis virus (Doi et al., 1967). These authors initially observed a small 
scale infection of the posterior midgut, followed by virus spread through the posterior 
midgut and then infection of the fat body. In a fourth and final step, the salivary glands 
and other organs became infected. In the same virus-vector system, infection of the 
midgut following intrathoracic inoculation was observed, suggesting that the abluminal 
midgut cell membrane contained suitable virus receptors (Doi, 1970). The question 
whether the abluminal midgut cell membrane of C. sonorensis can be penetrated by 
AHSV will be explored in chapter 6. 
It is also of interest to note that in the C. sonorensis-BTV system, two types of 
midgut infection have been observed following oral infection. In the first type, virus 
was present in the whole cytoplasm while in the second type, virus appeared 
compartmentalised and was restricted to endosome-like structures within the cytoplasm 
(Fu, 1996). It is quite possible that these two distinct patterns reflect the varying ability 
of a virus strain to escape from an infected midgut cell. 
Since the total infection rates discussed above represent not only insects with a 
fully disseminated infection but also include a significant number of insects with a 
localised midgut infection, it is difficult to elucidate the mechanisms responsible for 
different infection rates elicited by different viruses. These results are also very difficult 
to interpret with regard to their epidemiological significance. Since only insects with a 
fully disseminated infection can transmit the virus, the proportion of insects out of the 
total population that are able to achieve such an infection is crucial to the epidemiology 
of the disease. For experiment II, this DI rate is illustrated in Figure 4-4, page 95. Due 
to the lower sensitivity of the virus assay and the resulting quality of the data, the DI 
rates in experiment I were not further illustrated. However, they are included in Table 
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4-4 (page 93) and are discussed in this section. The results illustrated in Figure 4-4 
show that in the VC colony, the identity of virus genome segment 10 has a massive 
effect on the percentage of the insect population that develop a disseminated infection. 
This effect is also seen in experiment I and suggests that variation in this AHSV genome 
segment is of major significance to the epidemiology of the disease. The presence of 
various different types of this segment (a, ß, y; see section 1.2.3, page 26) seems to 
indicate that they represent adaptations to distinct environmental conditions, vector 
species or even to the interaction of NS3/3a with other viral proteins. To establish that 
variation in segment 10 can affect infection rates not only in the laboratory, but also in 
field vectors of AHSV, both reassortants were used for vector competence studies with 
wild-caught C. imicola and C. bolitinos (chapter 5). 
While the proportion of insects with a disseminated infection is a good 
indication of potential transmission in the field, it does not allow a judgement to be 
made on whether it is the MIB or the MEB that leads to the observed differences in 
virus dissemination. The reason for this is that on its way from the midgut to the 
salivary glands, the virus needs to overcome both barriers, making the disseminated- 
infection rate a function of both, virus competence to overcome the MIB and 
competence to overcome the MEB. In order to decide which part of the overall result is 
an effect of the MEB, it is useful to look at the proportion of insects with a detectable 
infection (as shown in Figure 4-3, page 93) that go on to develop a fully disseminated 
infection. For experiment II, these data are illustrated in Figure 4-5 (page 96) and 
suggest that, for both insect colonies, segment 10 has a highly significant effect on virus 
ability to overcome the MEB. Although this assertion is not supported by the results 
from experiment I, this may well be the result of its lower test sensitivity. As before, it 
seemed logical to consider the results of the more sensitive experiment H the more 
accurate of the two. 
The implication of this result is that variation in NS3/3a affects virus spread 
within the midgut in the same way as it affects virus dissemination from the midgut 
through the rest of the insect body. This is not surprising since both events require a 
functioning cell escape mechanism. Furthermore, a heavily infected midgut will almost 
certainly increase the chance of sufficient progeny virus escaping from the abluminal 
side to cause dissemination of infection to secondary target organs. The gradual 
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infection of the midgut could thus be seen as a preselection process for virus strains 
capable of further dissemination. 
Effect of variation in other AHSV genome segments on virus infection and 
dissemination in C. sonorensis 
The absence of significant differences in infection rates between AHSV-8wt and 
AHSV-A79 suggests that variation in segments 7 (coding for the serogroup defining 
VP7) and 9 (coding for the core associated protein VP6), either does not dramatically 
affect infection rates, or the effects of these two proteins cancel each other out. VP7 has 
been shown to possess a binding site for C. sonorensis in BTV (Mertens et al., 1996; Xu 
et al., 1997; Hutchinson, 1999). However, recent sequence analysis of BTV VP7 found 
no evidence for significant variation in the putative receptor binding site in this protein 
across isolates from different continents, which are associated with different insect 
vectors (Wilson et al., 2000). This suggests that the highly conserved VP7 is not a 
major factor in the evolution of mutual vector-virus preferences. The high variability of 
VP2, the other virus protein involved in cell attachment, makes this protein more likely 
to be involved in adaptation to various insect vectors. It would not be surprising if VP2 
and NS3/3a, the two most variable proteins in AHSV and involved in cell entrance and 
cell exit, turned out to be the two major virus proteins governing virus adaptation to 
insect vectors. One recent study examined the effect of alternating passages of BTV in 
the insect vector C. sonorensis and the mammalian hosts sheep and cattle (Bonneau et 
al., 2001). Although the virus was passaged only twice through the insect and once 
through each mammalian host, some mutations in segment two (VP2) and segment 10 
(NS3) were identified and the existence of BTV as a quasispecies was confirmed. This 
indicates a potential for rapid evolution and almost certainly applies to all orbiviruses. 
Most significantly, in the same experiment it was found that C. sonorensis "fixed" a 
mutation of NS3 that occurred in the sheep by replicating this virus strain (founder 
effect). The present work was not designed to investigate variation in genome segment 2 
but the lack of significant variation in infection rates and DI rates between AHSV-3att 
and AHSV-A790, which differ in segments 1 to 6 and 8, does not provide evidence for a 
strong effect of the variations in these genome segments, including segment 2. 
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Susceptibility of C. sonorensis to AHSV-6wt 
The fact that AHSV-6wt does not infect C. sonorensis by the oral route but does 
replicate if the midgut is bypassed indicates that the failure of AHSV-6wt to replicate 
after oral ingestion is either due to the inability to enter the midgut cells (from the gut 
lumen), or to replicate in them to detectable titres (or a combination of both). This 
inability to overcome the MIB makes this virus strain a potentially very useful tool for 
the further investigation of the MIB. For instance, the production of reassortant virus 
strains with another parent that, like AHSV-8wt, achieves high infection rates in C. 
sonorensis, should allow the identification of the responsible genome segment(s). 
AHSV-6wt and the appropriate reassortants could be used to study the mechanisms 
involved, for instance using immunofluorescence or immunogold labelling techniques. 
An advantage of that hypothetical system over the reassortant pair A79/A790 used here 
would be that, since oral infection rates with AHSV-6wt are zero, it should be possible 
to obtain qualitative rather than quantitative data. 
In the present study, AHSV-6wt was also used to attempt infection of the midgut 
from the abluminal side, thus hoping to establish whether the C. sonorensis midgut cells 
are inherently unable to replicate the virus or whether, during oral infection, the virus 
simply fails to enter them from the luminal side (chapter 6). This virus was also used for 
vector competence studies with the two South African field vectors C. imicola and C. 
bolitinos (chapter 5). Taken together these experiments may provide some evidence of 
whether the zero infection rates recorded via the oral route in C. sonorensis are the 
result of virus mutations during mouse brain or tissue culture passaging and extend to 
other Culicoides species, or whether AHSV-6wt is able to orally infect other Culicoides 
vector species. 
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5 Culicoides imicola and C. bolitinos vector competence for AHSV 
5.1 Introduction and rational 
The Afro-Asian C. imicola is the main field vector of AHSV and its sibling 
species C. bolitinos has been connected with recent outbreaks of AHS (Meiswinkel & 
Paweska, 1999). Both species have now also been implicated in the transmission of 
BTV and C. imicola is the main Old World vector of this virus (Mellor & Boorman, 
1995). C. imicola has also been associated with equine encephalosis virus (Venter et al., 
1999). 
Neither C. imicola nor C. bolitinos have been successfully colonised. AHSV and 
BTV vector competence studies have therefore often been carried out using laboratory 
colonies of C. sonorensis as a model (Boorman et al., 1975; Wellby et al., 1996). C. 
sonorensis is the major North American vector of BTV (Jones et al., 1981) and a 
laboratory vector of AHSV (Boorman et al., 1975; Mellor et al., 1975; Wellby et al., 
1996). It does not occur in the Old World and belongs to a different subgenus 
(Monoculicoides) from C. imicola and C. bolitinos (Avaritia). While the defined age, 
geno- and phenotype of the model species C. sonorensis has facilitated highly controlled 
experiments, it has not been possible to relate the detailed findings with this species to 
the situation in the Old World since the vectors are so different. The chance to carry out 
vector competence studies on wild-caught C. imicola and C. bolitinos at the 
Onderstepoort Veterinary Institute (OVI) in South Africa has therefore provided a 
valuable opportunity to compare the findings with C. sonorensis, reported in the 
previous chapter, with those obtained using field vector populations. Some of the aims 
of this chapter are, therefore, closely related to the aims and results of chapter 4. 
The first aim of this chapter was to establish the virus titre that indicates the 
presence of a fully disseminated AHSV infection in C. imicola. Knowledge of this titre 
allows differentiation between infected but non-transmissive insects and those that are 
transmissive and, therefore, determine the epidemiology of the disease. The experiments 
carried out in chapter 4 established that adults of C. sonorensis, which develop a virus 
titre in excess of 2.5-3.0 1og10TCID50/insect after oral infection, possess a fully 
disseminated infection and are able to transmit virus. However, no data exist for any 
vector species outside the C. sonorensis-AHSVIBTV model vector system. 
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The second aim of the work described in this chapter was to determine whether 
variation in AHSV genome segment 10 (and NS3/3a) can influence infection rates and 
possibly the vector status of the two field vectors C. imicola and C. bolitinos. Chapter 4 
shows that in the model vector C. sonorensis, variation in segment 10 can affect virus 
dissemination through the insect body and consequently vector competence. These 
experiments were carried out using two reassortant viruses, AHSV-A790 and AHSV- 
A79, which differ in segment 10 only. An effect of AHSV genome segment 10 on virus 
dissemination in C. imicola and C. bolitinos would indicate that it does have an effect 
on field vector competence and disease epidemiology. 
The third aim of this chapter was to determine the ability of AHSV-6wt to infect 
C. imicola and C. bolitinos. AHSV-6wt has previously been shown to be incapable of 
infecting the model vector C. sonorensis by the oral route (section 4.3.4, page 97). It 
does, however, grow to high titres following intrathoracic inoculation and is therefore 
capable of replicating in cells of this insect species (section 4.3.4). Failure of AHSV-6wt 
to infect C. imicola and C. bolitinos would suggest either that this virus strain had 
mutated during mouse-brain and tissue-culture passaging (passage history, see Table 
2-1, page 50), or that it is adapted to another, so far unidentified, vector species. 
The fourth aim of the work described in this chapter was to determine the ability 
of attenuated virus strains to infect the field vectors of AHSV. This might provide some 
indication of the ability of AHSV vaccine strains to infect field vectors and, therefore, 
their potential for reversion to virulence and reassortment with other virus strains in the 
field. These questions are of great practical significance. Vaccination is an important 
tool in the control of AHS and also of BT, which is caused by the orbivirus type species, 
BTV. Live attenuated virus vaccines have been used during the recent outbreak of AHS 
in Iberia (1987-1990) and the ongoing outbreak of BT in Turkey and Bulgaria (Dr. P. 
Mellor, personal communication). 
To achieve the aims set out above, Culicoides insects were collected from the 
wild at two sites in South Africa. One of these sites was at the OVI, the other one was 
near Clarens in the eastern Free State (for exact locations and altitudes, see Table 2-3, 
page 55). The OVI was originally founded at its present location near Pretoria because 
of the high incidence of AHS in the area and the institute grounds still provide a reliable 
site for catching large numbers of C. imicola. C. bolitinos, however, is not very 
abundant at this location. When C. bolitinos was first associated with AHS outbreaks, 
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vector competence studies required that a suitable location for catching large numbers 
of this species be found. Such a location was discovered near Clarens at the South 
Africa-Lesotho border (Venter et al., 1998; Meiswinkel & Paweska, 1999). 
In brief, insects were caught nightly with light traps and maintained as described 
in section 2.3.1 (page 54). They were orally infected with one of AHSV A790, AHSV- 
A79, AHSV 3wt, AHSV-3att, AHSV-8wt, AHSV-8att, AHSV-6wt or AHSV-6att and 
incubated for 10 days as described in section 2.3.3 (page 58). Insects were then 
immobilised and identified to species level, placed individually in Eppendorf tubes and 
shipped to the UK while frozen at -70°C. Virus assays were carried out at IAH Pirbright 
as described in sections 2.3.5 and 2.2.4 (pages 59 and 52) and infection rates calculated 
for comparisons between the different insect batches. 
Virus infectivity assays were successfully used to detect AHSV in the heads of 
C. sonorensis, demonstrating fully disseminated infections (section 4.2, page 86). The 
same technique was therefore attempted with C. imicola, using a batch of insects that 
had been infected with a AHSV-A79. This virus strain was selected after experimental 
determination of oral infection rates for all batches of insects showed that it generated a 
high infection rate. 
C. bolitinos is the dominant Culicoides species at Clarens and catches of C. 
imicola at this location are usually insufficient to allow vector competence studies with 
this species (Meiswinkel, 1997). In the year of this study (2000) however, unusually 
large numbers of C. imicola were trapped at Clarens and became available for this work. 
Large numbers of C. imicola and C. bolitinos were caught together and for the first 
time, vector competence studies became possible with mixed batches of both insect 
species. Batches of the two species (and some other Culicoides species) were infected 
and maintained together and species identification was carried out at the end of the EIP. 
As a result, the vector competence of the two species could be meaningfully compared. 
Equally importantly, trapping of large numbers of C. imicola at OVI and Clarens, 
approximately 350 km apart, meant that for the first time, two spatially separated 
populations of C. imicola could have their vector competence levels assessed in the 
same year, using the same virus strains and titres, and employing exactly the same 
laboratory techniques. 
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Targeted insect trapping resulted in mixed catches of mainly but not exclusively 
Culicoides species. Typically, over 90% of insects were identified as either C. imicola or 
C. bolitinos. Small proportions of other Culicoides species were often included in the 
catch and were exposed to the same blood-feeding and incubation procedure as C. 
imicola and C. bolitinos. They were identified to species level at the end of the 
incubation period and assayed in the same way as C. imicola and C. bolitinos as a 
screen for other potential AHSV vectors. 
5.2 Results 
5.2.1 Oral infection of C. imicola and C. bolitinos with eight AHSV strains 
Oral infection rates for batches of C. imicola (Onderstepoort), C. imicola 
(Clarens) and C. bolitinos (Clarens) batches, infected with one of the reassortant, wild- 
type or attenuated virus strains were determined and are shown in Table 5-1. Titres of 
the infectious blood meals are shown in Table 5-2 (page 111). 
Table 5-1: Oral infection rates of eight AHSV strains in C. imicola and C. bolitinos 
C. imicola C. imicola C. bolitinos 
AHSV strain 
(Onderstepoort) (Clarens) (Clarens) 
A79 61/167 (37%)1 61/133 (46%) 1/98 (1%) 
A790 4/91(4%) 16/210(8%) 2/176(1%) 
3wt 4/205 (2%) 4/96 (4%) 4/156 (3%) 
3att 15/308(5%) 7/64(11%) 5/171(3%) 
8wt 96/231 (42%) 24/52 (46%) 10/149 (7%) 
Batt 10/220(5%) 10/94(11%) 2/149(1%) 
6wt 0/86 (0%) 0/53 (0%) 2/128 (2%) 
Gatt 0/202 (0%) 0/133 (0%) 0/162 (0%) 
1-Number infected/number assayed (infection rate in percent, rounded to the nearest integer). 
Insects were caught at Onderstepoort and Clarens with UV light traps, given an infectious blood meal spiked with the 
appropriate AHSV strain and incubated for 10 days at 23.5±1°C. They were then identified to species level, stored at -70°C 
and individually assayed for AHSV. Infection rates were calculated as the percentage of insects tested in which AHSV 
could be detected (minimum detection level: 0.75 log, oTCIDy/fly). 
110 
Table 5-2: Titre of infectious blood-meals before and after feeding (log10TCID5dml) 
AHSV strain C. imicola (O'poort) 
C. imicola (Clarens) and C. 
bolitinos [blood-fed together] 
A79 6.75/6.25 7.0/6.5 
A790 6.25/6.25 6.5/6.25 
3wt 6.5/6.25 6.75/6.75 
3att 6.25/6.25 6.75/6.5 
8wt 6.5/6.25 7.0/7.0 
Hatt 6.5/6.25 7.25/7.0 
6wt 6.75/6.75 7.25/6.75 
Gatt 6.5/6.5 7.25/6.75 
For illustration, three figures have been derived from the results shown in Table 
5-1. Figure 5-1 shows that the reassortant virus AHSV-A79 achieves significantly 
higher infection rates than AHSV-A790 in two different populations of C. imicola 
(Onderstepoort: , 
J=32.267, p<0.001, d. f.. =1; Clarens: j=68.416, p<0.001, d. f.. =1). In 
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Figure 5-1: Oral infection rates of the two reassortant viruses in C. 
imicola and C. bolitinos 
Insects were caught at Onderstepoort and Clarens with UV light traps, given an infectious 
blood meal spiked with the appropriate AHSV strain and incubated for 10 days at 
23.5±1°C. They were then identified to species level, stored at -70°C and individually 
assayed for AHSV. Infection rates were calculated as the percentage of insects tested in 
which AHSV could be detected (minimum detection level: 0.75 1og10TCID50/fly). 
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contrast, there was no significant difference in infection rates between these two virus 
strains in C. bolitinos (j=0.008, p=0.930, d. f.. =1) which were both very low compared 
to the C. imicola results. 
Differences in oral infection rates between attenuated and wild-type virus strains 
are illustrated in Figure 5-2. AHSV-8wt infected both populations of C. imicola, as well 
as C. bolitinos, to significantly higher levels than AHSV-8att (C. imicola-O'poort: 
, 
j=85.861, p<0.001, d. f. =1; C. imicola-Clarens: j=23.639, p<0.001, d. f. =1; C. 
bolitinos: j=5.557, p=0.018, d f. =1). AHSV-8att also infected a proportion of all three 
insect populations and reached an infection rate of over 10% in C. imicola (Clarens). 
AHSV-3wt and AHSV-3att both infected a proportion of all three insect populations. 
The infection rates for the heavily attenuated AHSV-3att exceeded those for the far less 
attenuated AHSV-3wt in all three populations but these differences were statistically not 
significant (C. imicola-O'poort: j=2.940, p=0.086, d. f. =1; C. imicola-Clarens: 
j=2.750, p=0.097, d. f. =1; C. bolitinos: X2=0.039, p=0.843, d f. =1). AHSV-6wt did 
not infect any C. imicola but did infect 2% of C. bolitinos. AHSV-6att did not infect any 
insects at all. 
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Figure 5-2: Infection rates of wild-type and attenuated AHSV strains 
in C. imicola and C. bolitinos 
Insects were caught at Onderstepoort and Clarens with UV light traps, given an infectious 
blood meal spiked with the appropriate AHSV strain and incubated for 10 days at 
23.5±1 °C. They were then identified to species level, stored at -70°C and individually 
assayed for AHSV. Infection rates were calculated as the percentage of insects tested in 
which AHSV could be detected (minimum detection level: 0.75 log10TCID5(/fly). 
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Figure 5-3 compares infection rates with all eight virus strains across the two C. 
imicola populations and also between C. imicola and C. bolitinos. The difference 
between the oral infection rates of C. imicola (O'poort) and C. imicola (Clarens) with 
AHSV-8att (5% and 11%, respectively) was only just significant (, j=4.100, p=0.043, 
df. =1). There were no significant differences between C. imicola (O'poort) and C. 
imicola (Clarens) for any of the other seven virus strains. 
The infection rates for C. bolitinos differed significantly from those in C. 
imicola for both reassortant viruses (AHSV-A79: j=57.786, p<0.001, d. f.. =1; AHSV- 
A790: j=9.051, p=0.003, d. f. =1), for AHSV-8wt (, j=42.670, p<0.001, d. f. =1), 
AHSV-8att (X2=10.610, p=0.001, d. f. =1) and AHSV-3att (Z2 =6.172, p=0.013, d. f. =1), 
but not for AHSV-3wt (J=0.497, p=0.481, d. f. =1). 
50 ® C. imicola (Onderstepoort) 
45   C. imicola (Clarens) 
40 
0 C. bolitinos (Clarens) 35 
30 
2 I 
2 
1 
i 
o 
T 
0) AC=7 
cu 3-- 
C1 ) co C13 ?: 
co (. 0 cz 
Virus strain 
Figure 5-3: Susceptibility of C. imicola and C. bolitinos to eight 
strains of AHSV 
Insects were caught at Onderstepoort and Clarens with UV light traps, given an 
infectious blood meal spiked with the appropriate AHSV strain and incubated for 10 
days at 23.5±1 °C. They were then identified to species level, stored at -70°C and 
individually assayed for AHSV. Infection rates were calculated as the percentage of 
insects tested in which AHSV could be detected (minimum detection level: 0.75 
log10TCID50/flY). 
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5.2.2 AHSV titre that indicates dissemination of infection in C. imicola 
AHSV-8wt and AHSV-A79 registered the highest infection rates (Table 5-1, 
page 110) and also the highest maximum titres (Table 5-3) in C. imicola and were 
therefore identified as the most suitable virus strains for this experiment. Due to 
variable insect availability, feeding rates and survival, batches of infected insects 
available for assay varied considerably in numbers. The only batch large enough to 
make insects available for this experiment was C. imicola (Onderstepoort) infected with 
AHSV-A79. Insects were orally infected (6.75 log1OTCID50/ml), maintained, identified 
and stored in the same way as those insects used for determination of oral infection 
rates. 
No AHSV could be detected in any of the 50 C. imicola heads assayed. Infection 
rates in the corresponding bodies ranged from 0.75 to 2.75 1og10TCID50. 
Table 5-3: Maximum titres of eight AHSV strains in C. imicola and C. bolitinos 
(Iog10TCID50/fly) 
C. imicola C. imicola C. bolitinos 
AHSV strain 
(Onderstepoort) (Clarens) (Clarens) 
A79 3.0 3.75 0.75 
A790 1.5 2.0 1.5 
3wt 1.5 1.5 1.25 
3att 2.5 1.5 1.5 
8wt 3.25 3.5 3.5 
Batt 1.5 1.5 1.0 
6wt <0.75 <0.75 1.5 
Gatt <0.75 <0.75 <0.75 
Values refer to the insect batches shown in Table 5-1. The minimum detectable titre was 0.75 
1og10TCID50/fly. 
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Table 5-4: Oral susceptibility of various Culicoides species to AHSV 
Insect species Number AHSV-positive/number tested 
C. enderleini 0/1 
C. gulbenkiani 0/43 
C. leucostictus 0/10 
C. nivosus 0/10 
Insects were caught with UV light traps, given an infectious blood meal spiked with 
AHSV and incubated for 10 days at 23.5°C. They were then identified to species level, 
stored at -70°C and individually assayed for AHSV. The lowest detectable titre was 
0.75 log10TCID50/fly. 
5.2.3 Infection rates of other Culicoides species 
Small numbers of various other Culicoides species, trapped in the collections 
aimed at C. imicola and C. bolitinos, were blood-fed as chance dictated, with any one of 
the eight virus strains used in this study and were incubated together with C. imicola 
and C. bolitinos. Survivors were assayed for AHSV but no virus was detected in any of 
these insects (Table 5-4). 
5.3 Discussion 
AHSV titre that indicates dissemination of infection in C. imicola 
Although virus titres in the insect bodies ranged from 0.75 (the lowest detection 
level) to 2.75 1og10TCID50, no virus was detected in any of the corresponding insect 
heads. This either indicates that the titre indicative of a fully disseminated infection in 
C. imicola is higher than 2.75 1og10TCID50, or that the virus infectivity assay failed to 
detect AHSV despite its presence in the insect head. C. sonorensis insects with an 
AHSV titre of 2.5 1og10TCID50 have been shown to have a fully disseminated infection 
(chapter 4). C. imicola is a much smaller insect than C. sonorensis and it seems unlikely 
that individuals of C. imicola would develop a titre above 2.5 1og10TCID50, without the 
virus having disseminated through the whole insect body. It is possible that the result of 
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this experiment reflects a failure of the virus infectivity assay. The small size of C. 
imicola probably means that less virus, possibly below the minimum detection level of 
0.5 log1OTCIDs0/head (section 4.2, page 87), will be present in the head of an insect with 
a fully disseminated infection. The small insect size may also have a negative effect on 
the reliability of insect dissection and processing compared to C. sonorensis. 
In the absence of data on disseminated virus infection of C. imicola, it can only 
be speculated that AHSV-8wt and AHSV-A79, which achieved maximum titres of 3.0 
1og10TCID50/fly or above (Table 5-3) in both C. imicola populations, would probably be 
transmitted by this species. The same applies to AHSV-8wt in C. bolitinos (maximum 
titre: 3.5 log1OTCID50/fly). Since only a small proportion of insects developed titres 
above 2.0 log1OTCID50/fly, the higher maximum titres might simply be a reflection of 
the higher infection rates elicited by the two virus strains, with an associated higher 
chance of detecting a number of insects with high titres. The titre of 3.0 1og10TCID50/fly 
is well above that indicating a disseminated infection in the much larger C. sonorensis 
(2.5 1og10TCID50/fly). However, C. imicola and C. bolitinos are both members of the 
subgenus Avaritia, whereas C. sonorensis belongs to the subgenus Monoculicoides. This 
relationship means that the latter species is more closely related for instance to the 
refractory palaearctic C. [monoculicoides] nubeculosus than to the two field vector 
species, illustrating the fact that Culicoides are a biologically highly diverse genus and 
that extrapolation from one species to others is fraught with uncertainty. 
Effect of variation in AHSV genome segment 10 on oral infection of C. imicola 11 
The significant difference in oral infection rates of C. imicola with AHSV-A790 
and AHSV-A79 shows that variation in AHSV genome segment 10 modifies infection 
rates in its main field vector (Figure 5-1, page 111). The similarity of the results for two 
populations of C. imicola underlines the significance of the results and they are further 
supported by the similar results in the model vector C. sonorensis (chapter 4). 
The more than five-fold increase in infection rates with AHSV-A79 over AHSV- 
A790 strongly suggests that the variation in genome segment 10 between different 
AHSV isolates is an effective way of virus adaptation to different vector species. In 
such a scenario, one might expect one variant segment 10 to confer an advantage over 
the other variant (in the form of higher oral infection rates) in some insect species, with 
a reverse situation in other vector species. This has not been the case in this study 
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(AHSV-A79 recorded higher infection rates than AHSV-A790 in C. imicola and C. 
sonorensis and an equal infection rate in C. bolitinos while AHSV-A790 never recorded 
higher infection rates than AHSV-A79). However, the segment 10 present in AHSV- 
A790 might confer an advantage over the segment 10 in AHSV-A79 in as yet 
unidentified vector species. Hypothetically, it is also possible that the competitive 
advantage in the insect vector of one variant segment 10 is offset by a longer viraemic 
period in the mammalian host caused by another variant, thus assuring the survival of 
two or more existing variants of this genome segment. Such a hypothesis is supported 
by experiments showing that variation in AHSV segment 10 can affect virulence in a 
mouse model (OHara et al., 1998). 
The high degree of variation in ability of AHSV-A79 and AHSV-A790 to orally 
infect C. imicola, combined with the absence of significant variation in infection rates 
between the reassortant strains and the respective parent that supplied genome segment 
10 (A790 - AHSV-3att; A79 - AHSV 8wt), follows a pattern also seen in the VC colony 
of C. sonorensis (chapter 4). The data suggest that, for the virus strains used in this 
work, AHSV segment 10 may have the strongest effect of all virus genome segments on 
the oral infection rate in the vector insect. As discussed in section 4.4 (page 105), the 
lack of variation between A79 and AHSV 8wt suggests little effect of genome segments 
7 or 9, or effects that cancel each other out. The consistent absence of variation between 
A790 and AHS V 3att suggests the same for segments 1-6 and 8. 
Susceptibility of C. imicola and C. bolitinos to infection with AHSV-6wt and AHSV-6att 
The results with AHSV-6wt and AHSV-6att (AHSV-6wt infected no C. imicola 
and only two C. bolitinos insects, AHSV-6att infected no insects at all) contrast with the 
results for all other virus strains used in this study (each of them infected both C. 
imicola and C. bolitinos insects). These differences are probably not due to the passage 
histories of AHSV-6wt and AHSV-6att, since these differ little from those of the wild- 
type and attenuated strains, respectively, of serotypes eight and three (Table 2-1, page 
50). The completely negative results for AHSV-6wt in C. imicola are supported by the 
results of C. sonorensis-studies with this virus, with no infected insects recorded 
(chapter 4). However, chapter 4 also showed that AHSV-6wt can replicate in the insect 
if inoculated intrathoracically, indicating that this virus is incapable of breaching the 
midgut barriers in orally infected C. sonorensis. Similarly, the negative results with C. 
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imicola may be due to an inability of AHSV-6wt to cross the midgut barriers in this 
species. 
There is a possibility that a "leaky gut" is the cause of AHSV-6wt infection of 
the two positive C. bolitinos. If this is so then the apparent higher incidence of "leaky 
guts" in C. bolitinos, compared to C. imicola and C. sonorensis (none of these recorded 
an infection following oral infection with AHSV-6wt) could be due to the potentially 
higher larval rearing temperatures of the dung-breeding C. bolitinos. An increase in 
larval rearing temperature has been shown to lead to leaky guts in C. nubeculosus 
imagoes (Wittmann, 2000). 
If infection of C. bolitinos is in fact caused by a "leaky gut" then the failure of 
AHSV-6wt to infect by the oral route involves one or more of these processes: 
Attachment to the midgut cells, entry into the midgut cells and replication in them. In 
short, it fails to overcome the M. The ability of AHSV-6wt to abluminally infect and 
replicate in Culicoides midgut cells is explored in chapter 6 and compared to AHSV- 
8wt, which successfully infects C. sonorensis, C. imicola and C. bolitinos by the oral 
route. 
The oral infection rates registered with AHSV-6wt in the model and field vectors 
included in this study raise the question of how this virus strain may survive in the field. 
One possibility is that it uses an as yet unidentified vector. Alternatively, it might use C. 
imicola or C. bolitinos as a field vector, but then the population present at the time and 
place of the outbreak that led to the virus isolation must have differed significantly in 
vector competence from the populations used in this experiment. 
Susceptibility of C. imicola and C. bolitinos to AHSV-3att and AHSV-8att 
This is the first time that heavily attenuated AHSV strains have been shown to 
infect their field vectors. Although no other data are available for orbiviruses, concern 
about the potential spread of live attenuated viruses following vaccination of humans 
has led to more extensive research on other arthropod-borne viruses. Work carried out 
on attenuated strains of Rift Valley fever, Chikungunya, dengue-1 and dengue-2 viruses 
suggests that all these viruses can successfully infect laboratory colonies of Aedes 
aegypti by the oral route (Turell & Rossi, 1991; Turell & Malinoski, 1992; Khin et al., 
1994; Jirakanjanakit et al., 1999). However, no evidence has been published to show 
that heavily attenuated arboviruses can infect field vectors, collected from the wild in 
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areas where the virus is endemic. Although AHSV-3att achieved marginally higher 
infection rates than AHSV-3wt in both C. imicola populations and also in C. bolitinos, 
this cannot be unequivocally interpreted as an effect of attenuation since the two isolates 
may not have been derived from the same parent strain. Nevertheless, the oral infection 
of two field vector species with AHSV-3att and AHSV-8att shows that the live 
attenuated AHSV vaccine strains which are currently used in commercial vaccines will 
also be likely to be able to infect Culicoides species. To assess this risk in detail, AHSV 
strains included in the commercial vaccines should be used in vector competence 
studies similar to the ones described in this chapter. Vaccine strains should also be 
checked for their potential to cause viraemia. There is some limited evidence to suggest 
that tissue-culture attenuated vaccine strains of AHSV do not induce detectable 
viraemia in ponies (House, 1998). Transmission studies involving the exposure of 
recently vaccinated horses (and other equids) to the bite of susceptible Culicoides 
vectors could verify the significance or otherwise of that finding. However, it could be 
dangerous to extrapolate from the possible negative outcome of such studies to suggest 
that the investigated vaccines are safe, since in a field situation the number of vectors 
and potentially viraemic horses is likely to be much greater than in simulated laboratory 
experiments. An AHS outbreak in non-endemic areas is likely to lead to emergency 
vaccination in the presence of the field virus, which would almost certainly mean that 
some equids would contain simultaneously the wild type and the vaccine virus strains. 
This could result in reassortment, with the potential to generate virus strains with new 
virulence and antigenic characteristics. The high oral infection rates in Culicoides 
insects with AHSV-A79 (the virus which resulted from the reassortment of the heavily 
attenuated AHSV 3att with the only lightly attenuated AHSV-8wt) emphasise that this is 
a realistic scenario. The use of non-replicative vaccines appears to be the only really 
safe way out of this situation. 
Comparison of oral infection rates between C. imicola and C. bolitinos 
Infection rates in C. bolitinos differ from those in C. imicola in two respects. 
Firstly, C. bolitinos infection rates are lower for all virus strains except for AHSV-6wt 
and AHSV-6att, which have been discussed above. This does not, however, mean that 
C. bolitinos is a universally poorer vector than C. imicola. A previous study recorded 
AHSV-5 infection rates of 20.6% in C. bolitinos, compared to just 8.5% in C. imicola 
(Venter et al., 2000). 
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Secondly, in C. bolitinos, there is no significant difference between the infection 
rates recorded by AHSV-A790 and AHSV A79, i. e. the variation in virus genome 
segment 10 had no obvious effect. This could indicate that neither type of segment 10 is 
particularly suited to infection of this vector species, or just this particular population. 
The results for C. bolitinos resemble those for the NVC colony of C. sonorensis at IAH 
Pirbright, which also combined low infection rates with lack of variation in infection 
rates between these reassortant viruses (chapter 4). This pattern might suggest that in 
highly susceptible vectors (such as the C. sonorensis VC colony and C. imicola) 
variation of segment 10 enables some virus strains (e. g. AHSV-A79) to achieve higher 
infection rates than others, while in vectors with a low oral susceptibility (such as C. 
sonorensis NVC colony and perhaps C. bolitinos), it confers no particular advantage or 
disadvantage. 
The following is highly speculative but it can be argued that highly susceptible 
insect vectors vary from less susceptible ones by having a factor that interacts with the 
(segment-10 encoded) NS3/3a. This factor could be the identity or expression level of a 
NS3/3a-interacting host cell protein. In this case it might be possible to identify such a 
protein, using cellular techniques like immunoprecipitation, yeast-2-hybrid systems and 
GST fusion assays. The results of such experiments could be used to compare the 
midgut cells of C. sonorensis from the VC colony with those from the NVC colony 
since it is a factor within these cells that is the basis of the difference between the two 
colonies. Alternatively, if highly specific anti-NS3 antibodies could be produced, this 
should allow immunofluorescence or electron microscopy studies to screen for NS3-co- 
localisation with cellular structures and a range of cellular proteins, for which antibodies 
are commercially available. To identify differences between vector-competent and non- 
competent insects, it would be necessary to carry out these experiments in situ, i. e. in 
the midgut cells. The VC and NVC C. sonorensis colonies would be an ideal tool for 
such studies. 
Susceptibility of two C. imicola populations to AHSV 
This is the first time that it has been possible to determine the vector competence 
levels of C. imicola, from two different geographical locations, for an orbivirus during 
the same insect season. The amazingly similar pattern of infection rates for the two 
populations of C. imicola, which originated from locations 350 km apart, suggests that 
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insects from the two sources were genetically closely related at the time these 
experiments were carried out. Since C. imicola have been caught in locations situated 
between Onderstepoort and Clarens, the most rational explanation for these results is 
that there is an uninterrupted gene flow between these two sites. This view is supported 
by the recent investigation of genetic variability within the C. imicola species complex 
(Sebastiani et al., 2001). Comparing patterns of randomly generated DNA fragments in 
insects from various locations across Southern Africa, it was found that there was less 
genetic variation between geographical populations in C. imicola than in other members 
of the species complex, e. g. C. bolitinos. Among others, the study included C. imicola 
from Onderstepoort and from several locations more remote from Onderstepoort than 
Clarens. Clarens was not included since until recently it was virtually C. imicola-free 
(Meiswinkel, 1997). The authors suggested that within southern Africa, C. imicola 
might be genetically quite homogeneous, a characteristic that may be facilitated by its 
utilisation of moist, organically enriched soil for breeding. Ideal breeding conditions are 
often provided by human activity and can cover large areas, enabling C. imicola to 
spread and preventing genetic isolation. In view of the results obtained in this chapter 
and the genetic evidence described above, C. imicola from different South African 
locations should be considered as parts of one large population. Interestingly, a recent 
study of the genetic variability of C. impunctatus, which is as ubiquitous in the UK as 
C. imicola is in South Africa, concluded that insects from Scotland and from southern 
England were very closely related (Dr. S. Carpenter, personal communication). 
Although the present study indicates that C. imicola can be quite uniform in its 
susceptibility to AHSV over a distance of several hundred kilometres, this might not 
always be the case. Depending on prevailing weather conditions, the situation may vary 
from season to season. Great differences in ambient temperatures between two 
locations, for instance, could lead to differences in vector susceptibility since larval 
rearing temperatures and adult incubation temperatures during the EIP have both been 
shown to affect oral infection rates of Culicoides insects with AHSV (Wittmann, 2000). 
The situation may also differ in regions where geographic features hinder the active and 
passive spread of insects. Hence, up to date evaluations of insect vector competence will 
always be desirable to provide an accurate estimate of the risk of disease outbreaks. 
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Variation of vector susceptibility to AHSV over time 
Vector competence studies similar to the ones described in this chapter were 
carried out with C. imicola from Onderstepoort and C. bolitinos in 1999, approximately 
one year before the completion of the experiment in the present study (Venter et al., 
2000). The virus strains designated as AHSV-3wt and AHSV-8wt here were also used in 
the 1999 study. Between the two sets of results, some striking similarities exist. AHSV- 
8(wt) reached a much higher infection rate (26.8%) than AHSV-3(wt) (0%) in C. 
imicola, just as in the present study (Table 5-1, page 110). Also, a low proportion of C. 
bolitinos proved susceptible to infection with these two viruses (AHSV-8: 1.7%, AHSV- 
3: 3.8% infection rate), which again bears similarity to the results obtained in the 
present study. These similarities are a sign of relative stability in the two insect species' 
susceptibility to AHSV. However, additional to the present work, C. bolitinos was 
highly susceptible to one virus isolate (AHSV-5) with an infection rate of 20.6%. This 
illustrates that some populations of C. bolitinos can be a highly competent AHSV vector 
for certain strains or serotypes of virus. 
Susceptibility of other Culicoides species to AHSV 
The failure of AHSV to infect C. enderleini, gulbenkiani, leucostictus and 
nivosus by the oral route confirms a previous study with the same result for these four 
and an additional 11 Culicoides species (Venter et al., 2000). As yet, AHSV has not 
been recovered at the end of a 10-day EIP from any Old World, non-Avaritia species. 
Nevertheless, due to the limited amount of data available (Venter et al., 2000, and this 
study), the ability of other Culicoides species to become infected and transmit AHSV 
cannot be ruled out. Moreover, the length, temperature and humidity of extrinsic 
incubation selected in the present study may not suit all species. The consistent absence 
of AHSV from other Culicoides species in the present work serves as a control, 
confirming that the virus detected in C. imicola and C. bolitinos at the end of the 10-day 
EIP is not residual virus from the infectious blood meal but is replicating virus. 
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6 Immunofluorescence studies of AHSV replication in insect cells and 
Culicoides midguts 
6.1 Introduction and rational 
The experiments described in chapter 4 show that the ability of AHSV to 
overcome the MIB of the vector C. sonorensis can be controlled by an insect-defined 
factor, such as genetic selection in the vector. On the other hand, variation in segment 
10 of AHSV, encoding the non-structural protein NS3/3a, has also been shown to affect 
oral infection rates in C. sonorensis (see chapter 4), which implies that this viral protein 
(i. e. a virus-defined factor) may influence infection. However, as a non-structural 
protein, NS3/3a is absent at the time of initial cell attachment and infection by virus 
particles. Consequently, it is difficult to understand how it can affect these processes. In 
this context, it is likely that the initial cycle of infection and replication in vector midgut 
cells is below the level of detection of the virus infectivity assays used in the present 
work (0.75 log1OTCID50/insect) and that the presence of replicating virus, therefore, 
only becomes detectable during additional cycles of infection. This secondary spread of 
virus would be in the presence of NS3/3a and could be controlled by it, thereby leading 
to the different infection rates detected for AHSV-A79 and AHSV-A790. This 
suggestion is supported by the findings of chapter 4, where the ability of AHSV to 
overcome the MEB of C. sonorensis seems to depend on the identity of NS3/3a. 
However, the findings of chapter 4 did not reveal the mechanisms by which this occurs. 
The overall aim of this chapter was to investigate the mechanisms by which 
NS3/3a affects the virus spread within the vector's midgut cells and from the midgut 
cells into the haemocoel. Immunofluorescent microscopy was chosen as a potentially 
quick and reliable method of localising NS3/3a within infected cells. The overall aim 
was approached via four closely related objectives: 
The first objective was to develop a reliable method for identifying infected cells 
in KC tissue culture and in Culicoides midguts. Efforts concentrated on guinea pig anti- 
VP7 polyclonal antibody because of the high conservation of VP7 within the AHSV 
species and the availability of the antibody in the laboratory. VP7 is highly hydrophobic 
and has been found, in the shape of hexagonal crystals, in BHK-21 cell lysates 
(Burroughs et al., 1994). It was reasoned that if VP7 produced similarly conspicuous 
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structures in live KC and Culicoides midgut cells then this might be an easy and reliable 
way of detecting AHSV infection. An anti-VP7 antibody has been used before for the 
detection of BTV in Culicoides insects (Fu et al., 1999). 
The second objective was to develop a reliable way of visualising NS3/3a in KC 
cells and in Culicoides midguts. To achieve this aim, two anti-NS3/3a antibodies were 
obtained from collaborating laboratories (PAb-SA and PAb-1-117, Table 6-1, page 127) 
and assessed in KC cell immunofluorescence studies. Polyclonal anti-NS3/3a-peptide 
sera were also produced at IAH Pirbright and tested in KC cells to address this issue. 
Anti-NS3/3a antibodies were used for Western blot analysis of infected and uninfected 
KC cell lysates to check for cross-reactions with other viral and cellular proteins. 
The third objective was to determine whether or not AHSV replicates (to low 
levels, which are undetectable by the virus infectivity assay) in those Culicoides that 
test negative in virus infectivity assays following attempted oral infection. C. 
nubeculosus were used for this purpose since this is a species that has been shown to be 
refractory to oral infection with AHSV and BTV unless very high infecting titres are 
used (Mertens et al., 1996) or unless the larval rearing temperatures are raised to near 
lethal levels (Wittmann & Baylis, 2000). Batches of C. nubeculosus insects were orally 
fed with either AHSV-6wt or AHSV-8wt. Their midguts were labelled with an anti-VP7 
antibody after an EIP of 10 days and subjected to immunofluorescence microscopy. The 
experiment was carried out in the same way with insects from the C. sonorensis (VC) 
colony. AHSV-6wt apparently failed to orally infect C. sonorensis in previous 
experiments, (chapter 4), but it remained unclear if it did infect some insects at a very 
low level (i. e. titre). However, AHSV-8wt achieved high infection rates in this colony 
(chapter 4). Here, evidence of midgut infection should be easy to find and would serve 
as a positive control. To ensure that the structures detected by the anti-VP7 antibody are 
an indicator of infection and do not detect residual virus remaining from the infectious 
blood meal, further C. nubeculosus insects, orally infected with AHSV 8wt, were 
dissected and used for immunofluorescence after EIPs of 0,1 and 2 days, respectively. 
The fourth objective was to investigate the ability of Culicoides midgut cells to 
become infected from the abluminal side. C. sonorensis (VC) were inoculated 
intrathoracically (IT) with either AHSV-8wt or AHSV-6wt. Insects from the C. 
sonorensis (NVC) colony and C. nubeculosus were also inoculated IT with AHSV-6wt. 
All insects were dissected and their intestines subjected to immunofluorescence with 
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anti-VP7 antibody after an EIP of 10 days. C. sonorensis has been found to replicate 
AHSV-6wt following IT inoculation (chapter 4) and C. nubeculosus has also been found 
to replicate IT inoculated AHSV (Mellor et al., 1975). Replication of AHSV in the 
midgut following IT inoculation could indicate the presence of AHSV receptors in the 
abluminal midgut membrane of the affected insect batches. In the case of AHSV-6wt, it 
would also show that the failure of the virus to orally infect insects (chapter 4) 
represents a failure to enter the midgut cells from the luminal side, rather than an 
inability to replicate in them. In addition, infection of midgut cells from the abluminal 
side would lend some credibility to the hypothesis that cell-to-cell spread within the 
midgut may occur via the haemocoel (chapter 4). The results obtained for the VC and 
the NVC colonies also test the assertion made in chapter 4 that selection of these 
colonies did not change the character of their abluminal membrane, representing the 
MEB. 
6.2 Methods 
6.2.1 Production of polyclonal antibodies against a NS3/3a peptide 
Using the sequence analysis program GCG 10, a potentially highly antigenic 
amino acid sequence, which is conserved in many variants of AHSV NS3/3a, was 
chosen (Figure 6-1). The amino acid sequence (ERLR DPEPI RQIKK) is located at as 
77-90 in the N-terminal region of the protein. A cysteine residue was added to the N- 
terminal and the peptide was produced as an amide by Dr. L. Hunt at IAH Compton. 
The amide structure mimics the internal peptide better than the alternative acid structure 
while the addition of a cysteine residue allowed the peptide to be conjugated to the 
carrier protein, keyhole limpet haemocyanin (KLH). KLH is the oxygen-carrying 
molecule of the mollusc Diodora aspera (Figure 6-2) and was used as a conjugate to 
enhance the molecular size and the antigenic properties of the molecule (Harlow & 
Lane, 1988). Conjugation of the peptide to KLH was carried out using the cross-linking 
molecule SMCC (see protocol in section 2.5.15, page 65). 
Five guinea pigs and two rabbits were inoculated subcutaneously with 1 ml of 
KLH-conjugated peptide in PBS, containing the equivalent of 1 µg/ml peptide. The 
injection was repeated seven times at 14-day intervals. All animals were exsanguinated 
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14 days after the last booster injection. Serum was obtained by leaving the blood to clot 
overnight and centrifuging the supernatant at 100 g for 5 min. It was then stored at - 
20°C. Small aliquots for day-to-day use were stored at 4°C. 
W2 
Gi: 
CTIIH 
Figure 6-1: Predicted secondary structure and antigenic regions of AHSV-NS3/3a 
Figure 6-2: The keyhole limpet Diodora aspera 
(http: //www. ocnms. nos. noaa. gov/LivingSanctuary/limpet. html) 
126 
6.2.2 Antibodies used in immunofluorescence studies 
All primary antibodies except for the monoclonal "anti-tubulin" used in this 
work are polyclonal antibodies (PAbs) and listed in Table 6-1. A total of seven PAbs, 
named PAb-R1, -R2 and -G1 through -G5, were produced at IAH Pirbright as a part of 
this project. Staining was by the method detailed in section 2.5.17 (page 65). Antibodies 
and stains were used in various combinations as indicated in the legends of the images 
obtained (section 6.3). No primary antibodies were used in control samples. PAb-VP7 
was used at a concentration of 1/2000 and anti-NS3/3a antibody concentrations ranged 
from 1/100 to 1/5000. All commercially available stains and antibodies were used at the 
concentrations recommended by the manufacturer. 
Table 6-1: Primary antibodies used in immunofluorescence microscopy 
Designation Raised in Raised against Origin 
PAb-VP7 Guinea pig 
PAb-SA1 Rabbit 
Purified AHSV-9 VP7 
AHSV-3 NS3/3a2 
Dr. P. Mertens, IAH Pirbright 
Dr. A. van Dijk, OVI Pretoria, 
South Africa 
PAb-1-1171 Rabbit 
PAb-R 1 and PAb-R21 Rabbit 
PAb-G1 to PAb-G5 (5 
antibodies) 
1 Guinea pig 
AHSV-4 (Morocco) NS3 as 1-117 (N- 
terminal) 3 
ERLR DPEPI RQIKK (NS3 peptide) 
ERLR DPEPI RQIKK (NS3 peptide) 
Dr. S. Zientara, AFSSA, 
Maisons Alfort, France 
See section 6.2.1 (page 125) 
See section 6.2.1 (page 125) 
Anti-tubulin Mouse a-tubulin Sigma 
1 PAb-SA, PAb-1-117, PAb-R1, -R2, -G1 to -G5 are collectively referred to as anti-NS3/3a antibodies. 2 No further information regarding the precise virus strain or NS3/3a type was available. 
3 This virus strain was also supplied by Dr. Zientara and was used together with PAb-1-117 throughout. 
6.2.3 Immunofluorescence studies in C. sonorensis (KC) cells 
KC cells were grown on 13 mm glass cover slips to 50% confluency and 
infected with one of AHSV-3att, AHSV-A790, AHSV-A79, AHSV-8wt, AHSV-6wt and 
AHSV-4 (approximate multiplicity of infection - MOI = 10). After 20 h incubation at 
29°C, cells were fixed (section 2.5.16, page 65) and immediately stained for 
immunofluorescence microscopy, using one of the nine anti-NS3/3a antibodies (Table 
6-1) in combination with PAb-VP7 and the DNA stain TO-PRO-3. Staining was 
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followed by mounting on microscopy slides. Microscopic examination was carried out 
immediately using a non-confocal microscope and within four days using a confocal 
microscope. The same procedure was applied to uninfected control cells. 
6.2.4 Immunofluorescence studies in Culicoides midguts 
Experimental approach 
The experiments on insect guts were designed to examine large numbers of gut 
cells. It was therefore decided to use the entire length of the midgut for 
immunofluorescence, thus increasing the chance of detecting even low levels of 
infection. This approach has not been documented before and involved the dissection of 
insects, fixing, staining and mounting of entire intestines. One potential problem, the 
inclusion of the gut lumen in the mounted gut (Figure 6-3) was addressed by the use of 
a confocal microscope. Confocal microscopy makes it possible to determine the precise 
level of origin of the signal within the sample, and therefore could be employed to 
differentiate between signals originating from the gut lumen and signals originating 
from the gut cells. Three different methods of visualising cell membranes within the 
insect gut were tested. These were staining of the cytoskeleton with anti-tubulin 
antibodies, demarcation of cell surface glycoproteins with wheat germ agglutinin 
(WGA) and labelling of actin with phalloidin. 
Nail vnrnich "wall" and coal 
Mounting 
medium 
Figure 6-3: Schematic cross-section through a Culicoides gut mounted 
for immunofluorescence microscopy 
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Glass slide Gut wall 
Infection, maintenance and dissection of Culicoides insects 
Batches of C. sonorensis (VC) and C. nubeculosus insects were fed infectious 
blood meals containing AHSV-8wt (6.75 1og10TCID50/ml) or AHSV-6wt (6.5 
log10TCID50/ml) as described in section 2.3.2 (page 56). Further batches of C. 
sonorensis (VC), C. sonorensis (NVC) and C. nubeculosus were IT inoculated with 
AHSV-8wt or AHSV-6wt, using the technique set out in section 2.3.4 (page 58). Insects 
were maintained for the duration of the EIP (1,2 or 10 days) as described in section 
2.3.2, anaesthetised with CO2 and dissected immediately. The entire intestinal tract was 
removed, rinsed with PBS and fixed as described in 2.5.16 (page 65). It was then stored 
at 4°C for up to five days before being stained using the methods described in section 
2.5.17 (page 65). Samples were stained with one of Oregon Green-Phalloidin, anti- 
tubulin antibody or Texas Red-WGA, with or without PAb-VP7, as indicated in figure 
legends. 
6.2.5 Western blots with anti-NS3/3a antibodies 
Western blots were carried out to test the binding characteristics of anti-NS3/3a 
antibodies with denatured antigen, using cell lysate from infected and uninfected KC 
cells. Standard protocols were used (section 2.5.18, page 66). 
6.3 Results 
6.3.1 Visualisation of VP7 and NS3/3a in C. sonorensis (KC) cells 
The majority of KC cells, when infected with AHSV, were seen to contain 
hexagonal structures after staining with PAb-VP7 (Figure 6-4 and Figure 6-5). These 
structures were not observed in uninfected control cells. This is the first time that VP7 
crystals have been observed in live cells, rather than after purification of cell lysates. 
Staining with the seven anti-NS3/3a antibodies (PAb-RI and -R2, -G1 to -G5) 
raised as a part of this project exposed no observable differences between the infected 
and uninfected KC cells (images not shown). All cells exhibited diffuse staining of the 
nucleus, cytoplasm and sometimes the cell membrane. This was also the case with the 
anti-NS3/3a PAb-SA. Variation of antibody concentrations between 1/100 and 1/5000 
failed to elicit differences between the infected and uninfected cells. 
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Staining of infected and uninfected KC cells with the polyclonal anti-NS3/3a 
peptide PAb-1-117 is shown in Figure 6-4 and Figure 6-5. This method repeatedly 
identified filamentous structures in AHSV-4-infected KC cells (red). Figure 6-4 also 
shows staining of the cell membrane, but this could not always be demonstrated in 
repeat experiments (Figure 6-5). Uninfected cells never showed filamentous structures 
but did show a high level of nuclear, perinuclear and cytoplasmic background staining 
with PAb-1-117 (Figure 6-4). 
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--0 VP7 crystals 
--+ Filaments 
-om-- Cell membrane 
Figure 6-4: Hexagonal and filamentous structures in AHSV infected KC cells (I) 
Top: AHSV-4 infected KC cells 
Bottom: Uninfected KC cells 
KC cells were grown on glass cover slips and infected or mock-infected with AHSV-4, incubated at 29°C for 20 
h, fixed with paraformaldehyde and permeabilised with Triton X-100. Incubation with guinea pig-anti PAb-VP7 
(1/1000) and rabbit-anti PAb-1-117 (1/500) was followed by incubation with anti-guinea pig antibody 488 nm 
(green) and anti-rabbit antibody 594 nm (red). Samples were mounted with Vectashield mounting medium and 
sealed with nail polish. 
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-+ VP7 crystals 
-p Filaments 
Nucleus 
Figure 6-5: Hexagonal and filamentous structures in AHSV-infected KC cells (II) 
The three images show KC cells infected with AHSV-4, stained with anti-NS3/3a PAb-1-117 (red), anti- 
VP7 antibody PAb-VP7 and DNA marker TO-PRO-3 (blue). The bottom image shows the same VP7 
crystal as the top right image at a higher magnification, but without the blue DNA label. Intensities of red 
and green were reduced in the top right image to enhance the (weaker) blue signal, thus leading to slight 
colour aberration for red and green in this image. 
KC cells were grown on glass cover slips and infected with AHSV-4, incubated at 29°C for 20 h, fixed 
with paraformaldehyde and permeabilised with Triton X-100. Incubation with guinea pig-anti PAb-VP7 
(1/2000) and rabbit-anti PAb-1-117 (1/500) was followed by incubation with anti-guinea pig antibody 488 
nm (green), anti-rabbit antibody 594 nm (red) and the TO-PRO-3 (blue). Samples were mounted with 
Vectashield mounting medium and sealed with nail polish. 
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6.3.2 Immunofluorescence studies in Culicoides midguts 
Visualisation of Culicoides midguts with Oregon Green-Phalloidin, Texas Red-WGA 
and anti-tubulin antibody 
Figure 6-6 shows that the actin-binding Oregon Green-Phalloidin is suitable for 
visualising the midgut of Culicoides insects. The structure highlighted by this stain 
probably represents the extensive smooth muscle network of the insect midgut. The 
computer-generated z-section (a vertical cross-section through the mounted sample) 
shows that phalloidin does not stain all gut cells and is therefore not suitable for 
outlining the luminal and abluminal borders of the midgut. 
Figure 6-7 shows that both anti-tubulin antibody and lectin-binding WGA will 
stain midgut cells. The computer-generated z-sections suggest that the anti-tubulin 
antibody may not penetrate the entire gut wall while WGA appears to penetrate the gut 
walls very well, showing the opposing gut walls compressing the gut lumen. 
These results suggest that WGA is the most suitable stain for outlining the gut 
cell margins, which would help to identify whether other signals originate from the 
intracellular space, the cell surface or the gut lumen. However, the quality of the WGA 
staining could not be reliably reproduced as shown in this experiment. Phalloidin and 
anti-tubulin antibody were therefore used in subsequent experiments. 
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Midgut walls 
enclosing gut lumen 
(A) Anterior midgut 
(M) Malphigian tubule 
(P) Posterior midgut 
Figure 6-6: Visualisation of C. sonorensis midgut with phalloidin 
Top left: Whole midgut; Top right: enlarged section of posterior midgut; Bottom: Computer-generated 
z-section through posterior midgut. The figure shows the phalloidin-stained smooth muscle network. 
Figure 6-7: Visualisation of C. sonorensis midgut with anti-tubulin antibody and 
WGA 
Posterior midgut surface stained with anti-tubulin antibody (top left) and WGA (top right). Computer- 
generated z-sections of these areas (bottom) show the gut walls enclosing the gut lumen (F- arrows). 
Adult female C. sonorensis were anaesthetised, dissected and their entire intestines removed. These were 
then fixed with paraformaldehyde, permeabilised with Triton X-100 and stained with Oregon Green- 
Phalloidin, mouse anti-tubulin antibody/anti-mouse 594 nm antibody or Texas Red-WGA, then mounted 
with Vectashield mounting medium, sealed with nail polish and examined under a confocal microscope. 
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Identification of VP7 crystals in Culicoides midguts 
Figure 6-8 shows that IT inoculation of C. sonorensis with AHSV-8wt results in 
the presence of characteristic VP7 crystals in the midgut. IT inoculation was chosen as a 
route of infection to ensure that (almost) all insects were infected, so that the ability of 
the test to detect VP7 crystals could be properly assessed. 
The VP7 crystals are concentrated in the posterior part of the midgut but are also 
common in the anterior midgut. The z-section strongly suggests that the crystals are 
located in the gut wall, i. e. the midgut cells. This suggests that they are not artefacts 
originating from residual virus from the IT inoculation but are the result of virus 
replication in the gut cells. To confirm that the breakdown of virus does not lead to 
detectable VP7 crystals in the absence of virus replication, a biological negative control 
was carried out (below). 
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VP7 crystals 
-ý Midgut wall 
(A) Anterior midgut 
(H) Hindgut 
(J) Midgut-hindgut junction 
(L) Midgut lumen 
(M) Malphigian tubules 
(P) Posterior midgut 
Figure 6-8: Infected C. sonorensis (VC) midgut contains VP7 crystals in the gut 
wall 
Top: Entire midgut with Malphigian tubules and midgut-hindgut junction. 
Bottom left: Enlarged VP7 crystals in posterior midgut. 
Bottom right: Computer-generated z-section through posterior midgut. 
3-day-old adult female C. sonorensis (VC) were IT inoculated with AHSV-8wt. After an EIP of 10 days 
they were anaesthetised, dissected and their entire intestines removed. These were then fixed with 
paraformaldehyde, permeabilised with Triton X-100 and incubated with PAb-VP7 and mouse anti- 
tubulin antibody, followed by incubation with anti-guinea pig antibody 488 nm (green) and anti-mouse 
594 nm antibody (red), then mounted with Vectashield mounting medium and sealed with nail polish. 
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Biological negative control 
Figure 6-9 shows that feeding of an AHSV-8wt-containing blood meal to the 
orally refractory species C. nubeculosus did not result in the formation of VP7 crystals 
after an incubation period of 2 days. Similarly, no VP7 crystals were detected after 
incubation periods of 0 and 1 days, suggesting the absence of AHSV in each case 
(images not shown). The results of IT injection of C. nubeculosus with AHSV-6wt are 
shown in the following section. 
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Figure 6-9: VP7 crystals are absent from the midguts of orally-refractory C. 
nubeculosus insects two days after a blood meal containing AHSV 
Top: Midgut with midgut-hindgut junction (right). 
Bottom: Enlarged part of posterior midgut. 
Green: Midgut smooth muscle network. 
Red: AHSV VP7 (none identified). 
3-day-old adult female C. nubeculosus were fed an infectious blood meal of AHSV-8wt. After an 
incubation period of 2 days they were anaesthetised, dissected and their entire intestines removed. These 
were then fixed with paraformaldehyde, permeabilised with Triton X-100 and incubated with guinea-pig, 
anti-VP7 PAb-VP7, followed by incubation with anti-guinea pig antibody 594 nm (red) and staining with 
Oregon Green-Phalloidin (green). Samples were then mounted with Vectashield mounting medium and 
sealed with nail polish. 
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Replication of AHSV-8wt and AHSV-6wt in Culicoides midguts following oral infection 
and IT inoculation 
Confocal microscopy was not available at IAH Pirbright and disease security 
regulations caused additional logistical problems in transporting such samples to a 
location where a confocal microscope was sited. Therefore, following the experiments 
above, which showed that the presence of VP7 in Culicoides midguts indicates virus 
replication, samples were stained with Oregon Green-Phalloidin and PAb-VP7 and 
checked for the presence of VP7 crystals under a non-confocal microscope. The results 
in Table 6-2 show that the feeding of infectious blood meals containing AHSV-8wt 
results in a midgut infection of most C. sonorensis, but none of the C. nubeculosus 
insects were detectably infected. In contrast, the feeding of AHSV-6wt didn't result in a 
detectable midgut infection in either of these two species. 
Table 6-2 also shows that IT inoculation of AHSV-6wt results in a midgut 
infection in C. sonorensis (VC and NVC) but not in C. nubeculosus. IT inoculation of 
AHSV-8wt into C. sonorensis (VC) also resulted in a midgut infection. 
Table 6-2: Presence of VP7 in Culicoides midguts following oral infection and IT 
inoculation with two AHSV strains 
Number of insects positive/number tested 
AHSV Fed Orally 
strain C. sonorensis 
IC 
(VC) nubeculosus 
8wt 5/6 0/5 
6wt 0/6 0/5 
Inoculated IT 
C. sonorensis C. sonorensis c 
(VC) (NVC) nubeculosus 
8/8 n. d. n. d. l 
8/8 8/8 0/8 
1 n. d.: not done 
6.3.3 Western blot analysis of the anti NS3/3a PAb-1-117 
The anti-NS3/3a antibody PAb-1-117 was used in Western blots in an attempt to 
establish whether the filamentous structures identified with this antibody in AHSV-4 
infected KC cells (section 6.3.1) were due to binding of NS3/3a, or the result of cross- 
reactions with other proteins. Figure 6-10 shows that the antibody binds to three 
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proteins, with sizes of approximately 15,25 and 45-50 kDa. The 25 kDa protein is not 
visible in the negative control and has the expected size of NS3/3a. The 15 and 45 kDa 
proteins are thought to be cellular proteins since these bands also appear in uninfected 
cells. 
Negative 
AHSV-4 
control 
Figure 6-10: Western blot analysis of AHSV-4 infected KC cell lysate with anti- 
NS3/3a PAb-1-117 
AHSV-4 infected KC cells were lysed 24 h post infection, denatured at 100°C and resolved alongside a 
broad range protein marker by SDS-PAGE. Proteins were transferred onto an Immobilon P membrane and 
blocked in 5% Marvel (in TBS Tween) overnight. PAb-1-117 was added at 1/1000 and incubated for 1 h. 
4 TBS/Tween washes were followed by incubation of the secondary antibody (anti-rabbit peroxidase- 
linked antibody, 15 µl/10 ml blocking buffer) for 1h and further washes as before. All incubation was at 
room temperature under constant rotation. Development was with Luminol enhancer and Stable Peroxide 
(Pierce) for 1 min, followed by immediate exposure to film. 
6.4 Discussion 
The work described does not entirely reflect the original objectives of the 
present chapter. To investigate how NS3/3a may affect virus spread within the midgut, 
or release from the midgut into the haemocoel, the first objective was to localise NS3/3a 
in infected KC and C. sonorensis midgut cells, and compare the results between the two 
reassortant viruses. The second objective was to test the hypothesis that vector 
competence of the C. sonorensis VC colony is linked to the type of NS3/3a present (see 
chapter 4) by localising NS3/3a in C. sonorensis VC and NVC midgut cells, and 
comparing the results for the two colonies. This approach met with two obstacles. 
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The first obstacle was that the difference in the ability of AHSV-A790 and 
AHSV-A79 to escape from host cells is quantitative in nature. In KC and BHK-21 tissue 
culture, both viruses are released into the supernatant, although AHSV-A79 regularly 
grows to higher titres in KC cells (chapter 7). Similarly, in C. sonorensis insects, both 
viruses have the potential to be released from the abluminal midgut cell membrane 
(chapter 4). Since this is true for both the NVC and the VC insect colony, there is no 
virus-host system that always allows the virus to be released into the haemocoel and no 
system that always prevents virus release. Consequently, single observations in 
immunofluorescent microscopy cannot be firmly associated with the release or non- 
release of the virus from the observed cell. However, immunofluorescent microscopy, 
especially of entire insect guts, is not well suited to large scale repetition to provide 
statistically significant numbers of observations. 
The second obstacle towards association of different cellular NS3/3a- 
localisations with release or non-release events was the lack of anti-NS3/3a antibodies. 
Identification of infected KC and Culicoides midgut cells 
The results of this chapter show that AHSV infection of KC cells and Culicoides 
midgut cells leads to the formation of cytoplasmic VP7 crystals. The significance of this 
finding is unclear but may reflect overexpression of VP7. The experiments also show 
that the anti-VP7 antibody PAb-VP7 can be used successfully as a control to detect 
AHSV infected cells. Staining of Culicoides guts with anti-tubulin, WGA or phalloidin 
did not consistently succeed in outlining the margins of individual cells but the 
"biological negative control" (Figure 6-9) detected no VP7 crystals in C. nubeculosus 
guts. This shows that the presence of these crystals in Culicoides guts is a sign of AHSV 
replication, rather than an indicator of residual virus protein from the infectious blood 
meal. The location of the VP7 crystals in the insect wall of Figure 6-8 also supports the 
view that that these crystals are produced during virus replication in the gut cells and 
are not due to the presence of degraded virus particles in the gut lumen (following oral 
infection) or the haemocoel (following IT inoculation). 
Assessment of anti-NS3/3a antibodies 
Immunofluorescence microscopy in KC cells revealed no significant differences 
between AHSV-infected and uninfected cells when analysed with the NS3-antipeptide 
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antibodies (PAb-R1 and -R2, -G1 through -G5) or PAb-SA. 
It is possible that the target 
region of these antibodies is an internal structure and is thus not available for antibody 
binding unless the protein is denatured. Western blot analysis of these antibodies 
showed bands at approximately 25 kDa (the size of NS3/3a, figures not shown) but 
proved inconclusive due to the simultaneous presence of several other bands in infected 
and uninfected cells, suggesting cross-reaction of the antibody with cellular proteins. 
Binding of the antibodies to both nuclear and cytoplasmic structures of infected and 
uninfected cells in immunofluorescence studies also suggest the presence of cross- 
reaction between NS3-antipeptide antibodies and cellular proteins. 
Labelling of AHSV-infected KC cells with PAb-1-117 revealed filamentous 
structures that were not present in uninfected control cells. However, the role of NS3/3a 
as a cell membrane protein does not easily explain this finding. Western blot analysis of 
KC cells with this antibody showed binding to an NS3/3a-sized protein in infected, but 
not in uninfected cells, suggesting that it does bind to NS3/3a. The binding of the 
antibody to 15 kDa and 45 kDa proteins in infected and uninfected KC cell lysates 
suggests the presence of cross-reactions of the antibody with cellular proteins. These 
cross-reactions might not occur to the same extent in immunofluorescence microscopy 
since some of the antigenic sites may only be accessible to the antibody in denatured 
proteins. The size of the bigger cellular protein interacting with PAb-1-117 in Western 
blot analysis suggests that this protein could be actin, which is an important part of the 
cytoskeleton. If this is the case then the structures seen in infected cells would suggest 
that infection with AHSV leads to the formation of so called actin stress fibres. 
Susceptibility of Culicoides midgut cells to AHSV infection from the luminal and the 
abluminal side 
The absence of VP7 crystals in C. nubeculosus midguts following oral ingestion 
of AHSV-8wt or AHSV-6wt (Table 6-2, page 139) strongly suggests that virus 
replication does not take place in C. nubeculosus midgut cells even at a level too low to 
be detected with the virus infectivity assay. It is therefore likely that the failure of C. 
nubeculosus to become orally infected with AHSV is due to a failure of the virus to 
enter and replicate in the midgut cells. In combination with the absence of infection 
from the abluminal side in the same species, these data suggest that C. nubeculosus 
midgut cells are resistant to infection with AHSV. Whether the midgut cells prevent the 
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virus from entering or permit virus entry but not replication, remains unanswered. The 
failure of C. nubeculosus midgut cells to become infected from the abluminal side sets 
this refractory insect species apart from both the VC and the NVC colonies of C. 
sonorensis. The fact that the midgut cells of both C. sonorensis colonies could be 
readily infected from the abluminal side suggests fundamentally different mechanisms 
underlying the very low susceptibility (reflected by 0 oral infection rates in the extreme) 
of some populations of essentially vector-competent species (e. g. the NVC C. 
sonorensis colony) and the resistance of non-vector species such as C. nubeculosus. 
The ability of AHSV-6wt to infect C. sonorensis midgut cells from the 
abluminal side shows that both laboratory colonies of this species, irrespective of oral 
susceptibility to AHSV, possess AHSV receptors on the abluminal side of their midguts. 
This result supports the view that it is possible for AHSV particles to spread from one 
midgut cell to another via the haemocoel, as has been suggested in chapter 4. It also 
supports the opinion that selection of the VC and NVC C. sonorensis colonies did not 
affect the abluminal cell membrane (representing the MIEB). Furthermore, the 
replication of AHSV-6wt in C. sonorensis midgut cells following IT inoculation shows 
that the failure of AHSV-6wt to infect these cells from the gut lumen represents a failure 
of the virus to enter the cell. This is most likely due to an inability of this virus strain to 
utilise the same receptors used successfully by other virus strains, such as AHSV-8wt 
and AHSV-A79. 
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7 Growth characteristics of AHSV in C. sonorensis (KC) cells 
7.1 Introduction 
The earlier parts of the present work showed that variation in AHSV genome 
segment 10 can affect oral infection rates in the model vector species C. sonorensis 
(chapter 4) and the field vector species C. imicola (chapter 5). The identity of segment 
10 was also shown to have an effect on AHSV dissemination through the body of C. 
sonorensis, thus affecting vector competence (chapter 4). These data were obtained 
using the reassortant virus pair AHSV-A790 and AHSV-A79. The two viruses were 
originally produced by co-infection of BHK-21 cells with the parent virus strains 
AHSV-3att and AHSV-8wt (O Hara, 1994). AHSV-A790 shares segments 1-6 and 8 
with AHSV-8wt and segments 7,9 and 10 with AHSV-3att. AHSV-A79 shares 
segments 1-6,8 and 10 with AHSV-8wt and segments 7 and 9 with AHSV-3att (OHara, 
1994). AHSV-A790 and AHSV-A79 therefore only differ in genome segment 10. 
The first aim of this chapter was to acquire preliminary data to establish whether 
the different oral infection rates and dissemination rates in vector insects with the two 
reassortants could be based on differences in virus release rates from the host cells. 
Experiments with BTV VLPs in baculovirus expression systems indicate that NS3/3a 
(encoded by genome segment 10) is essential for virus exit from insect cells (Hyatt et 
al., 1993). The presence of ubiquitin-ligase recruiting motifs in AHSV NS3/3a also 
suggests a role for this protein in virus exit from the cell (section 3.2.3, page 72). These 
motifs have been found to be essential in several retroviruses for budding to take place 
(Strack et al., 2000). Since budding is the principal orbivirus exit mechanism in C. 
sonorensis (KC) insect cell culture (Fu, 1996) and this cell line is closely related to the 
model vector insects used in chapters 4 and 6, KC cells were used in this study. They do 
not undergo lysis or show CPE when infected with AHSV or related orbiviruses. 
The second aim of the work described in this chapter was to verify whether 
AHSV-6wt replicates in KC cells. This virus strain has been routinely grown in 
mammalian (BHK-21) cells but C. sonorensis and C. imicola have been found to be 
refractory to infection with this virus by the oral route (Wittmann, 2000). It did, 
however, infect two C. bolitinos (equalling 2% IR) by the oral route, and replicated in 
C. sonorensis following IT inoculation. 
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To address the stated aims, two experiments were carried out. In the first 
experiment, growth curves were generated, analysing the titres of the two reassortant 
viruses and their two parent strains in KC tissue culture supernatants. In the second 
experiment, flasks of KC cells were infected with one of the four virus strains, or with 
AHSV-6wt. The amount of virus that was retained intracellularly or released into the 
supernatant was measured in each case and used to calculate the proportion of virus 
released from the cells at each time point. 
7.2 Methods 
AHSV growth curves in KC tissue culture supernatant 
Four 25 cm2 tissue culture flasks, containing confluent monolayers of KC cells, 
were each infected with 4.25 1og10TCID50/ml supernatant (7 ml) of one of AHSV-3att, 
AHSV-A790, AHSV-A79 or AHSV-8wt. The virus was gently removed after 1h and 
replaced with an equal volume of tissue culture medium. The flasks, each containing 7 
ml of tissue culture supernatant, were incubated at 29±1 °C and 200 µl supernatant from 
each flask was removed at regular intervals. These intervals progressively increased 
from initially 2h to over 24 h at the end of the six day experiment. The samples were 
stored at -70°C and later assayed using the virus infectivity assay described in section 
2.2.4 (page 52). 
Linear regression was carried out for the exponential part of some virus growth 
curves (0-84 h pi). 95% confidence intervals were calculated from the standard errors of 
the regression and plotted with the regression lines. This allowed comparison of the 
speeds at which virus strains accumulated in the supernatant. The limitations of the data 
obtained and the consequences of this for the data interpretation are discussed in section 
7.4 (page 152). 
Retention and release of AHSV from KC tissue culture 
25 cm2 tissue culture flasks, containing confluent KC cell monolayers, were 
infected with one of five virus strains. These were the reassortant and parent virus 
strains used in the experiment described above and AHSV-6wt. Each strain was used to 
infect four flasks with 3 log1OTCID50 of virus each. Virus-containing supernatant was 
removed after 1h and replaced as described above. The infected flasks were incubated 
145 
at 29±1°C. One flask of each strain was removed at 3,24,48 and 120 h post infection. 
Flasks did not show an obvious increase in cell numbers over this time period. The 
supernatants were carefully removed to avoid detaching cells from the cell sheet. 
Supernatants were then centrifuged for 5 min at 700 g to remove cells and cell debris. 
They were stored at -70°C until assayed for AHSV. The cell sheet was rinsed carefully 
with PBS three times to remove remaining supernatant, suspended in a volume of tissue 
culture medium equal to that of the removed supernatant (7 ml) and sonicated for one 
minute to break up the cells and release intracellular virus particles. Samples were then 
stored at -70°C until assayed. Absolute amounts of intracellular and extracellular virus 
(per flask) were calculated from the measured virus concentrations and the volumes of 
tissue culture medium used. The total amount of virus synthesised in each tissue culture 
flask was calculated from the absolute amounts of intra- and extracellular virus. These 
values were used to determine the proportions of synthesised virus released into the 
supernatant with each virus strain. 
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7.3 Results 
AHSV growth curves in KC tissue culture supernatant 
Table 7-1: Titres of four AHSV strains in KC tissue culture supernatant 
Hours post AHSV titre (1og, oTCIDj/m1) 
infection 3att A790 A79 8wt 
0 4.25 4.25 4.25 4.25 
2 4.25 4.0 4.25 4.5 
4 4.0 4.5 4.5 4.5 
6 4.25 4.25 4.25 4.5 
8 4.5 4.75 4.75 4.5 
10 3.75 4.5 5.0 4.5 
12 4.0 4.5 4.75 4.5 
14 4.25 4.5 5.25 4.75 
18 4.5 5.0 5.25 4.5 
22 4.5 4.75 5.5 5.0 
26 4.75 4.75 5.75 5.25 
30 4.75 5.0 5.75 5.5 
34 4.75 5.0 6.0 5.75 
38 5.0 5.25 6.0 6.0 
42 5.25 5.25 6.25 6.25 
46 5.0 5.5 6.25 6.0 
50 5.25 5.25 6.0 6.5 
54 5.25 5.25 6.25 6.75 
58 5.5 5.75 6.5 6.75 
62 5.5 5.75 6.5 7.0 
66 6.0 6.0 6.75 7.0 
70 6.5 6.25 7.0 7.25 
74 7.25 6.5 7.25 7.75 
78 6.75 6.5 7.5 8.0 
82 6.75 7.0 7.5 8.0 
104 7.5 7.0 7.75 7.75 
146 7.25 7.25 8.25 8.5 
Four 25 cm2 tissue culture flasks, containing confluent monolayers of KC cells, were infected with 
4.25 (7 ml) 1og10TCID50/ml of one of AHSV-3att, AHSV-A790, AHSV-A79 and AHSV-8wt. The 
flasks were incubated at 29±1°C. The supernatant from each flask was sampled at regular intervals 
and assayed for AHSV by virus infectivity assay.. 
The development of virus titres from 0 to 146 hours pi in tissue culture 
supernatant is shown in Table 7-1 and illustrated in Figure 7-1 (page 148). The four 
curves suggest that virus growth was exponential until about 84 hours pi when it began 
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to plateau. AHSV-A79 and AHSV-8wt reached end titres approximately 1 
1og10TCID50/ml higher than those reached by the other two virus strains. No viral 
eclipse was observed. Linear regression was carried out for the exponential growth 
period from 0 to 84 hours pi (Figure 7-2 top, page 149). Figure 7-2 (bottom) shows 95% 
confidence intervals for the regression lines. The equations for the regression lines and 
their confidence intervals are also included. Figure 7-2 shows that, in this experiment, 
the two reassortant viruses accumulated in KC tissue culture supernatant at significantly 
different speeds. 
Figure 7-1: Growth curves of four AHSV strains in KC cell tissue culture 
supernatant 
Four 25 cm2 tissue culture flasks, containing confluent monolayers of KC cells, were infected with 4.25 
log10TCID50/ml (7 ml) of one of AHSV-3att, AHSV-A790, AHSV-A79 and AHSV-8wt. The flasks were 
incubated at 29±1°C. The supernatant from each flask was sampled at regular intervals and assayed for 
AHSV by virus infectivity assay. 
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Figure 7-2: Linear regression for two reassortants (top) and their regression lines 
with 95% confidence intervals (bottom) 
X: time (hours) 
Y: virus titre (log10TCID5(Vml) 
Tissue culture flasks containing confluent monolayers of KC cells were infected with 4.25 
log, 0TCID50Jml supernatant of AHSV-A790 or AHSV-A79 and incubated at 29±1°C. 
The supernatant 
from each flask was sampled at regular intervals and assayed for AHSV. Regression lines and their 95% 
confidence intervals were calculated. 
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Retention and release of AHSV from KC tissue culture 
The results in Table 7-2 show that the five AHSV strains replicated to final 
supernatant titres between 6.35 (AHSV-A790) and 8.35 (AHSV A79)1og10TCID50/flask 
(a 100-fold difference between these virus strains). Final titres of intracellular virus 
ranged from 6.35 (AHSV-A790) to 8.1 (AHSV-A79) 1og10TCID50/flask (a 56-fold 
difference). The growth curves for released and intracellular virus are illustrated in 
Figure 7-3 (top, page 151). Growth curves for total virus (calculated from supernatant 
and intracellular virus) are also shown (Figure 7-3, bottom). Figure 7-3 illustrates that, 
in this experiment, AHSV-A79 reached higher intra- and extracellular titres than AHSV- 
A790 and that the absolute replication level of AHSV-A79 was also higher than that of 
AHSV-A790. Figure 7-3 also shows that AHSV-6wt replicates in KC cells. Titres of 
AHSV-6wt were all within the range established by the other virus strains. 
Since the intracellular and extracellular virus titres are functions both of virus 
replication levels and virus release efficiency, Figure 7-3 does not clarify whether the 
observed differences between the virus strains indicate a difference in the efficiency of 
virus release from the cell. Quantities of released virus are therefore illustrated as 
proportions of the total virus titre in Figure 7-4 (page 152). The figure shows that virus 
release into the supernatant was more efficient in AHSV-A79 than in AHSV-A790 at all 
four time points, but especially so at 24 and 48 h post infection. Values for the parent 
virus strains are included for comparison. 
Table 7-2: AHSV release from and retention in KC insect cells 
Hours post AHSV released into supernatant/retained intracellularly/sum (1og, oTCIDSwflask) 
infection 
Satt A790 A79 8wt 6wt 
0 3.0143.0 3.0/-/3.0 3.0/-/3.0 3.0/-/3.0 3.0/-/3.0 
3 3.35/2.6/3.42 2.6/2.35/2.79 3.1/2.6/3.21 2.6/1.85/2.67 2.35/2.35/2.65 
24 4.35/5.1/5.17 3.1/3.6/3.71 5.35/3.85/5.36 4.85/4.35/4.96 4.6/4.35/4.79 
48 5.1/6.1/6.14 4.1/4.1/4.4 8.1/7.35/8.17 6.35/5.85/6.46 5.35/5.35/5.65 
120 7.35/7.1/7.54 6.35/6.35/6.65 8.35/8.1/8.54 7.85/7.6/8.04 7.35/7.35/7.65 
150 
Supernatant 
1og10TCID50/flask 
10 
8 
6 
4 
2 
0 
1og10TCID50/flask 
10 
8 
6 
4 
2ý 
o ý__. _ý_ ___ __, __. _________ 
Supernatant + cells 
Iog10TCID50/flask 
10-1-- 
8 
6 
4 
2 
0 
-*- A790 
--ý- A79 
8wt 
3att 
6wt 
Figure 7-3: AHSV release from KC cells (top left), intracellular retention (top 
right) and total virus synthesised (bottom) 
Confluent KC cell monolayers in 25 cm2 tissue culture flasks were infected with 3 1og10TCID50 AHSV 
(one of AHSV-A790, AHSV-A79, AHSV-8wt, AHSV-3att or AHSV-6wt). Four flasks per virus strain 
were incubated at 29±1°C and 1 flask per virus strain was removed at 3,24,48 and 120 h post 
infection. The supernatants were removed and centrifuged for 5 min at 700 g, then stored at -70°C 
until assayed for AHSV. The cell sheet was rinsed with PBS 3 times, suspended in a volume of tissue 
culture medium equal to that of the removed supernatant (7 ml) and sonicated for one minute to break 
up the cells and release intracellular virus particles. Samples were then stored at -70°C and later 
assayed. Supernatant and intracellular virus quantities per flask were calculated from the measured 
concentrations and the volume used. Total virus quantities were calculated from extracellular and 
intracellular virus quantities. 
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Figure 7-4: Release of synthesised virus into KC tissue culture supernatant 
for two reassortants and their parent virus strains 
Confluent KC cell monolayers in 25 cm2 tissue culture flasks were infected with 3 log10TCID50 
AHSV (one of AHSV-A790, AHSV-A79, AHSV-8wt or AHSV-3att). Four flasks per virus strain 
were incubated at 29±1°C and 1 flask per virus strain was removed at 3,24,48 and 120 h post 
infection. The supernatants were removed and centrifuged for 5 min at 700 g, then stored at -70°C 
until assayed for AHSV. The cell sheet was rinsed with PBS 3 times, suspended in a volume of 
tissue culture medium equal to that of the removed supernatant (7 ml) and sonicated for one minute 
to break up the cells and release intracellular virus particles. Samples were then stored at -70°C and 
later assayed. Supernatant and intracellular virus quantities per flask were calculated from the 
measured concentrations and the volume used. Total virus quantities were calculated from 
extracellular and intracellular virus quantities. 
7.4 Discussion 
In the first experiment described in this chapter, AHSV-A79 accumulated in KC 
tissue culture supernatant faster and reached higher titres than AHSV-A790. Due to time 
constraints, the experiment was carried out with one flask per virus strain only. 
Consequently, only one measurement existed for each time point and there was no 
indicator of the degree of natural variation in the growth curves (i. e. it is unknown how 
much virus titres in duplicate flasks would have diverged from the presented results). 
Analysis of these data must therefore be based on the assumption that the recorded data 
represent the true values, i. e. duplicate experiments would have registered exactly the 
same results. This would in all likelihood not be the case. Therefore, the statistically 
significantly different regression lines between the two reassortant virus strains (Figure 
7-2, page 149) apply to the described experiment only and may not be confirmed on 
more intensive study. However, the similarity of the shown results with those of the 
second experiment (Figure 7-3) and with previous observations (when growing AHSV 
strains in KC cells for other purposes, results not shown) suggest that the results are 
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representative and based on a real phenomenon. This should be verified by further 
work, carried out with four to five replicate flasks per virus strain. The sensitivity of 
such an experiment to variation between virus strains could also be enhanced by 
increasing the number of replicate wells used in the virus infectivity assay (section 
2.2.4, page 52) from four to, say, ten wells per sample. This would reduce the lowest 
measurable difference between two virus titres from 0.25 log10TCID50/ml to 0.1 
log10TCID50/ml. 
In the second experiment, AHSV-A79 again replicated faster and to higher titres 
than AHSV-A790. Ratios between released and intracellularly retained virus quantities 
allow speculation that AHSV-A79 possesses a more effective release mechanism than 
AHSV-A790 and such a finding could explain the higher infection and dissemination 
rates with AHSV-A79 in Culicoides vector insects (chapters 4 and 5). However, the 
limitations described for the first experiment of this chapter also apply here. 
Additionally, derivation of decimal numbers for calculation of ratios from values that 
were measured on a logarithmic scale makes these ratios extremely sensitive to 
variations in the measured (logarithmic) titres. 
Variation in genome segment 10 may affect AHSV growth curves in two ways. 
Firstly, an increased rate of virus escape from the host cell will aid rapid virus spread 
through the tissue culture and accelerate the infection of all susceptible cells in the flask. 
Secondly, a more efficient virus release mechanism will enhance superinfection of 
(already infected) cells, thus making these cells more productive (Hyatt et al., 1989). 
Progeny virus particles cannot replicate while being retained in the cell since the 
possession of outer capsid proteins VP2 and VP5 renders them inactive (section 1.2.4, 
page 30). 
It can only be speculated which structural differences between the NS3/3a 
proteins of the reassortant virus strains could be responsible for the differences seen in 
the two experiments described in this chapter. NS3/3a's of AHSV-A79 and AHSV-A790 
possess an identical ubiquitin ligase recruiting motif in the same position. Differences in 
this motif could affect virus budding from host cells (Strack et al., 2000), although it has 
not yet been shown to be active in orbiviruses. The two virus strains differ in 
myristylation (membrane anchoring) motifs and may also differ in their transmembrane 
configuration (section 3.2.3, page 72). Differences in membrane anchors could result in 
different efficiencies of membrane targeting while different transmembrane 
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arrangements could expose or obscure yet unidentified protein domains from interaction 
with other viral or host cell proteins. Alternatively, differences between the reassortants 
may result from other, yet unidentified motifs. The discovery of further, function- 
defining motifs in NS3/3a is not unlikely since its mode of action has not yet been 
defined. 
The second experiment described in this chapter also shows that AHSV-6wt 
grows to high titres in the C. sonorensis-derived KC cell line. This virus also replicates 
in the BHK-21 cells used in all virus infectivity assays. This rules out the hypothesis 
that AHSV-6wt may be defective and for this reason is unable to infect C. sonorensis or 
C. imicola by the oral route. Such a hypothesis also seems unlikely in light of the 
finding that AHSV-6wt replicates in C. sonorensis following IT inoculation (section 
4.3.4, page 97). The present result supports the suggestion that this virus strain is unable 
to penetrate the midgut infection barriers of its potential vector species. This may be 
caused by a different VP2, which may require a different cell surface receptor to other 
AHSV strains tested. This receptor would be absent on the luminal surface of the C. 
sonorensis midgut cells, but present on their abluminal surface and on the surface of KC 
tissue culture cells. Appropriate receptors for the binding of VP2 of AHSV-6wt might 
be present on the luminal midgut cell surface of other Culicoides populations/species, 
allowing them to become infected and act as vectors. 
AHSV-A790 and AHSV-3att possess the same segment 10 and the virus pair 
AHSV-A79 / AHSV-8wt are also identical in this genome segment. Therefore, it might 
seem logical to expect similar results (in both of the described experiments) for these 
respective virus pairs. However, these viruses differ in several other genome segments, 
which may also have an effect on virus titres through their role in host cell infection, 
virus replication, packaging etc. 
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8 Conclusions and future work 
8.1 Summary of Conclusions 
" Variation in AHSV NS3/3a affects oral infection rates with the virus in the model 
vector C. sonorensis and the field vector C. imicola. It also affects disseminated- 
infection rates in C. sonorensis. These findings illustrate the potential of NS3/3a 
variation to have an effect on AHSV transmission in the field. 
" Variation in AHSV NS3/3a affects the virus dissemination from midgut cell to 
midgut cell, and from the midgut cells into the haemocoel of C. sonorensis. 
9 Differences in membrane association of NS3/3a variants could be responsible for 
the different biological properties of the two reassortant viruses AHSV-A79 and 
AHS V A790. 
0 The original selection process for C. sonorensis vector competence for AHSV was, 
at least in part, a selection for successful interaction with an a-group NS3/3a. It led 
to increased insect susceptibility to at least one other AHSV strain with an a-group 
NS3/3a. 
" The C. sonorensis mesenteronal infection barrier to AHSV is insect- and virus- 
defined. It can be modified by insect selection for and against vector competence. 
" The C. sonorensis mesenteronal escape barrier to AHSV is mainly virus-defined 
and is not affected by insect selection for and against vector competence. 
" Midgut cells of an insect belonging to a C. sonorensis colony with low vector 
competence will usually replicate AHSV if infection takes place from the abluminal 
midgut membrane. Conversely, midgut cells of the non-vector species C. 
nubeculosus do not replicate AHSV under these conditions. This qualitative 
difference could be used to differentiate between potential vector species and non- 
vector species of AHSV and, potentially, other orbiviruses. 
0 Heavily attenuated AHSV strains can infect their field vectors C. imicola and C. 
bolitinos. This raises the question whether live attenuated virus vaccines may also 
be able to infect Culicoides insects, which could lead to virus spread, reversion to 
virulence and reassortment with field virus strains. 
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8.2 AHSV NS3/3a affects virus dissemination in Culicoides biting midges 
Chapter 4 showed that the identity of AHSV NS3/3a significantly affects oral 
infection rates with the virus in C. sonorensis insects. Similarly, variation in this protein 
affected oral infection rates in the main field vector C. imicola. These findings 
demonstrate that NS3/3a can have a major effect on the spread of AHSV, and, therefore, 
the epidemiology of AHS. By implication, the large extent of variation in this protein 
may, in combination with reassortment, be an important factor in virus evolution and 
adaptation to insect vector populations and species. 
The possible role of variation in AHSV NS3/3a in virus adaptation to different 
insect vectors begs the question why similar degrees of variation have not been found in 
NS3/3a's of other Orbivirus species. The apparent lack of variation may, in part, be 
explained by the limited amount of sequencing data available for these viruses. 
Additionally, the life cycles of orbiviruses remain relatively poorly understood and these 
viruses may vary in their precise cell exit mechanisms. 
Analysis of infection rates and disseminated-infection rates in orally infected C. 
sonorensis showed that NS3/3a affects virus dissemination from one midgut cell to 
another in the VC colony only, while it had an effect on virus dissemination from the 
midgut to the haemocoel in both the VC and the NVC colonies. The most logical 
explanation for the different effects of variation in NS3/3a in the two colonies would be 
that the AHSV-9 that was used in the original selection process for vector competence, 
possesses a type of segment 10 similar to the one found in AHSV-8wt and AHSV-A79 
(the virus strains which achieved high infection rates in the VC colony). The results of 
sequencing work carried out previously in the Orbivirus group confirm that the AHSV-9 
used in the selection process possesses an a-group segment 10, as do AHSV-8wt and 
AHSV-A79 (accession number AJ007308, Martin et al., 1998). This means that the 
original selection of the VC colony was, at least in part, a selection for an a-group 
NS3/3a. 
It appears likely that virus spread within the midgut (which modified vector 
competence) of a Culicoides insect is affected by a factor (e. g. a protein) that is unique 
to the vector-competent colony and interacts with AHSV NS3/3a. This hypothetical 
factor does not interact equally efficiently with all types of this viral protein. The 
molecular basis of how variation in NS3/3a affects virus dissemination through the 
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insect vector remains unclear, but analysis of the two reassortant virus NS3/3a protein 
sequences showed possible differences in their transmembrane configuration. They also 
differed in some myristylation (membrane anchoring) motifs. 
Future work should concentrate on the exploration of these protein regions since 
this could help to establish the mode of action of NS3/3a. It could also shed light on the 
nature of virus dissemination barriers in the insect vector (see below). In the absence of 
virus rescue systems, approaches could include the mutation of the two NS3/3a variants 
and their expression in baculovirus expression systems (for more detailed suggestions, 
see page 79). Such an approach could verify the significance of the potential 
myristylation motifs in which the two reassortant NS3/3a proteins differ. In addition, 
mutation of AHSV NS3/3a transmembrane regions has been shown to affect 
cytotoxicity (van Niekerk et al., 2001a) and could thus be used to verify the suggested 
differences in membrane configuration between the two reassortant virus NS3/3a's. 
8.3 Midgut barriers to AHSV dissemination in Culicoides insects 
Analysis of infection rates and disseminated-infection rates in the VC and NVC 
colonies of C. sonorensis indicated that selection of these colonies for and against 
vector competence for AHSV resulted primarily in a modification of the virus ability to 
infect and colonise the insect midgut (MIB), while the abluminal midgut cell membrane 
(representing the MEB) remained essentially unchanged. The latter finding was 
supported by the observation that the midguts of both C. sonorensis colonies can be 
infected from the abluminal side (following IT inoculation) equally well. This is in 
contrast with the midgut cells of the (orally refractory) C. nubeculosus, which did not 
replicate AHSV following attempted infection from either the luminal or the abluminal 
midgut membrane (chapter 6). 
In summary, midgut dissemination barriers of Culicoides vector species can be 
characterised as follows: 
1) The MIB is insect- and virus-defined. It can be modified by selection for 
and against vector competence. This shows that the Miß is, at least partly, genetically 
defined. AHSV ability to overcome the Miß is modified by virus protein NS3/3a. This 
modification apparently controls the efficiency of virus dissemination from one midgut 
cell to another. 
157 
2) The MEB is mainly virus-defined and not affected by selection for or 
against vector competence. It is modified by NS3/3a. Virus strains that disseminate well 
within the midgut also disseminate more successfully from the midgut into the 
haemocoel. 
3) There is a qualitative difference between populations of potential vector 
species with low vector competence (e. g. C. sonorensis NVC colony) and non-vector 
species (e. g. C. nubeculosus): Midgut cells of an insect belonging to a vector species 
will usually replicate AHSV if infection takes place from the abluminal midgut 
membrane, while midgut cells of a non-vector species insect seem unable to do so. The 
absence of AHSV replication in midgut cells of the non-vector species C. nubeculosus 
indicates that either these cells are intrinsically unable to replicate the virus, or that the 
abluminal membrane of the midgut cells cannot be penetrated by AHSV. Since other C. 
nubeculosus cells are capable of replicating AHSV (section 4.3.4, page 97), the latter of 
the two possibilities seems to be more likely. The abluminal side of the midgut cells is 
covered by the basement lamina, which, in C. nubeculosus, may not possess suitable 
receptors for the attachment and penetration of AHSV particles. 
The described difference between C. sonorensis (NVC) and C. nubeculosus 
could potentially be used as a marker to assess the risk of AHSV transmission by 
Culicoides insects in regions threatened by outbreaks of AHS. The same difference may 
apply to the infection of Culicoides insects with other orbiviruses, such as BTV. This 
means that, if crystallisation of BTV VP7 could be shown to occur in insect cells, 
Culicoides populations could also be screened for their potential to transmit BTV. 
Future work should aim at identifying the genetically determined factor or 
factors in which the VC and the NVC Culicoides colonies differ. Since the VC colony 
appears to possess a factor which interacts with NS3/3a (chapter 4), it might be possible 
to identify such a factor by looking for proteins that interact with this NS3/3a in C. 
sonorensis midgut cells. Techniques could include immunoprecipitation, yeast-2-hybrid 
systems and GST fusion assays, using midgut cell lysates from the VC and NVC 
colonies and comparing the results between them. 
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8.4 Susceptibility of Culicoides field vectors to infection with attenuated AHSV 
strains 
Chapter 5 showed that heavily attenuated AHSV strains can infect their field 
vectors C. imicola and C. bolitinos. This causes concern about the safety of using live 
attenuated virus vaccines against AHSV and other orbiviruses, such as BTV. Potential 
risks include vaccine virus reassortment with wild-type virus strains in the mammalian 
host or insect vector, virus spread by the insect vector and reversion to virulence of 
vaccine virus strains. A further disadvantage of these vaccines is that they do not allow 
a distinction to be made between vaccinated animals and those that have been in contact 
with a field strain of the virus. 
While such risks may not matter much in endemic areas, where several virus 
strains circulate simultaneously and may reassort freely, they could undermine the 
success of disease control measures in non-endemic areas, which must be aimed at the 
eradication of the virus from the affected region. Examples include the AHS outbreak 
on the Iberian peninsula (1987-1990) and the recent outbreaks of BT in parts of 
southern Europe (since 1998). A more detailed risk analysis of AHS (and BT) live 
attenuated virus vaccines is therefore desirable and should include the assessment of 
commercially available vaccine strains for their potential to cause viraemia in the 
potential target species (horses, mules and donkeys). To assess their potential to revert 
to virulence, these virus strains could be subjected to multiple alternating passages in 
mammalian hosts and insect vectors. They should also be included in field-vector 
competence studies similar to the ones described in chapter 5. 
To avoid the risks of live attenuated virus vaccines, ideally only non-replicative 
vaccines should be used in non-endemic areas. These could include inactivated virus 
vaccines or subunit vaccines, which contain some or all structural proteins but no 
genome. A European Union project is currently working towards the development of 
such vaccines. 
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9 Appendix I: AHSV NS3 sequence alignment 
The following pages show the predicted protein sequences of the 
AHSV NS3 strains sequenced in this project, aligned to all other available 
AHSV NS3 protein sequences. Protein sequences obtained from databases are 
identified by their serotype (ST), followed by their TrEMBL or SwissProt 
accession number. NS3 isolates belonging to the a group are positioned on top 
(14 sequences), followed by ß group (12 sequences) and then y group (6 
sequences). Amino acid (aa) residues that are conserved across all isolates are 
highlighted black, residues conserved across the a group are highlighted 
yellow, residues conserved within the 0 group are turquoise and those 
conserved within the y group are pink. 
Potential glycosylation motifs are coloured red, ubiquitinase-binding 
motifs are green, myristylation binding motifs are blue and glycosaminoglycan 
binding sites are pink. The presence of these motifs does not indicate that they 
are active. The degrees of conservation in NS3, the motifs and possible 
membrane arrangements are discussed in chapter 3. 
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